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ABSTRACT 
RNA molecules have a high propensity in becoming kinetically trapped in misfolded, inactive 
conformations that have similar thermodynamic stability as the native fold. This is vastly due to 
the homogeneity in chemical composition of the four nitrogenous bases. To ensure native folding 
and biological activity, RNA species undergo post-transcriptional modifications (PTMs) while 
concomitantly associating with RNA-binding proteins. tRNAs are essential noncoding RNAs that 
are ubiquitously subject to PTMs and in constant interactions with various RNA-binding proteins. 
La proteins are a class of highly abundant RNA chaperones, characterized as the initial factors that 
contact pre-tRNAs. La proteins make sequence specific contacts to the UUU-3’OH ends of pre-
tRNAs as well as less specific contacts to the core body of tRNAs which is associated with the 
RNA chaperone activity function. La proteins function redundantly with tRNA PTM enzymes that 
are predicted to be influential in native pre-tRNA folding and N2, N2-dimethylation of G26 by the 
methyltransferase Trm1p is an example of such modification enzyme. La deletion in 
Saccharomyces cerevisiae (S. cerevisiae) is synthetically lethal when combined with deletion of 
Trm1p, presumably due to numerous G26 containing pre-tRNAs undergoing degradation due to 
structural instability. Whether La as an RNA chaperone selectively identifies such misfolded pre-
tRNAs from their folded counterparts has not been addressed. In this work, we demonstrate that 
like S. cerevisiae, La and Trm1p are essential for viability in Schizosaccharomyces pombe (S. 
pombe). We have identified G26 containing pre-tRNAs that benefit from the presence of Trm1p 
and/or S. pombe La (Sla1p) for their native steady state abundance and charging state. Using in 
vivo and in vitro assays we test the affinity of La as an RNA chaperone towards misfolded Trm1p-
hypomodified pre-tRNAs and their folded Trm1p-modified counterparts.  Our data indicates a 
nonspecific and transient nature of La in engaging misfolded and folded pre-tRNAs 
indiscriminately but specifically as processing intermediates. These findings signify the challenges 
that exist for RNA chaperones in resolving misfolded RNA structures with the inability to directly 
specify a binding determinant in these misfolded species. We also demonstrate that m""G26 on 
both mitochondrial and nuclear encoded-tRNAs may play a regulatory role on tRNA functional 
activity in translation, with the potential to directly regulate global protein expression levels and 
mitochondrial fitness. 
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CHAPTER I: Literature Review 
1. The RNA folding problem 
 
RNA molecules are central to many cellular processes and their biological functional role is linked 
to their three-dimensional complex structures. One of the earliest evidence for RNA structural 
conformation dominating its biological function was exemplified with tRNAs (1). In vitro studies 
identified multiple conformations for a single tRNA, in which only one conformer was 
aminoacylated and biologically active in translation (1). While some RNA molecules possess a 
single functionally active conformation other RNAs such as Riboswitches and RNA thermometers 
exist in two functionally active conformations that are dependent on cellular conditions (1). 
Evidence of structural conformation dictating RNA function has been demonstrated for numerous 
RNA substrates (1–3).  
Specifying a biologically active conformation for a single primary sequence of RNA is 
challenging given the simplicity of the building blocks of RNA. The chemical configuration of 
RNA consists of a polymer of ribonucleotides that have emerged from the covalent interactions 
between the four nitrogenous bases and the ribose sugar-phosphate backbone (2, 4). The purine 
and pyrimidine nitrogenous bases are vastly similar and are distinguished from one another only 
in the positioning of the carbonyl and amino groups. This results in the slow folding of the RNA 
and formation of multiple stable secondary structures that are biologically inactive (2, 4). 
Challenges in identifying a functionally active conformation is recognized as the RNA Folding 
Problem. Thermodynamic and kinetic resistance define the RNA folding problem. Firstly, RNA 
molecules develop multiple secondary structures that are thermodynamically stable and in 
competition with the native conformation (2). The thermodynamic challenge of the RNA folding 
problem lies within the ability of the biologically active conformation to outcompete the inactive 
intermediate species in thermodynamic stability. RNA molecules undergo several cycles of folding 
and unfolding for the search of the active conformation and often become kinetically trapped in 
long-lived misfolded conformations. The capacity to escape the kinetic folding trap defines the 
second RNA folding problem (1–3, 5).  
Free energy landscapes are used to identify the likelihood of a sequence of RNA to fold 
into its native conformation based on the relative energy differences of intermediate folds and the 
kinetic barriers in escaping these entrapments. The kinetic partitioning model recognizes that an 
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unfolded sequence of RNA can undergo various cycles of folding before the functionally active 
structure is formed, and in the process generating a population of RNA molecules that transition 
into the native fold efficiently and those that are slow-folding (6, 7). The kinetic partitioning model 
has been exemplified for the folding of Tetrahymena group I ribozyme using both in vivo and in 
vitro studies. In vitro folding of Tetrahymena group I ribozyme has been shown through Single 
Molecule FRET (Fluorescence Resonance Energy Transfer) experiments demonstrating that the 
folding of the ribozyme occurs with ~ 10% of the RNA folding directly into the native 
conformation, leaving ~ 90% of the ribozyme in search of the native fold, through several cycles 
of intermediate folds (6, 7). In vivo studies in S. cerevisiae have shown a similar partitioning 
pattern of the Tetrahymena group I ribozyme into active and misfolded transcripts shortly after 
synthesis. The escape from degradation relies on the efficient folding of the intron and subsequent 
splicing of these elements. The processing of the Tetrahymena group I intron is shown to be 
significantly more efficient in vivo than in vitro predictably due to the larger population of pre-
rRNAs that fold into the active state versus the misfolded conformation. The increase in efficiency 
in folding of Tetrahymena intron in yeast in comparison to in vitro studies has been linked to the 
availability of RNA-binding proteins that refold misfolded species (7, 8). 
Other examples of in vivo and in vitro RNA folding studies include splicing of the T4 phage 
thymidylate synthase intron. The catalytic activity of the RNA relies on the correctly folded tertiary 
structure which is dependent on the efficient splicing of the group I intron. Splicing factors enforce 
correct folding of the group I intron in vivo, allowing for efficient splicing. Conversely, in vitro 
splicing of T4 phage td intron is inefficient due to the absence of splicing factors and the 
accumulation of misfolded, splice-defective conformations (9). Previous findings have also 
indicated that in addition to splicing factors, the ribosome also enhances folding of group I intron 
and that translation of the T4 phage thymidylate synthase intron relieves misfolding in vivo (7, 9). 
While numerous examples of RNA folding problems have been reported in vitro, many of these 
RNAs fold more efficiently in vivo (7). RNA folding is better modulated in vivo through a plethora 
of RNA molecule interacting partners that facilitate RNA folding. In vivo, RNA molecules may 
be engaging small ions, bound by small ligands or associating with various classes of RNA-binding 
proteins (1). These proteins coordinate RNA folding by decreasing the propensity of misfolding 
while resolving kinetic and thermodynamic barriers. Some examples of proteins that assist RNA 
folding include RNA chaperons, RNA helicases, and specific RNA binding proteins (7).   
 3 
1.1 RNA binding proteins resolve the RNA folding problem  
1.1.1 RNA chaperones  
	
RNA molecules are almost invariably associated with one or more proteins in vivo with majority, 
if not all RNA-facilitated reactions involving a protein cofactor. RNA chaperones are a class of 
RNA-binding proteins that resolve the RNA folding problem (5). These proteins are 
multifunctional and are essential in numerous cellular processes such as RNA export, 
ribonucleoprotein (RNP) assembly, regulation of transcription and translation as well as virus 
replication (7). Ranging from distinct groups of families of proteins, it has been challenging 
identifying a uniform mechanism that RNA chaperones employ in targeting their substrates. One 
distinct commonality amongst these proteins is their capacity to engage their targets non-
specifically through weak electrostatic interactions in the absence of external energy such as ATP 
(adenosine triphosphate) hydrolysis (6, 7). In accordance with the kinetic partitioning model, RNA 
substrates that have a low partitioning factor (high probability of folding incorrectly) are subject 
to several cycles of remodeling by RNA chaperones to fold into their native functionally active 
state (6). In the absence of external energy, RNA chaperones assist RNA remodeling by taking 
advantage of the differences in the free energy between the unfolded, intermediate and native state 
of the RNA. RNA chaperones are thought to associate with single stranded RNA more readily than 
double stranded RNA and support unfolding by tightly and transiently engaging these regions (1). 
This interaction results in the destabilization of the misfolded-intermediate fold as well as the 
decrease in the free energy state between the intermediate and native fold. In this way, the folding 
of the RNA into the native conformation is driven by the factor that the formation of the native 
RNA is more thermodynamically favoured than the chaperone-bound RNA complex (1). This will 
encourage the release of the RNA chaperone from the newly folded intermediate state into a 
chaperone-free RNA that is functionally active (Figure 1) (6). Previous studies have indicated the 
importance in weak and transient interactions between RNA chaperones and their targets. StpA is 
a recognized RNA chaperone identified in E. coli (Escherichia coli). Mutations generated in this 
RNA chaperone that diminish the RNA binding capacity of the protein, displayed better RNA 
chaperone activity compared to wildtype StpA. This emphasizes the idea that RNA chaperones 
transiently associate with unfolded RNA species and once the RNA is folded, they must be released 
onto their next target (7).  
 4 
The second common element amongst proteins with RNA chaperone activity is the propensity of 
these proteins possessing highly disordered regions, rich in amino acids that favor disorder over 
an ordered configuration such as Ala, Arg, Gly, Gln, Ser, Pro, Glu and Lys. These disordered 
regions are predicted to facilitate the lack of substrate specificity that these proteins possess and 
models have been proposed in which the disordered regions become ordered upon interaction with 
RNA targets (7, 10) (Figure 2). While in vitro RNA chaperone activity assays have led to the 
identification of numerous proteins that are accredited as RNA chaperones, it has been nonetheless 
challenging verifying and studying the RNA chaperone activity of such proteins in vivo. The 
nonspecific nature of these proteins allows for multiple chaperones to facilitate the folding of the 
same RNA substrate therefore eliminating the opportunity for a visible phenotype in the absence 
of a specific chaperone (3). 
 
 
               
Figure 1. Hypothesized RNA folding model facilitated by RNA chaperones. Folding pathway and 
free energy barrier schematic illustrating the unfolding and refolding of a misfolded secondary 
structure of an RNA to a correct secondary and tertiary structure in the presence (dotted line) and 
absence (solid line) of an RNA chaperone. For simplicity only one incorrect 2° structure is 
represented. Figure adapted from (2). 
 5 
1.1.2 Examples of RNA chaperones 
Heterogeneous nuclear ribonucleoproteins (hnRNPs)   
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a class of RNA-binding proteins with 
RNA chaperone activity. hnRNPs, similar to other RNA chaperones have established roles in the 
cellular system and are ubiquitously active in gene expression with roles in transcription, 
translation, pre-mRNA processing and stability, RNA localization, export and RNA silencing (11). 
hnRNPs have 3 established RNA binding motifs: the arginine glycine boxes (RGG), RNA 
recognition motif (RRM), and K-homology (KH) motif (7, 11). The first evidence that these 
proteins harbor RNA chaperone activity was observed nearly 35 years ago where it was indicated 
that a fragment of hnRNP A1 protein (UP1) can renature an inactive tRNA Leucine. The same 
study also reported RNA chaperone activity of UP1 for renaturation of a misfolded 5S RNA (12). 
The idea that one protein can assist the renaturation of two distinct RNA substrates that differ in 
structure, gave rise to the proposition that single stranded regions on these RNAs could be the 
common factor for the UP1-mediated remodeling (12). Since these findings, further evidence of 
the RNA chaperone activity of hnRNPs has been reported with other RNA substrates (eg. 
hammerhead ribozyme) as well as studies demonstrating strand annealing activity of hnRNP A1 
for DNA and RNA which has been mapped to the C-terminal fragment of A1 (13, 14).  
StpA protein  
Another example of a well-recognized RNA chaperone is the E. coli derived StpA protein, first 
identified for its capacity to suppress a mutant of bacteriophage T4 thymidylate-synthase (td) gene 
that is defective in splicing (15–17). In accordance with the speculative mechanism for an RNA 
chaperone, StpA recognizes RNA nonspecifically and relies on weak and transient electrostatic 
interactions to unfold and restructure its bound RNA to a native conformation. An in vivo splicing 
assay has been used that takes advantage of the T4 thymidylate-synthase pre-mRNA inability to 
fold in the absence of translation to measure the RNA chaperone activity of StpA. The transient 
interaction between StpA and the T4 thymidylate-synthase gene allowed for the loosening of the 
tertiary structure and an opportunity for the RNA to search for the correct fold that favors splicing 
(16, 17). Restructuring and refolding of T4 thymidylate-synthase gene by StpA was possible only 
if wildtype or mutants that resembled the structural stability of the wildtype gene were used. 
Interestingly, mutants of the td gene that were structurally destabilized compared to wildtype were 
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sensitive to StpA as depicted by the decrease in splicing. These findings suggested that the 
structural stability of the RNA might dictate a positive or non-beneficial interaction between the 
chaperone and the RNA substrate, at least for what has been revealed for StpA (16, 17). 
 
 
Figure 2. Predicted model for RNA chaperone assisted RNA folding. (A) RNA chaperones (blue) 
associate with unfolded RNA, prevent misfolding and favor formation of the native structure. (B) 
Disordered regions in the RNA chaperones interact with a misfolded RNA and in this interaction, 
the transfer of energy resolves the misfolded RNA and orders the RNA chaperone. Upon folding 
of the RNA, the chaperone is no longer needed. Figure adapted from (10).  
 
Ribosomal proteins  
Protein synthesis relies on the complex assembly of the ribosome. Eubacterial ribosome biogenesis 
comprises of the assembly of the small and large subunit which consists of the 16S rRNA in a 
complex with over 20 proteins for the 30S small subunit and the interplay of the 23S rRNA and 
the 5S rRNA with over 30 ribosomal proteins which constitutes the 50S large subunit (9, 18). 
Large RNA substrates such as the 23S rRNA have the tendency to become kinetically trapped in 
inactive conformations (9, 19). Several examples of E. coli ribosomal proteins have been reported 
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harboring RNA chaperone activity. One of the first evidence of RNA chaperone activity was 
observed with E. coli S12 ribosomal protein that was catalytically active in a strand annealing and 
strand displacement activity in vitro in the absence of ATP (19). Other studies showed that 
ribosome biogenesis can occur efficiently in vitro with the presence of the rRNAs and ribosomal 
protein components, in the absence of added assistance from protein cofactors or RNA chaperones. 
This confirmed the notion that ribosomal proteins independently harbor RNA chaperone activity 
and can facilitate ribosome biogenesis (18). In vitro trans-splicing assay of the T4 thymidylate-
synthase gene was also used to test for the RNA chaperone activity of ribosomal proteins. At 37°C, 
where trans-splicing is inhibited in the absence of RNA chaperones, the addition of ribosomal 
protein enhanced splicing (18). Since these findings, other ribosomal proteins from the large 
subunit have been tested for RNA chaperone activity and of the 34 E. coli ribosomal proteins 
tested, a third of these proteins displayed RNA chaperone activity with the RNA chaperone activity 
of L1 ribosomal protein being conserved in Archaea, Bacteria and Eukarya (7, 18).  
Lupus autoantigen (La) protein   
Another well characterized RNA chaperone is the Lupus autoantigen protein (La) which is a 
ubiquitous RNA binding protein that is highly conserved and essential in higher eukaryotes, but 
can be deleted in fission and budding yeast (20–24). La proteins associate with both coding and 
noncoding RNA substrates and are involved in their processing and metabolism (20–24). The best 
characterized substrates of La are polyuridylate-containing RNAs, which consists of all 
polymerase III (pol III) transcripts (pre-tRNAs, pre-5S rRNA, pre-U6 snRNA etc.), and some 
polymerase II (pol II) substrates that terminate in UUU-3’OH such as U1, U2, U3, U4 and U5 
snRNAs found in yeast (20, 25). For poly U-tail containing RNA substrates, La association serves 
to protect these RNA transcripts from 3’ exonucleases and assists in their maturation. Aside from 
poly U-tail containing noncoding RNAs, La has also been shown to engage cellular (Bip and cyclin 
D1) and viral (poliovirus and Hepatitis C virus) mRNAs, either enhancing or inhibiting translation 
through mechanisms still under investigation and not in the scope of this review (20, 26–28). Some 
common features present in the mRNAs that La associates with include, internal ribosome entry 
sites (IRESs), terminal oligopyrimidine tracts (5’TOPs) and upstream open reading frames 
(uORFs) (20). The RNA chaperone activity of human La (hLa) has been shown using in vitro self-
splicing intron assay as well as confirmed with FRET based assays demonstrating strand annealing 
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and displacement activity for both human and Sla1p (29, 30). This activity has been mapped to the 
RRM1 and the adjacent a3-helix that is part of a highly conserved N-terminal domain of La 
proteins. Interestingly, mutants defective in RNA chaperone activity are also incapable of rescuing 
mutated, misfolded tRNAs in vivo as shown using a tRNA mediated suppression (TMS) assay 
(29). 
	
1.1.3 RNA helicases assist RNA folding 
 
RNA helicases are a well characterized class of RNA binding proteins that resolve the RNA 
folding problem. All proteins with helicase activity are apportioned to a class of helicase super 
families 1 through 4 which also includes proteins with DNA helicase activity (7). For the interest 
of this review, the focus in this section will be on some examples of RNA helicases that belong to 
superfamily 2 (SF2) such as DEAD-box, DEAH and the DExH RNA helicases (7, 31). The SF2 
RNA helicases all possess ‘RecA-like’ domains that have insertions with sites dedicated to ATP 
binding and hydrolysis as well as insertions for polynucleotide binding ((31), Figure 3). The two 
helicase domains are predicted to have an undefined orientation in the absence of ATP or nucleic 
acid binding and this is particularly noted for the DEAD-box proteins. Biochemical studies have 
suggested a cooperative relationship between ATP binding and nucleic acid association, 
specifically for the DEAD-box proteins which rely on nucleic acid binding for ATP hydrolysis 
(31, 32). Contrary to the DEAD-box proteins, DExH and DEAH proteins are active in ATP 
hydrolysis in the absence of nucleic acid binding. DEAD-box proteins are involved in many 
cellular processes such as translation initiation with eIF4A (eukaryotic initiation factor 4A) as an 
example (32). eIF4A assists in the preparation of the mRNA for the small ribosomal subunit by 
resolving RNA-duplex structures or by removing proteins that may be bound by the mRNA. Other 
DEAD-box proteins such as Ded1 and Vasa have also been identified to partake in translation 
initiation, but their exact roles are still under investigation. Studies in S. cerevisiae have identified 
15 DEAD-box proteins as well as 3 other RNA helicases that are involved in ribosome biogenesis 
(32). One possible role for these proteins in ribosome biogenesis is to resolve duplexes that are 
formed between snoRNA and rRNA, two rRNAs or resolving interactions between RNA-protein 
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complexes. Aside from the examples mentioned above, DEAD-box proteins are predicted to play 
essential roles in RNA decay and export, pre-mRNA splicing and transcription (32). 
	
	
 
Figure 3. Architecture of the SF2 helicases. DEAD-Box, DEAH and DExH of the SF2 helicases 
carry two helicase domains that are ‘Rec-A like’ (dark grey bars) positioned between the N and C-
terminal domain (light grey bars). The helicase domains have multiple insertions responsible for 
the helicase activity of this class of proteins including a polynucleotide binding site and ATPase 
activity (yellow) and a site of ATP binding and hydrolysis (red). The Nucleic acid binding site is 
shown in blue. Figure adapted from (31). 
	
	
1.1.4 Specific RNA binding proteins 
 
Specific RNA cofactors are recognized as RNA-binding proteins that like RNA chaperones resolve 
the RNA folding problem, but in contrast, display substrate specificity and are committed to one 
or a defined set of RNA substrates. Specific RNA binding proteins, recognize a conserved structure 
on their target RNA substrates and similar to RNA chaperones, engage the RNA molecule 
transiently (and in some cases remain bound to their substrates in the form of a “stabilizer”), 
resolving misfolded structures and accelerating the search for the native conformation (1, 7). The 
Neurospora crassa CYT-18 protein (tyrosyl- tRNA synthetase) is an example of a specific RNA 
binding protein. CYT-18 promotes splicing of group I introns by directly contacting and stabilizing 
either conserved structures or specific sequence elements on the intron (1, 7, 33). CBP2 (yeast 
mitochondrial protein) is an example of another specific RNA binding protein that promotes 
splicing of bI5 group I intron. Single molecule FRET studies have indicated that aside from 
specific interactions between CBP2 and bI5 group I intron, that CBP2 also makes nonspecific 
contacts to the intron that result in large structural rearrangements on the RNA, reminiscent of 
RNA chaperone activity (1).   
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2. La proteins and their nuclear and cytoplasmic targets 
 
The Lupus autoantigen (also known as Sjogren’s Syndrome Antigen, SS-B) is a 46kDa protein 
factor identified as a component of a ribonucleoprotein complex, first recognized as an antigen 
targeted by autoantibodies in the sera of patients diagnosed with systemic lupus erythematosus and 
Sjogren’s syndrome (34). Although evidence underlying the autoantigenicity of La proteins 
remains weak, speculations have been made suggesting that its cellular localization and 
phosphorylation status may be influential (20, 34–36). La proteins are ubiquitous factors, essential 
in multicellular eukaryotes including Drosophila and mice. Studies on La function has been 
conducted in unicellular eukaryotes S. pombe and S. cerevisiae where the gene can be deleted 
without loss of viability (20, 37–39). La proteins associate with a multitude of RNA substrates 
with nascent pol III transcripts (such as pre-tRNAs, pre-5S rRNA, pre-U6 snRNA, 7SK snRNA, 
Y RNAs and Alu RNAs) identified as the primary RNA species in La ribonucleoprotein particles. 
In addition, some pol II transcripts have also been targeted by La and those include U1, U2, U3, 
U4 and U5 snRNAs in yeast as well as human pre-U1 snRNA (20, 40–42). La proteins 
preferentially associate with pol III and pol II transcripts by making sequence specific contacts to 
the polyuridylate tail present at the end of these nascent transcripts. This specific binding mode is 
entirely dependent on the length of the 3’ terminal oligo (U), with human La binding transcripts 
that terminate in 3 or more terminal oligo (U) residues and S. pombe La binding with highest 
affinity to transcripts with 4 or more terminal uridylate residues (20, 43). These findings coincide 
with the minimal number of dT residues required for efficient transcription termination by pol III 
which has been identified to be a minimum of 4 dT residues for human pol III and 5 dTs for S. 
pombe pol III (20, 43, 44). Findings by Huang et al. suggested a link between transcription 
termination by Rpc11p (subunit of pol III with 3’exonulcease activity) and La dependent 
processing of nascent pol III transcripts (43). More specifically, the heterogeneity in the length of 
3’oligo-U tracts produced at the end of pre-tRNAs was shown to dictate the extent to which 
processing and maturation of a pre-tRNA would rely on La (43). Two distinct pathways for pre-
tRNA processing have been identified in S. pombe and S. cerevisiae; a La-dependent and a La-
independent pathway. Pre-tRNAs processed through the La dependent pathway, associate with La 
via their 3’ oligo-U tracts and in this way are shielded from 3’exonucleases (Rex1p or Rrp6p) (20, 
45). La-bound pre-tRNAs are initially subject to 5’ leader maturation by RNAse P, followed by 
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the endonucleolytic processing of the 3’ end by RNAse Z which cleaves at the first unpaired 
nucleotide in the acceptor stem, releasing La from the tRNA with subsequent addition of CCA to 
the mature 3’end (45). Pre-tRNAs processed via the La-independent pathway (in the absence of 
La or for those pre-tRNAs that do not engage La) are initially subject to 3’ end maturation by an 
exonuclease (Rex1p or Rrp6p if pre-tRNA is defective and targeted by the nuclear exosome) 
followed by processing of the 5’ leader by RNAse P (20, 43, 45). It should be noted that while La 
is the best characterized factor involved in pre-tRNA processing, other protein factors have also 
been shown to impact pre-tRNA metabolism and processing in S. cerevisiae such as Lsm proteins 
(Lsm2p-8p complex) in which their role moderately resembles La function in pre-tRNA 
processing (42, 45). Synthetic lethality has previously been detected in a lhp1D strain (La homolog 
in S. cerevisiae) bearing a mutation made to LSM8, suggesting a functional link between these 
proteins. Furthermore, it has been speculated that in S. cerevisiae, Lsm proteins may play a role in 
the assembly of pre-tRNA/protein complexes such as those described between La and pre-tRNAs 
(Figure 4) (42, 45).  
           In addition to the well characterized role of La proteins in the processing and maturation of 
nascent pol III transcripts such as pre-tRNAs via their oligo (U) tracts, these factors have also been 
implicated in rescuing structurally impaired pre-tRNAs which can result from DNA mutation, 
deletion of an essential modification enzyme or errors in transcription. Hypomodified pre-tRNAiMet 
at residue A58 is subject to polyadenylation by the poly (A) polymerase Trf4p and subsequently 
degraded by the 3’ exonuclease, Rrp6p. The decay of the hypomodified pre-tRNAiMet is reversed 
with overexpression of La (43). Evidence of rescue of a misfolded pre-tRNA by La has also been 
made for tRNA-ArgCCG in S. cerevisiae. In search of mutants in S. cerevisiae that cause Lhp1p 
dependence, tRNA-ArgCCG carrying a mutation in the anticodon stem (G to A) was identified (46). 
tRNA-ArgCCG is the only tRNA in S. cerevisiae that bears a mismatch in the anticodon stem, 
amplifying the effect of this mutation in weakening of the anticodon stem. Chakshusmathi et al. 
showed that Lhp1p is required for efficient growth of strains carrying this mutation and that defects 
in aminoacylation of the mature tRNA-ArgCCG  was detected in cells depleted of Lhp1p (46). To 
determine whether rescue of misfolded pre-tRNAs reported in literature rely on La binding strictly 
to the oligo (U) tracts of these nascent transcripts or whether La interacts with other sites on pre-
tRNAs, Huang and colleagues used an opal suppressor tRNA-SerUGA with three base pair 
disruptions (C37:10 U40 U47:6) that uniquely relied on La function for successful suppression of  
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Figure 4. Pre-tRNA processing pathway in the presence and absence of La. (A) The heterogeneous 
3’oligo (U) tails generated at end of pre-tRNAs results from pol III pausing at the tRNA gene 
terminator and the subsequent 3’end cleavage carried out by an acidic hairpin located at the N-
terminal domain of Rpc11p (pol III subunit). (B) Nascent pre-tRNAs are segregated based on their 
3’oligo (U) tails into the La-dependent (right) or La-independent (left) pathway of processing. (C) 
Lsm2-8 proteins presumably play a role in early pre-tRNA metabolism and can impact the extent 
in which pre-tRNAs associate with La, but their role remains unclear. (D) Pre-tRNAs are processed 
through 1 of 4 pathways depending on La-associated processing and whether the pre-tRNA is 
deemed defective or is natively structured. Normal pre-tRNAs are subject initially to 5’ end 
processing by RNAse P if bound by La (pathway 1) and then 3’ end cleavage by an endonuclease 
(RNAse Z). This order is reversed in a La independent pathway such that 3’ end cleavage is 
initiated by an exonuclease (Rex1p) and then followed by 5’ end maturation by RNAse P (pathway 
2). For structurally defective pre-tRNAs, the La-dependent pathway protects these species from 
degradation by the nuclear exosome (pathway 3), whereas in the La-independent pathway, the 
defective pre-tRNA is subject to nuclear surveillance involving the TRAMP complex and the 
nuclear exosome, Rrp6p (pathway 4). Figure adapted from (45). 
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a nonsense codon in the ade6-704 gene (47). Their findings showed that the degree to which La-
dependent rescue was necessary correlated with the severity of the mutation, with tRNA-SerUGA 
U40 U47:6 and tRNA-SerUGA C37:10 U40 U47:6 relying more strongly on La for suppression than 
tRNA-SerUGA C37:10. This study also revealed that, while La-associated 3’poly (U) tail binding 
was sufficient for rescue of misfolded tRNA-SerUGA C37:10, that La engaging the main body of 
the tRNA might play a secondary but equally essential role in rescuing misfolded tRNA-SerUGA 
U40 U47:6 and tRNA-SerUGA C37:10 U40 U47:6. Other studies have followed since, providing 
evidence in La associating with the main body of tRNAs through a distinct binding mode unique 
from the poly (U) tail binding mode and this has been linked to the RNA chaperone activity 
function of La (22, 29, 47, 48).   
             Aside from the abundant nuclear pol III transcripts that associate with La, there is also 
evidence of La engaging cellular and viral coding RNAs with La implicated in translational and 
metabolic regulation of these transcripts (20). In the absence of a poly (U) tail, there are 
commonalities in regions that La targets in engaging these coding RNAs and some examples 
include mRNAs that possess either an IRES, 5’TOPS or uORF (20). While La has been recognized 
as a mRNP, its role in translation initiation has remained vastly unclear due to the opposing effects 
reported depending on the mRNA that La engages. La facilitates translation initiation for 
poliovirus mRNAs by making contacts with the IRES as well as enhancing translation initiation 
for both poliovirus and HIV-1 mRNAs by associating with the 5’UTR region (28, 49). Other 
studies have shown that La binding IRESs enforce a cap-dependent translation initiation by 
masking the ribosomal binding site. In this form, La can oppose a positive or a negative regulatory 
effect on translation initiation depending on the mRNA and the presence or absence of a 5’ 
terminus m7GpppN cap (50). Evidence for a more direct enhancement of translation has also been 
identified for the coding RNA mdm2. Expression of MDM2 was linked to La associated binding 
of the 5’ UTR of mdm2 mRNA, where overexpression of La enhanced translation and repression 
was induced in La mutants (51).  
  
2.1 Structure and architecture of La   
2.1.1 N-terminal domain  
 
The general architecture of La proteins is highly conserved, particularly the N-terminal domain 
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(NTD) and to a lesser extent the C-terminal domain (CTD). The NTD comprises of a La motif 
(LAM) and RRM1 connected via a short linker sequence. Like DNA binding transcription factors, 
studies in Human La have indicated a winged helix type fold for the LAM (20, 52). The RRM1 
takes on the typical b1a1b2b3a2b4, fold routinely recognized in other RRM containing proteins. 
NMR-based studies and site specific mutagenesis findings have identified regions with highly 
conversed basic and aromatic residues in the LAM and RRM1 that were proposed to be sufficient 
for La targeting poly (U) containing substrates (53, 54). In addition, Teplova et al. have 
successfully resolved the NTD crystal structure of human La while bound to a short RNA (U1-
G2-C3-U4-G5-U6-U7-U8-U9 OH-3’) substrate ending in 3’ polyuridylate tail giving further 
insight into the binding mechanism that La utilizes in associating with poly (U) tail containing 
substrates (55). While anticipated that the b sheet surface of the RRM1 motif or the typical 
recognition helix of the winged helix fold of the LAM would be essential in La-UUU-3’OH 
interaction, the co-crystal structure proved otherwise, suggesting the availability of these sites for 
a second potential La binding mode (55). Intriguingly, the results from the co-crystal structure 
revealed site specific contacts made to the poly (U) tail by highly conserved residues in the LAM 
and RRM1. A glutamine (Q20) and a tyrosine (Y23) residue in the LAM were shown to make 
uridylate specific contacts and stacking on the U-8 (U7U8U9-3’OH) of the RNA substrate 
respectively, while phenylalanine residues (F35 and F55) were involved in base and sugar stacking 
on U-9, respectively. Contact made by a conserved aspartate (D33) residue to the 2’OH and 3’OH 
of U-9 enforces La to differentiate between RNA and DNA substrates as well as RNA substrates 
that have been trimmed by ribonucleases as they terminate with a 3’PO4 (20, 55). While the LAM 
and RRM1 individually, weakly bind the RNA substrate, the formation of an alpha helix in the 
linker segment between the LAM and the RRM1 and subsequent rigidification of this site upon 
interaction with the poly (U) tail, contributes to the high affinity binding mode of La to poly (U) 
containing substrates (55). Aside from the contribution of RRM1 in high affinity binding of poly 
(U) tail containing substrates, studies in hLa have identified the role of RRM1, in particular loop-
3 (interlink between b2 and b3 strands) in making UUU-3’OH independent contacts (Figure 5B). 
Previous studies have suggested that loop-3 is responsible for engaging the main body of tRNAs 
during pre-tRNA processing, in addition to the canonical aromatic residues in RNP-1 and RNP-2 
of RRM1 that are typically used in RNA binding (20, 22). To date, structural and mutagenesis 
studies have summarized La binding to pre-tRNAs through two modes: the UUU-dependent and 
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UUU-independent binding mode which is facilitated through the high affinity binding of the LAM 
to the poly (U) tail of pre-tRNAs and secondly, through the loop-3 of RRM1 engaging the main 
body of pre-tRNAs (also associated with RNA chaperone activity) respectively (20, 22).  
	
2.1.2 C-terminal domain  
 
Contrary to the highly conserved NTD, the CTD of La is more divergent and this is partly linked 
to the expansion and complexity of this region in multicellular eukaryotes compared to unicellular 
eukaryotes (Figure 5A) (20, 24). In addition to RRM1, a second RRM has been identified in the 
CTD of multicellular eukaryotes with its function still under investigation. While studies with the 
NTD of hLa have revealed binding of the La module to nuclear encoded-poly (U) tail containing 
substrates, recent findings have elucidated a role for the CTD, specifically RRM2 of hLa in 
targeting cytoplasmic coding substrates. Distinct from the poly (U) tail binding mode, it was 
revealed that the LAM and RRM1 in conjunction with RRM2 are responsible for engaging the 
IRES domain IV of hepatitis C virus (HCV) mRNA (56). This binding mode was dictated through 
the recognition of structural elements on the RNA, specifically single stranded regions flanked by 
a double stranded stem loop, independent of the sequence of the RNA. These findings illustrate 
the plasticity in the binding modes that La utilizes in contacting various RNAs and a potential for 
La RNA chaperone activity on both nuclear and cytoplasmic targets (56).  
          In addition to RRM2 that is found in the CTD of higher eukaryotes of La, other elements 
such as the nuclear retention element (NRE), short basic motif (SBM) and nuclear localization 
signal (NLS) are also located C-terminal to RRM2 (20). The subcellular localization of La is under 
the control of the NRE and NLS which is positioned at the end of all La proteins with the exception 
of La in budding yeast in which the NLS is positioned more central in the protein (20). These 
elements not only assist with La shuttling but also directly influence the pool of RNA substrates 
that La engages. Defects in these regions have previously been linked to impaired pre-tRNA 
processing and maturation (57, 58). Adjacent to the NRE, the SBM motif is located which 
comprises of roughly 40 amino acids, harboring the site of phosphorylation at Ser-366 for hLa. 
The SBM serves as an additional RNA binding element that can alter the overall La-RNA 
interaction depending on the phosphorylation status of the motif by casein kinase II (CK2) at  
 16 
Ser-366. Phosphorylated La has been mapped to the nucleoplasm, while non-phosphorylated La 
has been largely located in the cytoplasm. Other sites of phosphorylation have also been identified 
in various species such as mouse (T-302) and S. cerevisiae La (Ser-14, Ser-18, Ser-234), however 
the lack of conservation in the sites of phosphorylation across species suggests varying 
requirements for phospho-La (20, 59).  
	
3. Pre-tRNAs: La’s preferred nuclear targets  
 
The role of tRNAs as adaptor molecules converting the genetic code to a functional polypeptide 
sequence has long been established. In addition, tRNAs have been characterized as multifaceted 
RNA substrates with the capacity to play essential roles in other biological processes such as 
serving as metabolic sensors in detecting nutritional stress, regulating apoptosis and functioning 
as signalling molecules in the general amino acid control pathway (GAAC) (60). As these 
multifunctional transcripts are crucial to the translational machinery, numerous biological 
processes and cellular survival, they are subject to a surplus of post-transcriptional processing and 
modifications which regulate the activity of these RNA substrates.  
 
3.1 From transcription to post-transcriptional processing of pre-
tRNAs  
 
3.1.1 5’ leader and 3’ trailer processing  
 
Nuclear tRNAs are products of RNA pol III transcription that are transcribed into their pre-mature 
state and subject to multiple cycles of processing before they are converted into their mature 
functional form (45, 61). While transcription of pre-tRNAs and termination of transcription by 
RNA pol III is highly conserved across species from vertebrates to yeast, some variations exist 
particularly in the length of oligo (U) generated at the 3’end of pre-tRNAs. Efficient transcription 
termination by RNA pol III is carried though the identification of an oligo (dT) tract at the 3’end 
of all transcripts (45). Interestingly, variability in the length of oligo (dT) requirement for 
transcription termination has been detected that is species specific. Moreover, while an oligo (dT) 
tract of four or five Ts is sufficient for complete transcription termination in Homo sapiens,  
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Figure 5.  Sequence alignment of La in three eukaryotic species (Human hLa, S. pombe Sla1p, 
and S. cerevisiae Lhp1p) and a detailed crystallographic representation of hLa engaging a short 
poly (U) tail-containing RNA. (A) Sequence conservation in La is maintained in the NTD which 
comprises of the LAM and the RRM1, followed by an extended and more divergent CTD in higher 
eukaryotes possessing RNA binding elements such as the SBM as well as NLS and NRE which 
regulate the subcellular localization of La. (B) The UUU-3’OH dependent binding mode of La is 
illustrated with contacts made to U-1 and U-3 (shown in red) by primarily the LAM (shown in 
purple) and assisted by the b-2 strand of RRM1 (shown in turquoise). The UUU-3’OH independent 
binding mode is facilitated by loop-3 of RRM1 (shown in blue), available to engage the main body 
of pre-tRNAs and presumably other structured RNA substrates. Other sites in the LAM and RRM1 
that assist RNA binding include residue D33 in the LAM and aromatic residues Y114 and F155 in 
the RRM1 which are essential in binding the 3’OH and 2’OH of terminal U (U-1) and aiding pre-
tRNA processing respectively. Figure 5 (A) adapted from (24) and (B) adapted from (20). 
A	
B	
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S. pombe RNA pol III transcription termination relies on the detection of five to six oligo (dT) 
tracts, with the length of oligo (dT) required for S. cerevisiae RNA pol III termination 
exceeding six oligo (dT) tracts (43, 45). The variability in the length of oligo (U) generated at the 
3’end of pre-tRNAs has been linked to the 3’-5’ exoribonuclease activity of RNA pol III subunit, 
Rpc11p, with defects in this subunit showing increase in the length of oligo (U) tracts (43, 45). 
La proteins are one of the first factors that contact pre-tRNAs upon transcription 
termination and this interaction is highly dependent on the length of 3’ oligo (U) tract, with Human 
La associating with pre-tRNAs carrying 3 or more oligo (U) tract and S. pombe La requiring 4 or 
more oligo (U) tract for stable interaction (43, 45). Pre-tRNA processing can be guided through a 
La-dependent or La-independent pathway dictating the order of 3’ trailer and 5’ leader processing 
(61, 62). La binding to the 3’ oligo (U) tail on pre-tRNAs, eliminates the competition between 
exonuclease (Rex1p or Rrp6p) and endonuclease (RNAse Z) cleavage of the 3’ trailer sequence 
and commits the 3’ trailer to endonucleolytic cleavage by RNAse Z (61, 62). In this fashion, the 
5’ leader is processed initially by the endonuclease RNAse P, while La remains bound to the 3’ 
oligo (U) tract protecting the tRNA from exonucleases. Upon completion of 5’ leader processing, 
RNAse Z cleaves the 3’end of the tRNA at N73 (discriminator base) preparing the 3’end for CCA 
addition (61). Since La is non-essential in unicellular eukaryotes and pre-tRNAs can be processed 
via a La-dependent or La-independent pathway, in the absence of La and for pre-tRNAs that do 
not engage La, the pre-tRNA is first subject to 3’trailer processing by exonucleases, followed by 
5’ leader processing by RNAse P. In preparation for tRNA aminoacylation, tRNA 
nucleotidyltransferase contacts 5’ and 3’ end-matured pre-tRNAs and is responsible for the 
addition of CCA to the 3’ end of pre-tRNAs (61, 62). While nucleotidyltransferase catalysis occurs 
post-transcriptionally for yeast and vertebrate tRNAs, E. coli tRNAs are encoded with a 3’ terminal 
CCA sequence. Nucleotidyltransferase (CCA1) is encoded in multiple isoforms which have 
distinct subcellular localizations. While the nuclear encoded CCA1 isoform is responsible for CCA 
addition to the 3’ terminal end of pre-tRNAs, the cytoplasmic isoform is responsible for 3’ end 
repair (61, 62).   
 
3.1.2 pre-tRNA splicing  
 
Although there is significant divergence amongst species in the presence or absence (0% intronic 
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regions in E.coli tRNAs) or even percentage (~5% in human genome compared to >20% and >50% 
in yeast and archaeal genome, respectively) of tRNAs that possess intronic regions, splicing of 
introns is unanimously considered essential for the functional activity of tRNAs (62). While 
eukaryotic tRNAs often possess intronic regions 3’ to the anticodon (between nucleotide 37 and 
38), introns have been found in other locations on tRNAs, particularly in archaeal tRNA genes 
(61, 62). Pre-tRNA splicing in yeast is divided into two major steps and is initiated by cleavage of 
the tRNA molecule by an endonuclease into two-half molecules at the site in which the exons are 
segregated by an intronic region, generating a 5’ half with a 2’-3’cyclic phosphate and a 3’ half 
with a 5’OH group. In yeast, tRNA splicing is catalyzed by a heterotetramer endonuclease Sen2, 
Sen34, Sen15 and Sen54, in which Sen2 and Sen34 are conserved between Archaea and humans, 
while Sen15 and Sen54 are entirely absent in Archaea and only poorly conserved between yeast 
and vertebrates (61, 62). The second step of tRNA splicing is compartmentalized into four sections 
and is catalyzed by the yeast protein Trl1. The initial step comprises of the hydrolysis of the 2’-3’ 
cyclic phosphate that was generated in the 5’ half of the tRNA molecule into a 2’phosphate by the 
cyclic phosphodiesterase activity of Tr1l (61, 62). This is then followed by the phosphorylation of 
the 5’OH group of the 3’half of the tRNA molecule. Subsequently, the 5’ phosphate is adenylated 
and used as the site of ligation for the two halves of the tRNA molecule, leaving the 2’ phosphate 
at the splice site which is lastly transferred to NAD by a phosphotransferase (Tpt1 in yeast) (61, 
62) (Figure 6). While a similar mechanism of tRNA splicing has been detected in vertebrates, a 
second splicing pathway has also been identified in which a vertebrate ligase directly catalyzes the 
ligation of the two halve tRNA molecules using the 2’-3’ cyclic phosphate. Although two pathways 
of tRNA splicing coexist in vertebrates, it is unclear which method of splicing is primarily utilized 
for tRNAs (61, 62). 
 
3.2 tRNA post-transcriptional modifications 
 
While differences exist amongst varying species in pre-tRNA processing, one intriguing 
commonality in all organisms is the abundance of tRNA modification enzymes that uniquely 
decorate tRNAs with the addition of chemical groups to the ribose sugar/base moieties, catalyzed 
by deamination, isomerization, glycosylation, thiolation or the addition of methyl groups (63).  
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Figure 6. tRNA splicing pathway. tRNA splicing in yeast is initially catalyzed by the Sen complex 
which is an endonuclease, comprising of Sen2, Sen15, Sen34 and Sen54 which generates two half 
tRNA molecules through the endonucleolytic cleavage at the junction of the intronic/exonic region 
generating a 5’ half bearing a 2’-3’ cyclic phosphate and a 5’-OH created at the 3’ half of the tRNA 
molecule. Introns are illustrated by blue circle and the white circle labeled “p” with a triangle 
depicts the 5’ half with the 2’-3’ cyclic phosphate. Yeast ligase Trl1, facilitates the next four steps, 
by (1) hydrolysis of the 2’-3’ cyclic phosphate generating a 2’ phosphate (2) phosphorylation and 
(3) adenylation of the 5’- OH and (4) final ligation of the 3’ and 5’ half of the tRNA molecule. 
The 2’ phosphate remaining at the splice site is subsequently removed by Tpt1, yeast 
phosphotransferase. Vertebrates utilize the same mechanism in yeast for splicing but also carry a 
second splicing machinery in which a vertebrate ligase can directly ligate the 2’-3’ cyclic 
phosphate to the 5’-OH of the 3’ half of the tRNA. Adapted from (61). 
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Previous analysis of 561 sequenced tRNA genes, collected from various organisms (archaea, 
eubacteria, fungi, animals and plants) has elucidated the universal modification of tRNAs in all  
phylogenies with a median of 8 modifications per tRNA (61). Although the prevalence of tRNA  
PTMs has been identified, challenges exist in determining the role of individual modifications on 
tRNAs. Firstly, not all tRNAs are uniformly modified by the same enzyme, and modification by a 
particular enzyme can vary not only between different tRNA groups, but also tRNA isoacceptors 
and even vary between similar tRNA families in different organisms from the same domain of life 
(63). Modification enzymes have been identified that specifically catalyze the addition of a 
functional group to a particular nucleoside, while other enzymes have been shown to function more 
promiscuously (63). Lastly, the over-abundance of PTMs on tRNAs in vivo exacerbates the 
challenges in determining the unique functional role of each modification enzyme as they likely 
function redundantly with one another in supporting the overall structure and function of these 
adaptor molecules (61, 63). Extensive research in this field has led to the categorization of tRNA 
PTMs into two classes: modification enzymes that assist tRNA folding and structural stability and 
enzymes that directly impact tRNA functional activity and mRNA decoding (61, 63).  
 
3.2.1 Post-transcriptional modifications support tRNA structural stability  
 
The L-shaped three-dimensional structure of tRNAs is maintained through an interplay of tertiary 
interactions and a plethora of functional chemical groups attached onto the nucleotides by 
numerous modification enzymes. Decades of research consensually agree upon the role of PTMs 
on the core body of tRNAs in supporting structural stability, rigidity and flexibility of the 
cloverleaf structure (61, 63). Example studies have shown that while one modification such as 
pseudouridylation can enforce rigidification of the tRNA structure, in opposition the presence of 
a dihydrouridine can confer flexibility. These intriguing findings delineate the role of modification 
enzymes in cooperatively devising the most suitable tRNA structure dependent on cellular 
conditions (63). More specifically, previous findings have demonstrated the requirement for 
flexibility-inducing dihydrouridines in tRNAs from psychrophilic archaea compared to their 
thermophilic archaea family. Other studies have shown an overall change in modification levels 
on tRNAs that is related to alterations in growth temperature, reinforcing the idea that tRNA 
modification can act as a regulatory element, controlling tRNA structural conformation (63). In  
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Figure 7. General secondary and tertiary structure of tRNAs. A) Secondary cloverleaf structure of 
yeast initiator tRNA. Acceptor stem (orange), D-stem/loop (DSL, black), anticodon stem/loop 
(ASL, purple), variable loop (V-loop, green) and TYC stem/loop (TSL, red) have been labeled. 
Some sites of tRNA post-transcriptional modifications have been indicated (e.g. N16, N26, N32 
etc.). B) Tertiary L-shaped structure of tRNA. The colors correspond to the respective sites on the 
cloverleaf, secondary structure. The sites of some PTMs have been indicated (e.g. N26 
corresponding to possible site of G26 dimethylation by Trm1p). Figure adapted from (64). 
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vitro studies, also demonstrate a link between PTMs of tRNAs and structural stability. A natively 
modified tRNA is structurally more stable and has ~ 5°C higher Tm in comparison to an 
unmodified tRNA (61). 
Investigating the essential role of individual modification enzymes in providing structural 
stability for tRNAs has proven to be challenging as the deletion of a single modification enzyme 
does not entail phenotypic growth defects. Studies in yeast have shown the redundant functionality 
of modification enzymes, as only the combination of modification gene deletions leads to synthetic 
lethality and only as a result of defects in a particular tRNA and not all tRNAs modified by the 
enzymes of these deleted genes (63). To exemplify this scenario, yeast cells depleted of Trm8 and 
Trm4 (catalyze methylation; m7G46 and m5C49 respectively) display a phenotypic growth defect 
and temperature sensitivity which has been linked to the degradation and deacylation of mature 
tRNA-ValAAC. While other tRNAs such as tRNA-Phe , tRNAi -Met and tRNA-ValCAC  are all targets 
of Trm8 and Trm4, the synthetic lethal phenotype is directly linked to structural defects imposed 
on tRNA-ValAAC (61, 65, 66). Similar growth defects and temperature sensitivity have also been 
reported for a combination of other modification enzymes, including Tan1 and Trm44 which 
catalyze the N-4 acetylcytidine formation (ac4C12) and 2’O methylation (Um44) on tRNAs, 
respectively (67, 68). Although, tRNA-Ser CGA, tRNA-SerUGA and tRNA-Ser IGA are all modified by 
Tan1 and Trm44, the synthetic lethality has been connected to the degradation of tRNA-Ser CGA 
and tRNA-Ser UGA (61). 
While many modification enzymes have reported to function redundantly with one another 
and have shown to cumulatively cause structural defects for tRNAs in their absence, other 
modification enzymes have been reported to function redundantly with the RNA chaperone, La. 
Anderson et al. have demonstrated that Trm6/61 (Gcd10/Gcd14) which catalyzes the methylation 
of A58 (m1A58) on pre-tRNAi-Met and 17 other tRNAs (including elongator pre-tRNA-Met)  is 
essential for the steady state levels of  pre-tRNAi-Met such that in trm6/61- cells, there was a 
reduction in mature pre-tRNAi-Met levels as a result of increase in turnover of the initiator tRNA. 
Intriguingly, this phenotype was reversible with either overexpression of pre-tRNAi-Met or 
overexpression of LHP1 (S. cerevisiae  La homolog) (61, 69). In addition to this finding, another 
methyltransferase (tRNA methyltransferase 1; Trm1) has shown overlapping function with La in 
supporting tRNA structural stability (70). Trm1p catalyzes the N2, N2-dimethylation of G26 on 
several tRNAs (71). Trm1p can modify both intron-containing and intron-less tRNAs and its 
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activity is transcriptionally regulated such that the subcellular localization and targeting of this 
enzyme is dependent on the transcription of Trm1 with or without an extended 5’ N-terminal 
region. The short transcript without the 5’ extended N-terminal region, commits the enzyme to the 
inner nuclear membrane, while the 5’ extended N-terminal region allows for shuttling to the 
mitochondria (62, 72). Previous studies in S. cerevisiae have revealed that the presence of G26 at 
the junction of the D-stem and the anticodon stem do not constitute as the determining factor for 
Trm1p modification and that this methyltransferase displays tRNA substrate specificity towards 
tRNAs that display a favorable 3D structure surrounding G26. These studies identified two 
determining factors for Trm1p modification on tRNAs: 1) The presence of a GC rich region 
preceding G26 in the D-stem in the form of C11 pairing with G24 and G10 pairing with C25 and 
2) the length of the variable loop in tRNAs facilitating an overall favorable 3D structure such that 
tRNAs bearing < 5nt in the variable loop are considered unsuitable substrates of Trm1p and were 
identified as tRNAs that are non-Trm1p targets (eg. tRNA-GlyGCC, GlnTTG and GlnCTG) (71, 73, 74). 
tRNAs that possess these elements are potential substrates of Trm1p and undergo dimethylation 
by the enzyme such that the N2 atom of the G26 residue is dimethylated in a reaction assisted by 
the methyl donor S-adenosylmethionine (SAM) ((73); Figure 7A and B). In addition to these 
preliminary studies carried two decades ago, more recent findings have added a level of confidence 
in the substrate specificity that Trm1p displays depending on tRNA identity. More specifically, 
recent next-generation tRNA sequencing (tRNA-HydroSeq) results, assaying mature tRNA 
sequences in S. pombe identified a list of 27 tRNAs from a total of 36 G26 containing tRNAs to 
be significantly modified by Trm1p (modification was measured as a factor of misincorporation 
by reverse transcriptase incorporating a “non-C” nucleotide at position 26 in the presence of m""G26; Figure 7C). These findings are of significant interest as unlike other modification enzymes 
that display minimal substrate specificity (eg. yeast Pus1 modifies many tRNAs at various 
positions U1, U26-28, U32 ,U34-36, U65 and U67 and Trm4 which catalyzes methylation of C34, 
40, 48,49 on numerous tRNAs), Trm1p not only specifically catalyzes modification exclusively at 
G26 but also does this in a manner related directly to tRNA identity (61, 71).   
           Although the evolutionary conservation of the cloverleaf structure of tRNAs has led to the 
assumption that all tRNAs are confined to this secondary structure, studies have shown that some 
mitochondrial tRNAs fold into alternate secondary structures, different from what is uniformly 
observed in cytosolic tRNAs (75). Mitochondrial tRNAs can take on a type 5 and 7 fold, distinct 
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from the canonical type 6 fold found in cytosolic tRNAs which carry 6 base pairs in the anticodon 
stem (75). Interestingly, further studies revealed that while these alternate configurations were 
originally identified for some mitochondrial tRNAs, some cytosolic tRNAs studied in unicellular 
eukaryotes (eg. tRNA-Lys, Arg and Ala) may also commit to these alternate folds. Cytosolic 
tRNAs that are subject to folding into mitochondrial type conformations (type 5 in addition to the 
canonical type 6 fold) all possess a dimethylated G26 (75). Type 6 tRNAs display base pairing 
between nucleotide 26 in the D-stem and 44 in the anticodon stem, whereas nucleotides 26 and 11 
are involved in a base pairing interaction in the mitochondrial type 5-fold tRNAs (75). These 
pairing rearrangements in cytosolic tRNA folding into type 5 conformation has been speculated to 
cause conformational instability for the tRNA and label the tRNA aberrant. Further analysis of 
these cytosolic tRNAs revealed that N2, N2-dimethylation at G26 eliminates the potential for G26 
to interact with N11 and invariably commits G26 to base pairing interactions with A, U or G at 
N44 (with some exceptions C) driving the formation of the canonical type 6 cytosolic tRNA 
conformation (75).   
            With plentiful evidence demonstrating the role of Trm1p in supporting tRNA structural 
stability, the overlapping function of this PTM enzyme with La as an RNA chaperone has further 
reconfirmed its functionality. While it has been repeatedly shown that La is involved in tRNA 
biogenesis and pre-tRNA processing and maturation, its’ dispensability in unicellular eukaryotes 
has been puzzling. In search for factors that function redundantly with La, it was shown that LHP1 
becomes essential for survival in trm1- cells subject to growth under elevated temperatures (70). 
This finding suggested the presence of one or more essential tRNAs that rely on either the presence 
of La or Trm1 for structural stability and to potentially divert these essential tRNAs from forming 
inactive conformations by stabilizing the anticodon stem (70).  
         In addition to the above mentioned PTMs (Trm1, Trm4, Trm8, Trm6/61, Trm44, Tan1 and 
Pus1) numerous other PTMs can be exemplified that are beyond the scope of this review that 
would demonstrate the crucial role of these enzymes and other RNA chaperone-like proteins that 
are essential in pre-tRNA processing and structural stability. While the cloverleaf structure is 
highly conserved, minor deviations from this structure would lead to inactive tRNA substrates that 
are either degraded or remain inactive and inoperative for the translational machinery. 
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Figure 8. tRNA identity elements associated with specific m""G26 modification by Trm1p. (A) 
N2, N2-dimethylation of G26 at the junction of the D-stem and the anticodon stem is favored by 
the presence of a GC rich region preceding G26 (C11:G24 and G10:C25) in conjunction with a 
variable loop possessing a minimum of 5 nucleotides (increase in the length of variable loop from 
4 to 5 with the insertion of either U47 or C47 produced favorable conditions for Trm1p 
modification of tRNAs). (B) SAM facilitates the transfer of two methyl groups to the N2 atom of 
G26 in the Trm1p catalyzed formation of m""G26. (C) tRNA-HydroSeq results identified 27 G26 
containing S. pombe tRNAs as Trm1p targets (measured by the level of misincorporation detected 
at G26) and 9 G26 containing tRNAs as non-Trm1p targets. Figure 7A&B adapted from (73) and 
Figure 7C adapted from (71). 
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3.2.2 Post-transcriptional modifications regulate tRNA activity in mRNA 
decoding 
 
The translational machinery has evolved to successfully produce elaborate protein sequences with 
minimal error with the assistance of tRNA molecules involved in decoding of the mRNA 
transcript. PTM of tRNAs, particularly in the anticodon loop region has been recognized as an 
elemental factor in avoidance of frame-shift mutations and ribosomal pausing with a post-
transcriptionally modified tRNA in the anticodon loop increasing translation fidelity and 
enhancing codon-anticodon interactions (76). Two sites that are unanimously modified in almost 
all tRNAs, in all organism is nucleotides at position 34 and 37 in the anticodon loop. Modifications 
made to N37, block potential Watson-Crick interactions between N37 and N33. This results in a 
U-shape, open loop conformation in the anticodon loop of tRNAs, an essential conformation in 
enhancing codon-anticodon interactions and avoidance of a frameshift mutation. N37 on tRNAs 
is occupied by a purine and depending on the presence of A or G, appropriate modifications are 
made to the tRNA aiming for the same outcome; inhibition of inappropriate base pairing 
interactions, avoidance of frameshift mutation and maintaining translation fidelity (63, 76). While 
various chemical groups have been identified that modify the purine residue at N37 (isopentenyl 
adenosine i6A, N-1-methylguanosine m1G, wybutosine yW, N6- threonylcarbamoyladenosine t6A), 
the most commonly reported modification is the methylation of G37 which is present in tRNAs in 
all domains of life. This modification is facilitated by the methyl donor SAM and is catalyzed by 
the methyltransferase Trm5p in Eukaryotes (61, 63). Hypomodification of tRNAs at G37 has been 
correlated with a frameshift mutation, imposing translational error (63, 77). Prevention of 
frameshift mutations is not the only purpose of methylation at G37, but rather this PTM also serves 
as the starting point for subsequent modification at this site such as the formation of a 
hypermodified tRNA-Phe bearing a wybutosine nucleoside (63, 77). In the presence of an adenine 
nitrogenous base at position 37, the common PTM identified on tRNAs is the isopentenylation of 
adenine in the formation of i6A which mediates translation efficiency (63).    
 In addition to PTMs made to N37 that ensure in-frame translation of the mRNA transcript, 
modifications made to N34 in the anticodon loop adds an additional layer of confidence to 
translation fidelity by rigidifying the anticodon-codon interaction. Numerous PTMs have been 
previously reported at N34 (methylation, acetylation, pseudouridylation etc.) but the most well 
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characterized modification is the hypermodification of U34 which includes a cascade of enzymes 
that cooperatively modify this base (63). U34 is initially modified by the elongator complex for 
the formation of 5-carboxy-methyluridine (cm5U) which is a substrate for Trm9 (in conjunction 
with Trm112) which catalyzes the synthesis of 5-methoxycarbonyl-methyluridine (mcm5U). 
Modification at U34 has been noted in several tRNAs including tRNA-LysUUU, GlnUUG Glu UUC  , 
ArgUCU and GlyUCC (63, 78). For tRNAs-LysUUU, GlnUUG and Glu UUC , mcm5U34 is subsequently 
thiolated to produce mcm5 S2 U34 (78). Quantitative proteomics studies in yeast have revealed that 
Trm9 modification of U34 is necessary for native expression levels of certain proteins enriched in 
AGA and GAA codons corresponding to conserved Trm9 tRNAs substrates (tRNA-ArgUCU and 
Glu UUC). These studies demonstrated that trm9- cells showed a general shift in translation of a 
subset of proteins, with repression of translation noted for the transcripts containing codon clusters 
of AGA and GAA. Although, not all Trm9 tRNA substrates (tRNAs translating GGA, GGG, AGG 
and AAA codons) were affected in their decoding capacity in trm9- cells, these findings are clear 
evidence of the role of PTMs in regulating tRNA activity in protein expression in vivo (78).  
 Other recent evidence for the role of PTMs in fine-tuning tRNA activity has also been 
made with Trm1. TMS assays have been used widely in assaying suppressor tRNA biogenesis and 
activity (47, 71). Arimbasseri and colleagues have shown that the activity of the opal suppressor 
tRNA-SerUCA in suppressing a nonsense codon in the adenine synthetic gene (ade6-704) relies on 
the PTM of the suppressor tRNA by Trm1 (71). Moreover, their studies demonstrated that the 
overall upregulation of tRNA transcription in maf1- cells (highly conserved global repressor of 
RNA pol III) concomitantly results in antisuppression due to limiting levels of Trm1 and an 
overabundance of Trm1 substrates such as suppressor tRNA-SerUCA which rely on Trm1 
modification for their activity (71). These intriguing insights suggest a potential role for Trm1, a 
PTM enzyme that modifies G26 on tRNAs, distant from the anticodon loop in playing a pivotal 
role in fine-tuning tRNA activity in mRNA decoding, in addition to the already characterized role 
for Trm1p in supporting tRNA structural stability. 
	
3.3 tRNA turnover  
 
During the entirety of tRNA biogenesis, from the time of transcription to 3’ and 5’ end processing, 
splicing and undergoing PTMs, tRNAs are under surveillance for their structural integrity. As these 
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adaptor molecules play an essential role in mRNA decoding, the cell has evolved to implement 
mechanisms in which aberrant tRNAs are subject to degradation and prevented from participating 
in the translational machinery (62). A well characterized example of pre-tRNA degradation has 
been made with initiator pre-tRNA-Met  that is hypomodified at A58 (69, 79). Anderson et al., 
showed a decrease in the levels of mature tRNAi-Met in trm6/61 mutants that was attributed 
specifically to the hypomodification of tRNAi-Met at A58 and its subsequent degradation by the 
nuclear exosome and the TRAMP complex (Trf4/Air2/Mtr4p polyadenylation) (69, 79). Nuclear 
degradation of aberrant tRNAs such as hypomodified tRNAi-Met  is initiated by the 
polyadenylation of the tRNA by Trf4 poly (A) polymerase which is mediated through the RNA 
binding capacity of zinc knuckle RNA-binding proteins Air1p or Air2p (79, 80). Upon 
polyadenylation of the tRNA by Air1/2p-Trf4p, the RNA helicase Mtr4p locates a 4 - 5 single 
stranded poly (A) extension at the 3’ end and begins unwinding the tRNA. At this stage, the tRNA 
is exposed to the two exonucleases of the nuclear exosome and is considered a favorable substrate 
for the 3’ exoribonucleases Rrp6p or Rrp44 (45, 80). In addition to hypomodified pre-tRNAs 
serving as substrates for degradation by the nuclear exosome, inappropriately processed pre-
tRNAs are also targeted by the TRAMP complex and the nuclear exosome (61). Pre-tRNAs are 
safe from 3’-5’ exonuclease decay during processing, if they possess a 3’ poly (U) tail, long enough 
in length for efficient La binding. In this way, the pre-tRNA is processed by the endonuclease, 
RNase Z which is involved in 3’ trailer processing and generating a single unpaired nucleotide at 
the 3’ end of the tRNA, an unfit substrate for Trf4p (45, 61).  
 More recent studies in alternative pathways of tRNA turnover, independent of the TRAMP 
complex, led to the identification of two 5’-3’ exonucleases (rat1 and xrn1) in co-operation with 
met22 (enzyme in the methionine biosynthesis pathway) to be the elemental factors in degrading 
structurally defective hypomodified tRNAs (Figure 8) (61, 80). The role of these exonucleases in 
rapid tRNA decay (RTD) were made clear in trm4- trm8- (m5C49 and m7G46) as well as tan1- 
trm44- cells (Um44 and ac4C12) with depleted levels of mature tRNA-ValAAC and tRNA-SerCGA/UGA 
respectively (65–67). The specificity of the RTD pathway for structurally defective and unstable 
tRNAs has been demonstrated by Whipple and colleagues reporting that only tRNA-SerCGA/UGA is 
subject to degradation in tan1- trm44- cells , even though tRNA-SerIGA is also a recognized 
substrate of Tan1 and Trm44 (81). Further investigation revealed that modification by Tan1 and 
Trm44 increase the structural stability of tRNA-SerCGA, particularly in the acceptor and T-stem of 
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the tRNA and in this manner protects the tRNA from decay (81). Conversely, tRNA-SerIGA is not 
reliant on Tan1 and Trm44 for structural stability and therefore remains active and protected from 
RTD in tan1- trm44- cells (62). As Xrn1 is located in the cytoplasm and Rat1 is nuclear, the 
location of degradation of tRNA substrates of the RTD pathway has been puzzling. Since deletion 
of just Xrn1 or Rat1 only leads to partial rescue of these hypomodified tRNAs, and only the 
deletion of both Xrn1 and Rat1 in conjunction with Met22 leads to complete stability of these 
tRNAs, it has been proposed that RTD can target structurally defective tRNAs both in the nucleus 
and the cytoplasm (62).  
 
3.4 tRNA subcellular localization  
 
3.4.1 pre-tRNA splicing: nuclear or cytoplasmic? 
 
Preliminary studies on tRNA biogenesis viewed precursor-tRNA processing to mature-tRNAs as 
a simple unidirectional process; transcription by RNA pol III, 3’ and 5’ end processing, PTMs on 
nucleosides and splicing, all of which presumably occurred in the nucleus followed by transfer of 
these tRNAs to the cytoplasm for aminoacylation and participation in the translation machinery 
(82). Decades of studies in tRNA nuclear-cytoplasmic localization have diverged from this 
mindset, demonstrating a more complex machinery involved in the subcellular localization of 
tRNAs, that is highly linked to cellular conditions (82). It is now known that pre-tRNAs are 
initially subject to 3’ and 5’ end processing and then further maintained in the nucleus for tRNA 
splicing in the case of vertebrates or transported to the cytoplasm for splicing in the case of yeast 
tRNAs. The finding that the yeast splicing machinery does not reside in the nucleus and is rather 
found in the cytoplasm (ligase and the 2’phosphotransferase) and the outer surface of the 
mitochondria (endonuclease), in combination with the lack of conservation in the localization of 
tRNA splicing machinery between yeast and vertebrates led to an expanded interest in tRNA 
subcellular dynamics.  
 
3.4.2 tRNA nuclear export 
 
To accommodate pre-tRNA splicing in yeast and the transfer of spliced pre-tRNAs in vertebrates  
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Figure 9. Model for structurally defective and unprocessed tRNAs subject to nuclear and 
cytoplasmic decay in S. cerevisiae. Upon transcription termination, pre-tRNAs undergo processing 
at the 5’ leader and 3’ trailer (purple circles) as well as acquiring PTMs on their nucleoside that 
aid in the structural stability and activity of the tRNA. Poorly processed pre-tRNAs (not shown), 
or lack of an essential PTM (white circle) such as m1A58 results in the nuclear decay of the tRNA 
via initial polyadenylation of the tRNA by the TRAMP complex (yellow circles) and subsequent 
degradation by 3’-5’ exonucleases of the nuclear exosome. Structurally defective tRNA or tRNA 
lacking more than one PTM (white circles) that is essential for its structural stability (eg. 
hypomodified C49 and G46 in trm4- trm8- cells) is also targeted for decay, both in the nucleus and 
the cytoplasm through the RTD pathway. Rat1 (nuclear) and Xrn1 (cytoplasmic) are the 5’-3’ 
exonucleases in charge of degradation of these aberrant tRNAs. Rat1 and Xrn1 are inhibited in 
met22- cells as a result of the presence of pAp, a by-product of the methionine biosynthesis 
pathway. Modified residues in the nucleus and the cytoplasm are shown in orange and brown 
circles respectively. Green circles depict processed, CCA containing tRNAs, and the anticodon is 
represented with red circles. Figure adapted from (62).   
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to the cytoplasm, pre-tRNAs associate with transport receptors (importin-b family member; 
exportin) that facilitate their export from the nucleus to the cytoplasm in a Ran-GTP dependent 
manner (83). Ran is a GTPase that is under the control of its regulators that reside in the nucleus 
(RanGEF; Ran guanine nucleotide exchange factor), and the cytoplasm (RanGAP; Ran GTPase 
activating protein), controlling whether Ran is bound by GDP or GTP (82, 84). These regulators 
enforce a Ran-GTP gradient across the two interface such that Ran-GTP levels are high in the 
nucleus and low in the cytoplasm, in this way allowing for import and export of tRNAs to and 
from the nucleus to the cytoplasm (82, 84). Pre-tRNA export in budding yeast is facilitated by the 
exportin Los1 (Xpo-t in fission yeast; exportin-t in vertebrates) that binds the trimeric complex 
which consists of the 3’ and 5’ end processed pre-tRNA bound to Ran-GTP in the nucleus, and 
delivers this complex to the cytoplasm. Once in the cytoplasm, Ran-GAP hydrolyzes Ran-GTP to 
Ran-GDP which results in the disassembly of the exportin-pre-tRNA complex and the recycling 
of Los1 for the transport of other tRNAs to the cytoplasm (82, 84). Crystallographic studies of  
S. pombe Xpo-t in association with tRNA and Ran-GTP have reported the specificity of the 
exportin not only towards intron-containing, 5’ and 3’ end processed tRNAs but more particularly 
towards the dihydrouridine (D-loop), TYC loop and the aminoacyl-stem of a correctly structured 
tRNA (62, 83). These findings are intriguing in that tRNA export by Xpo-t (and other exportin 
homologs) inhibits the entry of immature or damaged tRNAs to the cytoplasm, the site of protein 
synthesis (82). In addition to tRNA export and quality control, the localization of Los1 and its 
availability for tRNA transport from the nucleus to the cytoplasm is linked to cellular conditions 
(62). This is exemplified when cells are exposed to unfavorable growth conditions, such as glucose 
starvation and growth under a non-fermentable carbon source, leading to depletion of tRNA levels 
in the cytoplasm (62, 83). This was linked to both the downregulation of RNA pol III transcription 
of tRNAs but also by regulation of tRNA nuclear export by means of relocating Los1 to the 
cytoplasm where it is unable to facilitate tRNA-nuclear export (62). Similarly, Los1 confinement 
to the cytoplasm under other stress conditions such as DNA damage has also been reported, again 
regulating the level of tRNAs in the cytoplasm available for protein synthesis under unfavorable 
cellular conditions (62).  
While Los1 has been implicated in tRNA export, quality control and subcellular trafficking 
of tRNAs based on cellular conditions, it is found to be non-essential in yeast, in contrast to 
exportin-t which is essential and serves as the major exporter of tRNAs in vertebrates (62). Another 
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class of importin-b family of transport receptors in yeast that participates in tRNA nuclear export 
is Msn5. Like Los1, Msn5 transports tRNAs across the nucleopore using the Ran-dependent 
pathway of transport (62, 83). Although, Los1-/ Msn5- cells display no growth defects, indicating 
the presence of other undiscovered exportins in tRNA nuclear export in yeast, the overlapping 
function of Los1 and Msn5 is evident by the increase in the pool of tRNAs in the nucleus in the 
absence of both exportins (62, 83). However, Msn5 unlike Los1 displays minimal affinity towards 
intron-containing tRNAs and has been proposed to be responsible for transport of tRNAs that are 
either intron-less or intron-containing tRNAs that have already been transported to the cytoplasm 
for splicing and are in the nucleus, aminoacylated and ready for transport back to the cytoplasm 
(62).  
 
3.4.3 Retrograde pathway: re-import to nucleus and re-export to cytoplasm 
 
The unanticipated finding that the yeast tRNA splicing machinery is cytoplasmic and that nuclear 
spliced tRNA pools increase in nutritional stress conditions (glucose or phosphate deprivation), 
the presence of tRNA aminoacylation inhibitors or defects in aminoacylation led to the discovery 
of tRNA nuclear re-import and re-export; the retrograde pathway (82, 83, 85). While much has yet 
to be answered for the role and the protein factors involved in the retrograde pathway, based on 
current data it is widely speculated that the retrograde pathway serves to 1) regulate protein 
synthesis based on cellular conditions with controlling tRNA levels in the cytoplasm, and 2) as an 
additional form of quality control, ensuring only mature and correctly structured, functionally 
active tRNAs access the cytoplasm and participate in translation (83). These propositions have 
emerged from previous studies reporting, the increase in nuclear pool of tRNAs under nutritional 
stress (also with defects in aminoacylation) in conjunction with the relocation of mRNAs to P-
bodies from polysomes under conditions of glucose starvation (86, 87). The relocation of mRNAs 
and tRNAs during cellular stress conditions and the re-export of tRNAs to the cytoplasm and 
concurrent relocation of mRNAs back to polysomes with a replete of glucose have led to the 
speculations of the retrograde pathway playing a role in regulating protein synthesis based on 
cellular conditions (82, 83). It should be noted that while these independent findings have led to 
plausible propositions for role of tRNA retrograde pathway in protein synthesis regulation, further 
studies have yet to clearly verify this (83). 
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 To address the second plausible role of the retrograde pathway as an additional quality 
control mechanism, it has been suggested that tRNA processing and modification which primarily 
occurs in the nucleus is in direct competition with tRNA nuclear export which can lead to 
inaccuracy in processing of the tRNA and the export of an immature, hypomodified tRNA to the 
cytoplasm (83). Kramer and colleagues put this theory to test by reporting the accumulation of two 
types of aberrant tRNAs (5’, 3’ end-extended, spliced tRNAs and hypomodified tRNAs) in cells 
with defects in tRNA nuclear import factor (88). In addition to these findings, it has been reported 
that mtr10-/xrn1- cells (mtr10; nuclear import and xrn1; 5’-3’ exonuclease) are inviable suggesting 
that the RTD and the retrograde pathway may function in parallel in removal of aberrant tRNAs 
from the cytoplasm (88).  
Taken all together, the cell employs several mechanisms in ensuring the presence of only 
mature, functionally active tRNAs in the cytoplasm. The first quality control check of tRNAs is 
met through the nuclear exosome and the TRAMP complex which degrade hypomodified tRNAi-
Met lacking m1A58 and tRNAs with improperly processed 3’ ends (82, 88). Subsequently, Los1 
monitors 5’, 3’end processed unspliced tRNAs with a correctly structured D-loop, TYC loop and 
the aminoacyl stem for tRNA export but displays no particular affinity for tRNAs bearing or 
lacking nucleoside modifications (82, 88). The third opportunity for tRNA quality control involves 
the RTD pathway which degrades structurally unstable tRNAs that lack particular modifications 
and this can occur both in the nucleus and cytoplasm (65, 66). Lastly, and the more recently 
discovered quality control mechanism that appears to function in parallel with the RTD pathway 
is the retrograde nuclear import mechanism which recognizes 5’, 3’end processed, spliced and 
hypomodified tRNAs and is responsible for re-import of aberrant tRNAs to the nucleus (88). 
Although, it is now clear that the retrograde pathway functions in the delivery of aberrant tRNAs 
to the nucleus, the fate of these tRNAs is still a mystery; they may be subject to tRNA repair or 
degraded by the TRAMP complex or the nuclear RTD (88).  
As the retrograde pathway in tRNA subcellular localization is a more recently discovered 
phenomenon, there are still debates on factors involved in tRNA nuclear import. Mtr10 is among 
one of the members of the b-importin family of transport receptors and has been linked to tRNA 
nuclear import in the retrograde nuclear localization of tRNAs (83, 88). While the essential role of 
Mtr10 in tRNA nuclear import has been shown with increase in accumulation of aberrant tRNAs 
in the cytoplasm in mtr10- cells and the lethality of the mtr10-/xrn1- cells, the mechanism in which  
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Figure 10. Model for nuclear-cytoplasmic biogenesis and transport of tRNAs in S. cerevisiae. The 
nucleolus hosts the site of tRNA transcription and 5’ end processing while the 3’ end processing, 
CCA addition and certain modifications made to the tRNA (orange and yellow circles) are carried 
out in the nucleus. Intron-containing pre-tRNAs (blue circles) are exported to the cytoplasm and 
surface of mitochondria by Los1 where the splicing machinery in yeast resides. Following splicing, 
acquiring cytoplasmic PTMs (pink circles) and aminoacylation, the mature tRNAs are sent to the 
translation machinery. The retrograde import pathway facilitated by Mtr10 re-imports mature 
tRNAs to the nucleus. Re-export of mature tRNAs is dependent on cellular conditions (eg. 
nutritional stress) and facilitated by Msn5 and Los1. Figure adapted from (61). 
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Mtr10 associates with tRNAs and the mode of transportation is still under investigation with 
unclear insights as to the Ran-dependent or Ran-independent mode of transportation by Mtr10 
(Figure 9) (83, 88). 
	
3.4.4 tRNA import into mitochondrial organelle  
 
The mitochondrion is a double membrane-structured organelle that facilitates oxidative 
phosphorylation and is widely recognized as the major powerhouse of the cell in all eukaryotes 
(89). In production of ATP and maintenance of a functional respiratory complex, the 
mitochondrion is supplied with a large volume of nucleus-encoded proteins that are imported 
into the mitochondria, in addition to the proteins that are synthesized directly from the 
mitochondrial genome (83). For the small, but nonetheless essential proteins synthesized in the 
mitochondria, a complete set of tRNAs facilitating protein synthesis is required. The initial insight 
into nuclear-encoded tRNA import into the mitochondria was made over 50 years ago by Suyama 
et al. by noting that the tRNA fractions isolated from the mitochondrial of protozoan Tetrahymena, 
were largely nuclear-encoded tRNAs (90). Since these initial findings, many more claims of 
nuclear encoded-tRNA import into the mitochondria have been made, varying from the import of 
a few tRNAs into yeast and human mitochondria organelle to a complete set of nuclear-encoded 
tRNAs imported into the mitochondria of protists (83). The import of cytosolic tRNAs into the 
mitochondria have been most clearly studied in S. cerevisiae with the import of tRNAs coordinated 
through two pathways; the co-import and the direct import (90).The better characterized co-import 
pathway relies on mitochondrial protein import factors and a series of other proteins that engage 
the tRNA and translocate it from the outer membrane through the inner membrane and lastly 
deliver the tRNA to the matrix of the mitochondrial membrane, the site of protein synthesis (83). 
Protein entry into the mitochondrial matrix is directed through two major heteroligomeric protein 
complexes, TOM (translocase of the outer membrane) and TIM (translocase of the inner 
membrane) and other protein factors in association with these translocator complexes (90, 91). The 
heteroligomeric TOM complex comprises of Tom40 as the main component with Tom20, Tom22 
and Tom70 functioning as the pre-protein receptors, and a few smaller TOM proteins (90, 91). 
Generally, nuclear-encoded mitochondrial pre-proteins (precursor proteins) carry a targeting 
signal (commonly found in the N-terminal but also present internally in the pre-protein or  
C-terminal) that determines its localization in the subcompartments of the mitochondria (91).  
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Pre-proteins are initially recognized by Tom20 and Tom22 which direct the translocation of the 
pre-proteins through the import channel of Tom40 (90, 91). Once the pre-protein has passed 
through the TOM complex, it is either released in the inter-membrane space or transported to the 
inner-membrane or the matrix. This is directly related to the type of protein and the targeting signal 
present on the pre-protein (91). In the interest of this review, the focus will be on pre-proteins 
destined to the matrix using the TIM complex. The transfer of the pre-protein into the inner-
membrane is assisted by the TIM complex which consists of Tim23 as the central component and 
Tim17, Tim50 and Tim21 as the associating receptors (91). The TOM complex in cooperation 
with the TIM complex, translocate the pre-protein to the inner-membrane or directly to the matrix 
by interacting with the presequence translocase-associated motor (PAM) and its central subunit 
Hsp70 which coordinates the ATP-dependent transport of the pre-proteins to the matrix (90, 91).  
 While the import of tRNAs into the mitochondrion matrix is now well established, studies 
in this field are still premature with only a handful of well characterized tRNA import mechanisms 
reported. The most notable example is the import of tRNA-LysCUU using the co-import pathway 
of translocation that has been studied in S. cerevisiae (90). The glycolytic enzyme, enolase (Eno2p) 
specifically recognizes tRNA-LysCUU and subsequently carries the tRNA to the surface edge of 
the mitochondria, delivering tRNA-LysCUU to pre-LysRS (precursor of mitochondrial lysyl-tRNA 
synthetase) (90, 92, 93). At this stage, Eno2p is released in the outer mitochondrial membrane, 
associating with a glycolytic multiprotein complex, while the tRNA-LysCUU -pre-LysRS complex 
is directed to the mitochondrial matrix through the protein import pathway, mentioned above 
(Figure 10) (90, 92, 93). Recent in vitro FRET experiments have revealed a structural 
rearrangement noted for tRNA-LysCUU in association with Eno2p such that the tRNA diverts from 
the canonical L-shaped configuration while bound by Eno2p and regains a conformation like the 
tertiary L-shaped conformation when bound by pre-LysRS (90, 94). These new insights give 
possible reason for the specificity of Eno2p engaging tRNA-LysCUU instead of its isoacceptor 
tRNA-LysUUU as it is plausible that this conformational change may be unique to tRNA-LysCUU 
(90, 94). In addition to this structural specificity possibly dictating tRNA-LysCUU-mitochondrial 
import, tRNA-LysCUU must also be aminoacylated to engage pre-LysRS. Furthermore, the role of 
pre-LysRS is strictly limited to tRNA-LysCUU mitochondrial import and is incapable of 
aminoacylating tRNA-LysCUU , in direct contrast to its capacity in aminoacylation of mitochondrial 
tRNA-LysUUU (90, 95). In vitro and in vivo mutagenesis studies on pre-LysRS have identified the 
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N-terminal region of the protein responsible for tRNA import and the full-length protein 
possessing the aminoacylation activity (90, 95). Lastly, the notion that mitochondrial encoded 
tRNA-LysUUU can in theory decode both lysine codons, and the idea that tRNA-LysCUU is only 
utilized in one cycle of elongation as it cannot be aminoacylated in the mitochondria begs the 
question of the purpose of tRNA-LysCUU -mitochondrial import. Recent studies have addressed 
this counterintuitive phenomenon by revealing the essential role of tRNA-LysCUU in decoding 
AAG codons when cells are grown at 37°C in which tRNA-LysUUU is hypomodified at the wobble 
uridine and non-functional in decoding AAG codons (90, 96).  
 The second piece of evidence for cytosolic tRNA import into the yeast mitochondria has 
been reported with tRNA-GlnCUG and tRNA-GlnUUG (90, 97) . In contrast to the co-import pathway 
used for tRNA-LysCUU, the import of tRNA-GlnCUG and tRNA-GlnUUG is through the direct import 
pathway, eliminating the requirement for the protein import complex, a membrane potential and 
cytosolic factors. While evidence is missing for the purpose and the exact mechanism of import 
for cytosolic tRNA-Gln, the localization and import of this tRNA in the mitochondria was 
illustrated by the capacity of a suppressor cytosolic tRNA-GlnCUA in partially suppressing a 
nonsense mutation created in cytochrome oxidase subunit II (cox2) verifying the import and the 
role of this cytosolic tRNA in the mitochondrial translation machinery (90, 97). Albeit, there have 
been significant improvement in the field of tRNA subcellular localization and specifically 
translocation to the mitochondria, clarity is still much needed in identifying guidelines for import 
of nuclear-encoded tRNAs to the mitochondria through the co-import or direct import pathway 
and factors involved in this shuttling.   
 
4. Mitochondria, the powerhouse of eukaryotic cells  
 
The mitochondria, conserved in almost all eukaryotic cells are well characterized for their essential 
role in ATP production through oxidative phosphorylation (OXPHOS) and managing other 
biochemical processes of the cell such as citric acid cycle, pyruvate oxidation and electron 
transport (89, 98, 99) . These double-membrane bound organelles are also responsible for cellular 
metabolism, biogenesis of iron-sulfur proteins, regulation of cytosolic calcium levels, heme 
biosynthesis and apoptosis (89, 99). While the mitochondrion is the host of essential cellular 
processes, the maintenance of a functional mitochondrion is highly reliant on the elegantly  
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Figure 11. Model for cytosolic-tRNA import into the subcompartments of mitochondria in 
S. cerevisiae. (A) Cytosolic tRNA-LysCUU is directed to the mitochondrial matrix for use in mRNA 
decoding using the co-import pathway by initial binding to Eno2p (green) which induces structural 
changes on the tRNA, deviating from the canonical L-shaped configuration (tertiary conformation 
not represented here, note secondary structural changes). Pre-LysRS (orange) which is located at 
the surface of the mitochondria subsequently binds tRNA-LysCUU, releasing Eno2p which is then 
free to engage the glycolytic multiprotein complex (blue) found at the surface of outer-membrane 
of the mitochondria. The pre-LysRS- tRNA-LysCUU complex is then shuttled through the outer-
membrane to the inner-membrane and lastly the matrix of the mitochondria through the protein 
import pathway; TOM and TIM complex (see text for details). (B) Direct import is used for the 
translocation of cytosolic tRNA-GlnCUG and tRNA-GlnUUG into the mitochondrial matrix and this 
is carried out in the absence of assisting cytosolic factors, the protein import complex and a 
membrane potential through an undefined mechanism. Figure adapted from (90). 
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complex communications between the nuclear and the mitochondrial genome (89). The region of 
the inner membrane and the matrix of the mitochondria are protein-rich with proteomics studies 
in yeast identifying ~1000 mitochondrial proteins of which only 8 (in S. pombe and S. cerevisiae) 
of these proteins are encoded by mitochondrial DNA (mtDNA) and a product of mitochondrial 
translational machinery (98). These express the mitochondrial ribosomal protein of the small 
subunit (Var1; S. cerevisiae) as well as some components of the structural subunits of the five 
multimeric OXPHOS respiratory complex which includes the respiratory complexes III, 
cytochrome c oxidase (IV) and ATP synthase (V) (98, 100). Aside from the handful of 
mitochondrial encoded proteins reported to date, the rest of the mitochondrial proteins residing in 
the organelle are nuclear encoded, translated in the cytoplasm and subsequently imported into the 
mitochondria (98). Therefore, the maintenance of an operative respiratory complex and 
propagation of these semi-autonomous organelles relies on the communications between the 
nuclear and mitochondrial genome, facilitating in-house mitochondrial translation and the import 
of cytosolic proteins (89).  
 
4.1 Mitochondrial translation  
 
The expression of the few mitochondrial encoded genes, namely the assembly of the multimeric 
OXPHOS subunits is dependent on both the import of nuclear-encoded subunits of the respiratory 
complex and the concomitant translation of the mitochondrial-encoded OXPHOS subunits and 
their subsequent assembly. To facilitate mitochondrial translation, the genome of this organelle 
possesses mtDNA encoding 2 ribosomal RNAs and a set of tRNAs (98, 100). The number of 
tRNAs encoded in the mtDNA is reported to be highly species specific with yeast possessing a set 
of 25 tRNAs in the mitochondria and only relying on the import of a few cytosolic tRNAs, while 
conversely the mtDNA of some protists lack tRNA genes and rely on the import of a full set of 
cytosolic tRNAs (83, 100).The mtDNA also encodes some components of the mitochondrial 
ribosome (mitoribosome) which like the cytoplasmic ribosome, consists of a small (SSU) and large 
ribosomal subunit (LSU). The mitochondrial gene expression system follows the universally 
conserved steps of translation; initiation, elongation and termination (89, 101, 102). Translation 
initiation begins with mitochondrial initiation factors (IF2mt &IF3 mt; Ifm1 & Aim23 yeast 
homologs) associating with the mitoribosome and assembling the initiation complex. While there 
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are still many unanswered questions regarding the exact initiation mechanism of mitochondrial 
translation due to differences between mitochondrial mRNAs in comparison with prokaryotic 
(presence of Shine-Dalgarno sequence) and eukaryotic mRNAs (7-methylguanylate capped), it is 
currently postulated that the SSU of the mitoribosome initiates translation with the selection of 
unstructured regions in the 5’ end of mRNAs (101). Subsequently the initiation complex identifies 
the start codon (AUG) and the IF3 mt facilitates the correct binding of the mRNA AUG codon to 
the peptidyl site (P) of SSU (89, 102). IF2 mt assists the interaction between fMet-tRNA-Met and 
SSU. This results in joining of the LSU to SSU and the release of the initiation factors and the 
completion of translation initiation (101). Elongation is coordinated by mitochondrial elongation 
factor Tu (nuclear-encoded genes; EF-Tumt and Tuf1 yeast homolog) which orchestrates the 
interaction between the mitoribosome, tRNA and the mitochondrial elongation factor G1 (EF-
G1mt, Mef1 yeast homolog) (89, 102). Elongation proceeds with the continuous delivery of charged 
tRNAs to the growing polypeptide chain until the stop codon (UAA, UAG, AGA or AGG) is 
encountered by the release factor (RF1mt, Mrf1 yeast homolog) which works in conjunction with 
the recycling factor (RRF1 mt, Rrf1 yeast homolog) (101, 102). Termination results in the 
hydrolysis of the ester linkage between the nascent polypeptide chain and the last tRNA at the P-
site of SSU and the dissociation of the mitoribosome into SSU and LSU subunits, recycled for 
future cycles of translation (89, 102). While mitochondrial translational machinery is sufficiently 
operative in the expression of a set of the OXPHOS subunits, the remainder of the subunits and 
the majority of the mitochondrial proteins detected in the protein-rich matrix, the outer and inner-
membrane are all nuclear-encoded, expressed in the cytoplasm and imported. In addition to the 
import of OXPHOS nuclear encoded subunits, the mitochondria also significantly rely on the 
import of other nuclear encoded proteins to support the organelle and examples of these include: 
proteins supporting the mitochondrial translational machinery, protein folding and transport, 
turnover and tRNA PTM enzymes (98, 101).  
 
4.2 Import of cytosolic proteins   
 
Nuclear-encoded mitochondrial proteins are synthesized by the cytoplasmic ribosome and are 
post-translationally transported into the mitochondria as pre-proteins, carrying a mitochondrial 
targeting sequence (MTS). Mitochondria-destined pre-proteins are categorized into two main 
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groups: pre-proteins with a cleavable N-terminal MTS and pre-proteins that possess an internal 
non-cleavable MTS (103, 104). The class of proteins with a cleavable N-terminal MTS are largely 
destined to either the inner-membrane, inter-membrane or the matrix of the mitochondria (104). 
The MTS of these pre-proteins often comprise of 10-90 residues, highly enriched in positively 
charged amino acids such as arginine and lysine residues (103, 104). Previous findings have 
proposed a model wherein the MTS forms an amphiphilic a-helical structure in which the 
hydrophobic site associates with the Tom20 subunit of the TOM complex and the positively 
charged residues interact with Tom22 (103, 104). As a result, the pre-protein is directed towards 
the main import receptor, Tom40 by the sequential interactions with Tom20, 22 and Tom5. Once 
the pre-protein is delivered to its destination, the mitochondrial processing peptidase (MPP) 
removes the MTS from the pre-protein and with the assistance of molecular chaperons (eg. Hsp60) 
the protein is folded into a functionally active conformation (103–105).  
The proteins identified in the outer-membrane largely encompass the second class of 
nuclear-encoded mitochondrial pre-proteins carrying the internal MTS. While pre-proteins with 
internal MTS are routinely shuttled to the outer-membrane, many may also be transported to the 
inner and inter-membrane space. Examples of this class of pre-proteins consists of outer membrane 
proteins and some hydrophobic carrier pre-proteins of metabolites such as ATP/ADP or phosphate 
carrier pre-proteins, with no reports indicating any conservation in the sequence or location of the 
internal signal amongst this class of pre-proteins (104, 106). Cytosolic protein chaperones (eg. 
Hsp70 & Hsp90) play a large role in the transport of these pre-proteins to ensure minimal 
aggregation of the hydrophobic carrier proteins and to facilitate their interaction with the Tom70 
receptor. Although Tom70 has been recognized as the major site of entry for pre-proteins with 
internal MTS, with Tom20 and 22 being classified as major entry receptors for pre-proteins with 
N-terminal MTS, previous studies support the notion that defects in one receptor can be partially 
compensated by the role of other mitochondrial import receptors (104).  
 
4.3 Trm1: Nuclear and mitochondria targeted tRNA 
methyltransferase 
 
The ubiquitous and abundant nature of tRNA PTMs has led to decades of research in the role of 
these functional groups that decorate the clover-leaf structure. PTMs are now known to facilitate 
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the structural stability of tRNAs in addition to playing an elemental role in mRNA decoding (61, 
63). Like nuclear-encoded tRNAs, mitochondrial tRNAs have been postulated to benefit from 
PTMs particularly for structural stability to even a larger extend than nuclear-encoded tRNAs 
(101). Mitochondrial tRNAs (mt-tRNAs) are recognized to deviate from the canonical type 6 fold 
found in cytoplasmic tRNAs, are identified to be generally shorter, and display variability in the 
D and T-loop and are deficient in some conserved nucleotides that are thought to be essential for 
the formation of a stable tertiary L-shaped fold (101). Given the role of mitochondrial-encoded 
tRNAs in the translational machinery of the organelle and their susceptibility in forming non-
canonical and aberrant structures, the role of PTMs on these tRNAs should be emphasized.   
 Trm1, which facilitates N2, N2-dimethylation of G26 is an example of a PTM enzyme that 
shuttles between the nucleus and the mitochondria for modification of tRNAs. Early studies on 
Trm1 in S. cerevisiae revealed two-in frame start codons, the first positioned at amino acid 1 and 
the second ATG was found at amino acid 17 (107). This indicated the potential for the formation 
of two isoforms of the enzyme: Trm1p-I and Trm1p-II. Further investigation revealed that the 
translation of the two isoforms of Trm1p from either start codon is transcriptionally regulated with 
the 5’ends of the mRNA being located upstream of either ATG1 (translating Trm1p-I) or 
positioned between ATG1 and ATG17 (translating the shorter isoform, Trm1p-II) (107). With 
Trm1p being located strictly in the nuclear periphery and the mitochondria and entirely absent in 
the cytosolic region of the cell, the early simplistic insights categorized the two Trm1p isoforms 
into the two compartments, with the shorter Trm1p-II located at the nuclear periphery and the 
longer extended isoform (Trm1p-II) located in the mitochondria (107).  However, it was later 
discovered that while Trm1p-I is entirely imported into the mitochondria, that Trm1p-II can be 
found in the nuclear periphery as well as imported into the mitochondria at a level sufficient 
enough to modify G26-containing tRNAs in the organelle under wildtype conditions (72, 107). 
These insights led to the findings that the amino-terminus of Trm1p-II, in conjunction with the 
amino-terminal extension, form a MTS sequence for Trm1p that most efficiently delivers the 
enzyme to the mitochondria. More specifically the region between amino acids 1-48 serve as the 
MTS, while amino acids 70-213 are responsible for directing Trm1p to the nucleus with NTS-like 
(nuclear targeting signal) residues more primarily localized to amino acids 95-102, enriched in 
lysine residues (72, 107).   
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5. Summary of literature review  
 
The RNA folding problem, central to this review, emphasizes the barriers for a primary sequence 
of RNA in specifying a single, functional fold. The kinetic and thermodynamic problems that 
ensue the RNA folding problem are now known to be largely resolved with the assistance of 
various classes of RNA-binding proteins. With the focus on tRNAs as RNA candidates that 
routinely deviate from the canonical type 6 clover-leaf secondary structure, numerous examples 
of extensive post-transcriptional processing steps have been described that illustrate the level of 
cellular control devoted to ensuring a final, correctly structured functional tRNA. The role of the 
RNA chaperone La and PTMs made to the body of tRNAs such as dimethylation of G26 by Trm1p 
have been extensively reviewed. This demonstrates the influence of both an RNA chaperone and 
a PTM in specifying a unique functional fold for a tRNA and protecting the tRNA from misfolding 
and subsequent degradation. In addition, the role of Trm1p (a PTM distant from the anticodon 
loop) in potentially regulating the mRNA decoding capacity of tRNAs has also been emphasized. 
With a direct link between structure and function, elucidating the role of RNA chaperones and 
other PTM enzymes involved in RNA biogenesis and assembly has become central to the interest 
of researchers. 
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CHAPTER II: Statement of Purpose  
 
Noncoding RNAs facilitate a myriad of biological processes. The functionality of RNA molecules 
is tightly linked to their complex tertiary structural conformation (1). The similarities in the 
structural composition of the nitrogenous bases predispositions RNA molecules in forming non-
functional conformations that are thermodynamically as stable as the native, functionally active 
fold (2, 4). To ensure proper biological activity and native folding, RNA substrates constantly 
associate with a variety of RNA-binding proteins and concomitantly acquire numerous PTMs on 
their sugar-ribose moiety during processing (2, 4, 7, 63). RNA chaperones are a class of RNA-
binding proteins that nonspecifically and transiently interact with RNA substrates and facilitate 
their search for the native conformation (1-7). La proteins are highly abundant RNA chaperones 
that assist processing of all pol III transcripts with pre-tRNAs being their best characterized 
substrates (20). La proteins make specific contacts to pre-tRNAs via the UUU-3’OH tail and 
nonspecifically by interacting with the main body of the tRNA which is associated with the RNA 
chaperone activity function (20, 29, 47, 48). Given the limiting abundance of La proteins relative 
to the highly abundant UUU-3’OH containing substrates (43), the mechanism in which La 
differentiates between a misfolded and folded UUU-3’OH containing substrate such as pre-tRNAs 
has not been addressed. Additionally, tRNAs are highly post-transcriptionally modified with 
modifications made to the body of tRNAs facilitating structural stability (61–63). m""G26 
modification by Trm1p, functions redundantly with La in supporting structural stability of G26-
containing tRNAs (70). While Trm1p modification presumably stabilizes the “hinge” region 
between the anticodon and D-stem, the impact of m""G26 on tRNA functionality has not been 
investigated (74, 116). In this work, we aimed to elucidate the capacity of La as an RNA chaperone 
in differentiating a misfolded pre-tRNA from its folded counterpart. Secondly, we have sought out 
to investigate the impact of m""G26 on tRNA activity in mRNA decoding.  
 
Chapter III: The RNA chaperone La promotes pre-tRNA maturation via indiscriminate 
binding of both native and misfolded targets  
 
La deletion is synthetically lethal when combined with the loss of modification enzymes that 
support tRNA structural stability such as Trm1p. In this work, we have assessed the mechanism in 
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which the RNA chaperone La targets and differentiates a misfolded Trm1p-hypomodified tRNA 
from its folded, Trm1p-modified counterpart. We have identified S. pombe cytosolic G26-
containing pre-tRNAs that misfold in sla1-/trm1- cells. These candidate tRNAs showed reduced 
steady state abundance or were not as efficiently aminoacylated as shown in wildtype conditions. 
Using in vivo and in vitro assays, we tested for possible differential binding affinity of La towards 
a misfolded Trm1p-hypomodified tRNA candidate versus its modified, folded state. Our data 
conclusively demonstrates the non-discriminatory La binding affinity towards a misfolded and 
folded pre-tRNA. Our findings add clarity to the ambiguous mechanism previously hypothesized 
for RNA chaperone activity.  
 
Chapter IV: Global protein expression regulated by Trm1p-catalyzed 𝐦𝟐𝟐G26 modification 
of mitochondrial and nuclear encoded tRNAs   
 
N2, N2-dimethylation of G26 by Trm1p has been reported for S. pombe cytosolic tRNAs in recent 
tRNA-HydroSeq (71). Trm1p modification efficiency is variable depending on tRNA identity. 
TMS assay using S. pombe suppressor tRNA-SerUCA shows significant reliance on m""G26 in 
suppressing a nonsense codon in the ade6-704 allele (71). In this work, we have sought out to 
identify a novel role for m""G26 in altering tRNA activity and the impact of this modification on 
global protein expression levels. Using a SILAC (stable isotope labeling of amino acids in cell 
culture) proteomics approach we have identified changes in protein expression levels that coincide 
with Trm1p depletion. We have noted a correlation between the change in expression levels of a 
subset of polypeptides in trm1- cells with the enrichment of CTA codons in these transcripts, likely 
due to inefficient activity of the corresponding Trm1p-hypomodified tRNA-LeuUAG in decoding 
these CTA codons. Additionally, we have identified metabolic processes upregulated in trm1- 
cells, particularly those associated with mitochondrial function. We have reported robust presence 
of m""G26 on specific mt-tRNAs and have further assessed their charging state +/- m""G26. We 
have also evaluated the expression levels of mitochondrial and cytoplasmic translation products 
and demonstrate that while the expression of mitochondrial-encoded OXPHOS components is not 
altered in trm1- cells, the overexpression of mitochondrial-targeted Trm1 or its nuclear-bound 
counterpart displays a decrease in cytoplasmic translation products. Our data alludes to a novel 
role for Trm1p in modulating cytoplasmic and mitochondrial physiology potentially through 
altering tRNA functional activity and stability. 
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CHAPTER III: The RNA chaperone La promotes pre-
tRNA maturation via indiscriminate binding of both 
native and misfolded targets 
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PREFACE 
	
Noncoding RNAs have critical roles in biological processes, and RNA chaperones can promote 
their folding into the native shape required for their function. La proteins are a class of highly 
abundant RNA chaperones that contact pre-tRNAs and other RNA polymerase III transcripts via 
their common UUU-3’OH ends, as well as through less specific contacts associated with RNA 
chaperone activity. However, whether La proteins preferentially bind misfolded pre-tRNAs or 
instead engage all pre-tRNA substrates irrespective of their folding status is not known. La deletion 
in yeast is synthetically lethal when combined with the loss of tRNA modifications predicted to 
contribute to the native pre-tRNA fold, such as the N2, N2-dimethylation of G26 by the 
methyltransferase Trm1p. In this work, we identify G26 containing pre-tRNAs that misfold in the 
absence of Trm1p and/or La (Sla1p) in S. pombe cells, then test whether La preferentially 
associates with such tRNAs in vitro and in vivo.  Our data suggest that La does not discriminate a 
native from misfolded RNA target, and highlights the potential challenges faced by RNA 
chaperones in preferentially binding defective substrates. 
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INTRODUCTION 
	
Nascent RNA transcripts have a significant propensity to become kinetically trapped in non-
functional conformations. It has thus been hypothesized that one of the earliest functions of 
polypeptides would be to help resolve these aberrant structures so that RNAs can better access 
their functionally relevant, native folds (108). Proteins that promote the native fold have been 
classified based on their proposed mechanism of action (reviewed in (7)). One such class of factors 
is the RNA chaperones, which are hypothesized to unwind misfolded structures in the absence of 
ATP hydrolysis via mechanisms that remain ambiguous (2, 6, 109). By assisting RNA substrates 
in attaining their native fold, RNA chaperones can rescue defective or misfolded RNA substrates 
from RNA quality control systems such as nuclear surveillance (47, 69, 79). Though it’s been 
recognized that many noncoding RNAs are susceptible to folding into alternate inactive 
conformations, mechanisms by which RNA chaperones might discriminate misfolded RNA 
substrates are not well understood. It has been previously noted that the greater homogeneity of 
functional groups in RNA relative to amino acids might make for greater challenges in 
discrimination of fold for RNA chaperones relative to protein chaperones, even if thermodynamic 
models for misfolded target recognition by RNA chaperones have been proposed (2, 6). For RNA 
chaperones such as StpA and hnRNP A1, it has been proposed that these preferably engage single 
stranded regions of RNA that are hypothesized to be more prevalent in misfolded conformations 
(12, 16, 110). One significant challenge to accessing insights into target recognition is the 
identification of physiologically relevant, misfolded RNA conformations that the RNA chaperone 
in question samples in vivo. Thus, the issue of functional target discrimination by RNA chaperones 
has not been explored extensively. 
The La and La-related proteins are a conserved class of eukaryotic RNA-binding proteins 
that have been characterized as RNA chaperones (21, 22, 29, 30, 47). La proteins have important 
roles in the processing of nascent RNA polymerase (Pol) III transcripts, with pre-tRNAs being 
their best-characterized substrates (reviewed in (24)). This association relies in part on specific 
recognition of the uridylate containing trailer sequence (UUU-3’OH) that is found at the end of all 
Pol III transcripts and some noncoding RNA polymerase II processing intermediates. In yeast, La 
binding to the UUU-3’OH containing trailer results in pre-tRNA stabilization and accumulation, 
and commits the pre-tRNA to the La-dependent pathway of processing, in which leader processing 
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precedes endonucleolytic trailer processing, rather than trailer removal by exonucleases like Rex1p 
in the absence of La (25, 111).   
Structural and biochemical work have indicated that UUU-3’OH dependent La-RNA 
binding relies on a highly conserved N-terminal domain which comprises a winged-helix like La-
motif (LAM) and an adjacent RNA recognition motif (RRM1) that synergize to form the so-called 
La-module (20, 112). Co-crystal structures of the La module interacting with UUU-3’OH 
containing RNAs have revealed conserved residues in the LAM involved in recognition of the 
poly-uridylate sequence (55, 113), and this binding mode is associated with protecting nascent Pol 
III transcripts from exonuclease digestion (47). However, other non-UUU-3’OH dependent RNA 
contacts also make a major contribution to La/pre-tRNA binding. La binds short UUU-3’OH 
containing oligonucleotides approximately 10X less avidly than the same UUU-3’OH motif 
presented in the context of a full pre-tRNA (22). This is at least in part due to other regions of the 
RRM1 domain, as well as disordered amino acids C-terminal to this region, that engage the main 
body of the tRNA and promote the native fold through RNA chaperone activity (22, 29, 47, 48).  
Mutation of basic amino acids in RRM1 result in decreased pre-tRNA binding without affecting 
UUU-3’OH binding (22) , and mutation of aromatic amino acids in the RNP motifs of RRM1 
normally associated with canonical RRM-associated RNA binding result in defective RNA 
chaperone activity in vitro and degradation of defective (mutated) pre-tRNAs in vivo (29, 47).   
These mutations also result in decreased levels of the stable pre-tRNA species normally associated 
with the La-dependent pre-tRNA processing pathway (47). Importantly, decreased pre-tRNA 
accumulation due to RRM1 mutation only correlates with decreased mature tRNA levels if the 
tRNA is defective (mutated); conversely, wild-type pre-tRNAs show normal mature tRNA levels 
despite decreased pre-tRNA accumulation in the presence of La-RRM1 mutants.  These data led 
to a model in which La engages all pre-tRNAs regardless of folding status for the benefit of 
rescuing defective substrates and at the expense of processing efficiency for non-defective pre-
tRNAs (47). However, the ability of La to differentially bind any folded versus misfolded 
substrates within the UUU-3’OH containing RNA target cohort has not previously been tested in 
vitro or in vivo. Since La is hypothesized to be limiting relative to RNA Pol III transcript abundance 
(43), whether La discriminates native from misfolded substrates could play an important role in 
determining which pre-tRNAs access the La-dependent versus La-independent processing 
pathways. Attempting to experimentally test whether the affinity of La for a physiologically 
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relevant, misfolded RNA target differs relative to its natively folded counterpart is a major theme 
of this work. 
Pre-tRNAs are among the most highly post-transcriptionally modified classes of RNA 
species, with a median of 8 modified nucleosides per mature transcript (114). Several cases have 
been reported in which the absence of an essential modification has resulted in the degradation of 
select tRNAs. Mature tRNAs lacking particular modifications can be degraded at elevated 
temperatures via the rapid tRNA decay pathway (65, 115), or hypomodified pre-tRNAs can be 
degraded in the nucleus by nuclear surveillance. One such example is the methylation of A58 
(m1A58) by Trm6/61 on pre-tRNAiMet in S. cerevisiae; absence of this modification can result in 
degradation of pre-tRNAiMet via the TRAMP complex and nuclear exosome (79), but this can be 
rescued by overexpression of the La homolog Lhp1p (69). Similarly, deletion of Lhp1p is 
synthetically lethal with tRNA mutations shown to affect their folding (46) or with deletion of 
other tRNA modification enzymes (70, 116), consistent with La functioning redundantly with 
elements that stabilize native pre-tRNA structure. 
One tRNA modification associated with La function is the N2,N2-dimethylation of G26 
containing tRNAs by the methyltransferase Trm1p (70), a tRNA modification enzyme that 
localizes to the nuclear membrane (117). N2,N2-dimethylation of G26 has been hypothesized to 
stabilize tRNA structure in the “hinge” region between the coaxially stacked anticodon- and D-
stems , as well as prioritize the native fold of cytoplasmic tRNA anticodon stem loops over aberrant 
structures occasionally observed in native mitochondrial tRNAs (75).  Deletion of Trm1 is 
synthetically lethal with deletion of Lhp1 when S. cerevisiae is grown at elevated temperature (70), 
and N2,N2-dimethylated guanosine containing tRNAs are immunoprecipitated by La protein 
(118), suggesting that G26 modification occurs during the window of La-pre-tRNA occupancy.  
Taken together, these data suggest that La binds the nascent pre-tRNA transcript and promotes its 
stability and/or the native fold until this is reinforced by methylation of G26 by Trm1p.  Thus, the 
study of La binding to Trm1p modified versus unmodified pre-tRNAs represents an opportunity 
to compare the affinity of an RNA chaperone to a natively folded versus misfolded substrate in 
which the misfolded conformation is physiologically relevant and is sampled by the RNA 
chaperone in vivo.  
Previous work suggests that modification at G26 by Trm1p and La RNA chaperone activity 
function redundantly in stabilizing tRNA structure (70).  However, which tRNAs might misfold 
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in the absence of dimethylation at G26, or whether La can discriminate any folded versus 
misfolded substrate, has not previously been tested.  In this work, we have attempted to directly 
test whether La differentiates misfolded G26 unmodified versus Trm1p modified pre-tRNAs both 
in vitro and in S. pombe cells. We demonstrate that similar to S. cerevisiae, deletion of S. pombe 
La (Sla1p) and Trm1p is synthetically lethal at elevated temperatures. We then further show that 
Sla1p dependent suppression of lethality relies on amino acids associated with La-dependent RNA 
chaperone activity, consistent with Trm1p and La functioning redundantly to stabilize pre-tRNA 
structure. Using lead acetate chemical probing, we identify tRNA-SerUGA as a tRNA whose fold 
changes on the basis of Trm1 modification, and further demonstrate its impaired charging in a 
sla1-/trm1- strain, consistent with misfolding in vivo. We also identify cohorts of G26 containing 
tRNAs whose steady-state abundance is depleted in trm1-, sla1- and sla1-/trm1- cells, consistent 
with Trm1p functioning in the stabilization of certain tRNA species. Using pulldown of 
endogenous La-pre-tRNA complexes formed in vivo and gel-shift analysis of La-pre-tRNA 
complexes in vitro, we then test for the capacity of La to differentially bind pre-tRNAs with respect 
to their modification status at G26. In sum, our results suggest that La binds natively folded tRNAs 
and tRNAs that likely misfold due to hypomodification of G26 indiscriminately. Finally, we 
further demonstrate that human La also binds a fully modified tRNA substrate indiscriminately 
from its unmodified, T7 transcribed counterpart. Our data suggest that La is poorly capable of 
differentiating substrates whose folding and accumulation rely on the modification of G26 by 
Trm1p and the RNA chaperone activity of La, consistent with a model in which alternate tRNA 
folds may not form a primary binding determinant for La proteins. We propose that these RNA 
chaperones are directed to their substrates more by features related to the processing stage of their 
targets and less by their folding status, in an analogous manner to the variant protein molecular 
chaperones calnexin and calreticulin. Thus, our work adds an interesting new facet with respect to 
our understanding of how RNA chaperones can engage their targets.   
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MATERIAL AND METHODS 
 
Northern analyses 
	
Cells were grown in YES at 32oC and then shifted to minimal media for ten hours prior to harvest.  
Total RNA was extracted and purified from yeast cells and Northern analysis was performed as 
described (22). Values represent the mean fold abundance relative to the respective tRNA in the 
wild-type strain over a minimum of three independent growths/total RNA extractions.  These were 
normalized to U5 snRNA as a loading control and presented relative to the respective tRNA 
abundance in the WT strain. Significant differences in tRNA abundance between mutant strains 
and the wild-type strain were assessed by performing a one-way ANOVA to compare means across 
all treatments, followed by a Tukey posthoc test with alpha set to 0.05 (*, Figure 4B-D) or 0.01 
(**). DNA probes were made for indicated tRNAs by 5’ end labeling of the oligonucleotides using 
T4 polynucleotide kinase and 32P-γ-ATP.  Probes used for Northern analysis were all 
complementary to the TψC-loop of their respective targets.  Probe sequences are provided in 
Supplementary Table 3.  
 
Analysis of Aminoacyl-tRNA charging  
	
Cells were grown in YES at 32oC and then shifted to minimal media for ten hours prior to harvest.  
Total RNA was extracted under acidic conditions using Trizol reagent (Invitrogen). For acid-
Northern, half of the WT total RNA was deacylated with 0.2 M Tris pH 9.0 for 2 hours at 37°C 
and then ethanol precipitated and stored in 10 mM sodium acetate pH 5.0. All samples were 
fractionated on a 15% polyacrylamide acid (0.1 M sodium acetate pH 5.0) denaturing gel (vertical 
Gel Electrophoresis System V16-2, Apogee) and transferred onto a GeneScreen Plus transfer 
membrane (PerkinElmer) using the iBlot Gel Transfer system (Invitrogen). Periodate oxidation/b 
elimination based analysis of charging levels was performed as described (119). Briefly, total RNA 
was extracted under acidic conditions and half of the total RNA was deacylated as for acid-
Northern. Both the deacylated and untreated total RNA were subjected to periodate oxidation (5 
mM NaIO4, 50 mM NaOAc pH 5.0, 60 min at 37°C). The reaction was stopped with the addition 
of 50 mM glucose (0°C for 90 min) and ethanol precipitation. The RNA samples were subject to 
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b-elimination by resuspending the total RNA samples in 1 ml of 1M lysine pH 8.0 and incubating 
60 min at 45°C. All samples were then treated with 500 μl of 0.4 M Tris pH 9.0 (37°C, 30 min) 
for deacylation. RNA samples were treated with phenol chloroform and ethanol precipitated. 
Fraction charged was quantitated for each tRNA (N=1) as the ratio of upper to lower bands relative 
to the wild-type strain.  
 
Electromobility shift assays (EMSAs) 
	
Radiolabelled pre-tRNAs were generated by T7 transcription in the presence of 32P-a-ATP 
(Ambion Megascript) using T7 promoter containing DNA templates generated by annealing and 
PCR amplification of respective pre-tRNA sequences. Radiolabeled pre-tRNAs were purified 
using PAGE extraction. EMSAs were performed as described (22). Briefly, 3000 cpm 
(approximately 0.1 nM) of pre-tRNA was incubated with various concentrations of Sla1p in a 20 
μl reaction containing 20 mM Tris pH 7.6, 100 mM or 300 mM KCl and 5 mM b-mercaptoethanol. 
Pre-tRNAs were initially slow-cooled from 95°C to room temperature and then incubated with 
protein at 30oC or 37°C for 20 minutes. Complexes were resolved on 10% (w/v) polyacrylamide 
nondenaturing gels at 4°C at 100V. Supershifts were treated as supplementary binding events to 
the primary binding event, and binding curves were fit using a non-linear specific binding curve 
fitting program (GraphPad, Prism; Non-linear regression used to assess all EMSA analyses). 
 
In vitro modification of pre-tRNA transcripts by Trm1p 
	
Trm1p was cloned from S. pombe genomic DNA into the KpnI/EcoRI site of pET30a and purified 
by nickel affinity chromatography using standard methods.  Trm1p modification on pre-tRNAs 
was carried out in a 30 μl reaction containing 33.33 mM Tris-HCl pH 7.6, 0.083 mM EDTA, 8.3 
mM MgCl2, 33.3 mM NH4Cl, 0.83 mM DTT, and 83.3 mM S-Adenosyl methionine (SAM).  
Reactions were incubated at 32°C for 3 hours and purified using phenol chloroform extraction.  
Charging efficiencies were determined by performing modification reactions in the presence of 
14C-SAM (Perkin-Elmer) followed by TCA precipitation of modified RNA, filtration through 
Whatman GF/C glass microfiber filters and scintillation counting.  Reverse transcriptase primer 
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extension for detection of dimethylated Trm1p was performed using SuperScript III (Invitrogen) 
and standard methods.    
 
In vitro chemical probing assay with lead acetate 
	
Pre-tRNA SerUGA was generated by T7 transcription (Ambion Megascript) and then treated with 
Calf Intestinal Alkaline Phosphatase (CIP) (NEB) at 37°C for 30 minutes followed by 
phenol/chloroform extraction and ethanol precipitation. Pre-tRNA SerUGA was 5’ end labeled using 
T4 polynucleotide kinase and 32P-γ-ATP and purified using a denaturing gel. In vitro modification 
of pre-tRNA SerUGA transcript by Trm1p was carried out as above in the presence and absence of 
S-Adenosyl methionine (SAM). Chemical probing reactions were completed by the addition of 1 
μl of 1 mg/ml of yeast RNA and 1X Ambion structure buffer (10 mM Tris pH 7, 0.1 M KCl, 10 
mM MgCl2) to heat-renatured pre-tRNA SerUGA in a total volume of 8 μl. Pre-tRNA samples were 
treated with a final concentration of 5 mM lead acetate with incubation at 37°C for 2 minutes, 
compared to mock treated unmodified controls. The reaction was stopped with the addition of 
loading buffer and incubation on ice for 5 minutes.  
 
Harvesting yeast cells and immunoprecipitation of Sla1p-PrA pre-tRNA complexes 
	
Integration of the Protein A tag into the sla1+ chromosomal locus was performed and validated 
by sequencing and western blot as described (120).  Yeast strains were grown in YES at 30°C or 
37°C to OD600 ~ 0.8-1.0, harvested and subjected to cryogenic disruption in Retsch PM100 
planetary ball mill as described (120). Immunoprecipitation was carried out on 1 g of powder with 
magnetic Dynabeads (Invitrogen) conjugated with Rabbit IgG (MP-Biomedicals) as described 
(120). Lysate and wash buffer contained 50mM NaCl, 0.5% Triton X, 0.1% Tween-20, 20 mM 
Hepes pH 7.4, 55 mM KOAc, 1 mM b-mercaptoethanol, 0.2 mM PMSF and 1:100 Protease 
Inhibitor Cocktail (HALT, Pierce). Complexes were treated with proteinase K (Sigma) and RNA 
was purified using phenol chloroform extraction. 
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cDNA synthesis and quantitative real time PCR analyses 
	
RNA extracted from immunoprecipitation assays and was quantified by TaqMan qPCR. Primers 
and probes were from IDT. Reverse transcription on the purified RNA was done using the 
qScriptTM cDNA Synthesis kit (Quanta Biosciences). Elution cDNA was used at 5 ng and total 
cDNA at 10 ng for pre-tRNA and U5 snRNA analyses. Forward primers and probes used for qPCR 
provided in Supplementary Table 4. Forward primer (IDT) and PerfeCtaâ Universal PCR primer 
(Quanta Biosciences) were used at 0.4 μM and probes (IDT) were used at 0.2 μM. The cycling 
conditions were as follows: an initial 95°C for 3 minutes, followed by 40 cycles of 95°C for 3 sec, 
60°C for 20 sec for annealing and extension. qPCR results were evaluated using the DDCt method 
and pulldown efficiency between inputs and elutions were assessed using U5 snRNA as the 
endogenous control.  Comparison of enrichment within elution samples was performed by 
measuring the fold enrichment of the query pre-tRNA Ct versus the geometric mean Ct of three 
Trm1p non-modified pre-tRNAs (IleUAU, AlaCGC and TyrGUA) as described (121). Fold 
enrichments were calculated from the Ct values for each pre-tRNA performed as triplicate 
technical replicates; histograms of the means of these triplicate values were assembled from values 
obtained from two independent pulldowns each obtained from a minimum of two independent 
growths for each strain and temperature.  
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RESULTS 
 
La RNA chaperone activity is required to rescue growth of sla1-/trm1- cells at elevated 
temperature  
	
Mutations to the canonical RNA binding surface of RRM1 impair La RNA chaperone activity in 
vitro and La dependent rescue of defective (mutated) pre-tRNAs in S. pombe cells (29). Previous 
work in S. cerevisiae has demonstrated functional overlap of the dimethylation of G26 (N2, N2-
dimethylguanosine) by the methyltransferase Trm1p and the La homolog Lhp1p, as a 
trm1Δ/lhp1Δ strain displays a temperature sensitive lethal phenotype (70). To compare previous 
insights on La dependent RNA chaperone activity with La function on hypomodified pre-tRNAs 
in a homologous system, we generated a sla1-/trm1- strain of S. pombe and compared its growth 
to the respective single deletion mutants at 32oC versus 37oC (Figure 1A&B). We observed that 
growth of the sla1-/trm1- strain was slightly impaired compared to the sla1-, trm1- or wild-type 
strain at 32°C, and that transition to 37°C was lethal in the double mutant, similar to S. cerevisiae.  
Interestingly, the synthetic lethality at 37oC was seen only when cells were grown in minimal 
media (EMM), with no synthetic lethality observed when cells were grown in rich media.  This is 
consistent with previous work describing slow growth of sla1- strains under tRNA-associated 
stresses that accompany growth in media that use NH4 as a source of fixed nitrogen (122).   
Previous work has indicated that impairing nuclear surveillance by deletion of the nuclear exosome 
subunit Rrp6p can rescue tRNA-mediated suppression associated with a defective (mutated) pre-
tRNA (47). We also tested a sla1-/trm1-/rrp6- triple mutant in case this might suppress the 
synthetic lethality of the sla1-/trm1- strain.  Instead of a rescue, however, we observed that this 
strain grew worse than the sla1-/trm1- double mutant, as it was unable to grow on minimal media 
even at 32oC.   
To determine whether the RNA chaperone/RRM1 associated binding mode was important 
for La dependent rescue of the sla1-/trm1- strain, we transformed this strain with plasmids 
expressing wild-type human La (hLa) or Sla1p, as well as mutant hLa or Sla1p carrying mutations 
to the previously characterized RNP aromatic residues of RRM1 important for RNA chaperone 
function (hLa Y114A/F155A or Sla1 Y157A/F201A), or a vector control (Figure 1C). While all 
transformants grew at lower temperature, only the wild-type hLa or Sla1p transformants were able 
to rescue robust growth at 37oC, and the RRM1 mutants displayed poor rescue more similar to the 
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Figure 1. Synthetic lethality of sla1-/trm1- cells relies on La RNA chaperone activity. Indicated 
yeast strains were grown in liquid EMM media with essential supplements at 32°C (A) and 37°C 
(B) for 12 hours with absorbance collected at OD600. Growth of the sla1-/trm1-  was slowed at 
32oC and inhibited at 37°C, while sla1-/trm1-/rrp6- did not grow at either temperature. (C) La 
RNA chaperone mutants are defective in rescuing growth of the sla1-/trm1-  cells at 37°C. sla1-
/trm1- cells were transformed with empty pRep4 or pRep4 containing hLa, hLa Y114A/F155A, 
Sla1 or Sla1 Y157A/F201A (47).   
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vector control. We therefore hypothesize that the RNA chaperone activity of La proteins is 
important for the rescue of pre-tRNAs that misfold due to lack of modification at G26, and that 
tRNA misfolding due to lack of modification at G26 is sensitive to both temperature and the tRNA-
associated stress previously linked to growth in minimal media. 
	
Identification of candidate misfolded tRNAs in trm1- and/or sla1- strains of S. pombe   
 
In most native tRNAs, G26 extends the anticodon stem by making a non-Watson-Crick interaction 
with N44 (whose identity is biased against “C”) in the so-called “hinge” region, generating a six 
base-pair long (“Type 6”) anticodon stem (including the non-Watson-Crick 26-44 base pair).  
Dimethylation of G26 has been previously hypothesized to stabilize these non-Watson crick G26-
N44 interactions over particular folds previously observed for some mitochondrial tRNAs (75). 
For example, depending on a compatible sequence in the D-stem, lack of dimethylation of G26 
could result in an alternate Watson-Crick pairing of G26 with C11 and a resulting non-native 5 
base-pair long anticodon stem (“Type 5”). Alternatively, an unmodified G26 could form a Watson-
Crick pair with a rare C44 and promote a seven base-pair long anticodon stem (“Type 7”) should 
nucleotides 25 and 45 be compatible and available for pairing.  We examined the sequences of 
G26 containing tRNAs in S. pombe in an attempt to ascertain which tRNAs may be particularly 
prone to taking these misfolded forms (Supplementary Table 1).  We also took into consideration 
which G26 containing tRNAs are actually modified at G26 by Trm1, based on published results 
obtained by next-generation tRNA sequencing (tRNA-HydroSeq, (71)). Surprisingly, we found 
that contrary to the case in S. cerevisiae (i.e. tRNA-LysCUU), humans (i.e. tRNA-AsnGUU) and other 
investigated species, there was not a single G26 containing tRNA in S. pombe (with the exception 
of a single allele for tRNA-AsnGUU) that was predicted to be capable of forming the Type 5 fold, 
due to resultant mismatches in the remodeled D-stem (Supplemental Table 1). Among the G26 
containing tRNAs, there was only a single tRNA species (tRNA-GlyGCC) containing a C at position 
44, but interestingly, tRNA-GlyGCC is not a Trm1 target in S. pombe (71), consistent with a 
complete lack of GC base pairs in the Trm1p D-stem recognition element of tRNA-GlyGCC.  
Together, these data suggest that prevention of the aberrant Type 5 and Type 7 folds may not be 
as critical a consideration for tRNA misfolding in S. pombe tRNAs compared to other species.   
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Previous work has identified particular tRNAs that appear to be sensitive to impairment of 
La function in yeast. In S. cerevisiae, tRNA-ArgCCG has been linked to La associated rescue and is 
hypothesized to have a fragile anticodon stem due to a UC mismatch (46, 70).  We therefore also 
considered the possibility that fragile anticodon stems might sensitize tRNAs to loss of La and/or 
Trm1.  Since La function has also been linked to pseudouridylation of U38 and U39 by Pus3p (70), 
we also looked for the presence of uridines at these positions in G26 containing tRNAs 
(Supplementary Table 1). We noted that unlike in S. cerevisiae, the anticodon stem of tRNA-
ArgCCG does not have a mismatch in S. pombe. We did note, however, that uniquely among Trm1 
targets in S. pombe, tRNA-SerCGA/UGA has only a single G-C base pair in its anticodon stem, with 
all other Trm1 targets containing between 2 and 4 G-C base-pairs.  tRNA-SerCGA and tRNA-SerUGA 
have also been previously linked to Trm1 function:  they have been previously noted to undergo 
rapid tRNA decay in the context of a trm1Δ/trm4Δ strain in S. cerevisiae (115), and 
hypomodification of G26 in suppressor tRNA-SerUCA (an anticodon variant of tRNA-SerUGA) 
results in compromised tRNA-mediated suppression in S. pombe (71).   
To experimentally identify candidate tRNAs that might misfold causing functional 
impairment, we assessed the amino acid charging levels of several G26 containing tRNAs in wild 
type, sla1-, trm1-, and sla1-/trm1- strains, as it has been demonstrated that tRNA misfolding can 
result in lower charging levels by aminoacyl-tRNA synthetases (46, 123, 124). In order to assess 
tRNA charging levels we performed acid-Northern (125) (Figure 2A) or β–elimination (126) 
(Figure 2B) of tRNAs isolated from cells grown in minimal media.  As previously noted, we were 
particularly interested in investigating the charging efficiency of tRNA-SerCGA/UGA, tRNA-ArgCCG, 
as well as other tRNAs predicted to have less stable anticodon stems.  We observed a drop in 
charging efficiency (~25%) for tRNA-SerCGA/UGA in the trm1- and trm1-/sla1- strains, but no drop 
in charging efficiency for tRNA-ArgCCG or for other tested tRNAs containing two GC base pairs 
in their anticodon stems (tRNA-LeuAAG, tRNA-LysCUU, tRNA-SerAGA, tRNA-IleAAU, tRNA-TrpCCA, 
tRNA-ArgUCG) or an anticodon stem mismatch (tRNA-LeuUAA). To test the importance of growth 
conditions on tRNA charging, we also tested for the charging of several tRNAs from cells grown 
in rich media (Supplementary Figure 1). We found that tRNA-SerUGA/CGA again had the greatest 
decrease in charging level among the tRNAs tested, with most tRNAs showing no charging defect 
in the mutant strains, although the degree of impaired charging was slighter than observed in 
minimal media. These results identify tRNA-SerUGA/CGA as a tRNA whose fold is likely influenced 
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Figure 2. 
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Figure 2. Lack of Trm1p modification at G26 results in likely misfolding of tRNA-SerCGA/UGA. 
Acid-Northern (A) and periodate oxidation/β-elimination (B) to assay charging levels of various 
tRNA species indicates a Sla1p/Trm1p associated tRNA charging defect for tRNA-SerCGA/UGA.   (C) 
Reverse transcriptase primer extension of recombinant Trm1p modified tRNA-PheGAA confirms 
specific modification of G26 in vitro.   (D) Left:  Lead acetate chemical probing indicates altered 
structure in the anticodon stem loop and variable arm of pre-tRNA-SerUGA after in vitro 
modification with Trm1p.  Right:  Secondary structure of tRNA-SerUGA. Nucleotides with altered 
chemical reactivity to lead acetate probing +/- Trm1p modification indicated in bold.  Bottom: 
quantitated differential lead acetate reactivity +/- Trm1p modification.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 63 
by dimethylation of G26 in vivo, consistent with previous work in S. pombe and S. cerevisiae 
linking this modification and tRNA-SerUGA/CGA function (71, 115).   
	
Lack of G26 dimethylation causes conformational changes in tRNA-SerUGA in vitro  
	
Based on our results demonstrating impaired charging of tRNA-SerCGA/UGA in vivo, we attempted 
to ascertain whether dimethylation of G26 might alter the structure of pre-tRNA-SerUGA as 
measured by chemical probing in vitro.  In order to obtain G26 modified tRNAs, we cloned and 
purified recombinant Trm1p from S. pombe and used this to modify a T7-transcribed pre-tRNA-
SerUGA sequence.  We observed between 80 to 100% transcript modification of pre-tRNA-SerUGA 
as measured by use of 14C S-adenosylmethionine as the methyl donor, followed by TCA 
precipitation/filter binding and quantitation by liquid scintillation (data not shown). As the in vitro 
modification of pre-tRNAs by Trm1p from S. pombe has not previously been reported, we 
confirmed the specificity of our cloned enzyme by taking advantage of the propensity of Trm1p 
G26 dimethylation to cause an N-1 reverse transcriptase stop (127), and confirmed that a T7 pre-
tRNA transcript was modified exclusively at the G26 nucleotide by our recombinant S. pombe 
Trm1p in vitro (Figure 2C). As measured by primer extension, our Trm1p dimethylated our T7 
transcript to approximately 60% (ratio of G26 band to run off primer extension product), although 
this likely an underestimate as reverse transcriptase (Superscript III) can read through modified 
G26 through misincorporation of non-C nucleotides (71).  
We then investigated the structure of pre-tRNA-SerUGA in the absence or presence of 
dimethylation at G26 by lead acetate chemical probing, as this method has previously been 
demonstrated to be highly sensitive to changes in secondary and tertiary structures in tRNA 
substrates (128). Upon Trm1p modification we observed a significant decrease in Pb2+ based 
cleavage in the A-U rich anticodon stretch (U41, A42 and A43) immediately adjacent to the hinge 
region of pre-tRNA-SerUGA, and a concomitant slight increase in reactivity at C40 (Figure 2D).   
Notably, these nucleotides are next to the U44 nucleotide that base pairs with G26 in pre-tRNA-
SerUGA, and modification at G26 has been previously hypothesized to stabilize tRNA structure in 
this region (73, 75, 129). Furthermore, the accessibility of this region to chemical probing has been 
demonstrated to change upon S. cerevisiae La (Lhp1p) binding to pre-tRNA-ArgCCG (46). 
Interestingly, we also observed a G26 modification dependent decrease in reactivity near the 
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beginning of the variable loop, close to the hinge, around C47:8. It is notable that both the 
C40/U41/A42/A43 and C47:8 regions lie at or near nucleotides whose mutation (C40U; C47:6U) 
results in defective tRNA suppression for tRNA-SerUCA (an anticodon mutant derived from tRNA-
SerUGA) in S. pombe (130). While the exact nature of structural changes observed cannot be inferred 
from these results, they are strongly indicative that dimethylation at G26 can influence the stability 
of the hinge region of tRNA-SerUGA with consequent effects on tRNA function in vivo.  Since 
tRNA-SerUGA/CGA has only a single GC base pair in the anticodon stem, it is thus possible that the 
stability of the anticodon stem loop may be linked to La and Trm1 function, consistent with other 
work in S. cerevisiae (46). We did not notice any trend in tRNA fold or stability (see below) 
correlating with the possibility of pseudouridylation at positions 38 and 39 (Supplementary Table 
1).   
 
Trm1 promotes tRNA-mediated suppression of tRNA-SerUCA 
	
In order to further investigate the importance of modification of G26 in the native folding of pre-
tRNA-SerUGA, we tested for the capacity of Trm1p dependent dimethylation to promote tRNA-
mediated suppression in a red-white assay that relies on the activity of tRNA-SerUCA, a suppressor-
tRNA derivative of tRNA-SerUGA (Figure 3). We compared the overexpression of Trm1p (pRep4-
Trm1) to a vector alone control (pRep4) in both a sla1-/trm1+ (Fig. 3A) and a sla1+/trm1- (Fig. 
3B) background for the original tRNA-SerUCA as well as two other tRNA alleles (tRNA-SerUCA 
C40U & tRNA-SerUCA C40U C47:6U) that carry additional mutations that have been previously 
demonstrated to increasingly rely on Sla1p for their function in the assay (47). We observed that 
overexpression of Trm1p resulted in enhanced tRNA-mediated suppression relative to the vector 
control for all three tRNA alleles in the sla1-/trm1+ background, as well as for the tRNA-SerUCA 
C40U & tRNA-SerUCA C40U C47:6U alleles in the sla1+/trm1- background (the tRNA-SerUCA 
allele demonstrated no red pigment accumulation in this background and thus could not be 
assessed in this way), similar to previous results also testing for the function of Trm1p in tRNA-
mediated suppression in S. pombe (71).  Together, these data further support impaired function for 
a tRNA-SerUGA derived tRNA in the absence of dimethylation at G26, and are consistent with our 
other data indicative of a tRNA-SerUGA folding defect that is rescued by Trm1p.  
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Figure 3.  Dependence of tRNA mediated suppression on dimethylation at G26 by Trm1p.  (A) 
tRNA mediated suppression of tRNA-SerUCA, tRNA-SerUCA C40U and tRNA-SerUCA 
C40U/C47:6U in a sla1-/trm1+ strain background in the absence (pRep4) or presence (pRep4-
Trm1) of overexpressed Trm1p.  (B) Same as for A, but in a sla1+/trm1- background. 
 
	
 
Sla1 and Trm1 promote the accumulation of selective sets of G26-containing tRNAs 
	
We hypothesized that misfolding of tRNAs in sla1-/trm1- cells may alternatively result in their 
degradation, analogous to the demonstrated dependence of other tRNAs and pre-tRNAs on their 
modification status to protect these from rapid tRNA decay and nuclear surveillance. We therefore 
used Northern blots to quantify steady state levels of G26 containing tRNAs in S. pombe from 
sla1-, trm1-, and sla1-/trm1- strains relative to amounts in the wild-type parent strain, ten hours 
after a shift to minimal media (Figure 4).  To normalize for differences in loading, we also probed 
our blots for U5 snRNA.  As an internal control, we also measured steady state levels for a subset 
of tRNAs lacking a guanosine at position 26 (tRNA-IleUAU, tRNA-GlyCCC, tRNA-MetCAU, and 
tRNA-HisGUG) and for which deletion of Trm1p should thus not affect their relative abundance. 
Some representative Northerns are provided in Figure 4A. Certain tRNAs were more sensitive to 
deletion of Trm1p than others, for example, tRNA-SerAGA & tRNA-ArgACG accumulated to lower 
levels in the trm1- and trm1-/sla1- strains compared to the wild-type and sla1- strains (compare 
lanes 2 & 4 to lanes 1 & 3, Fig. 4A). We summarized the levels of all tRNAs sampled in the trm1- 
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strain normalized to a loading control (mature U5 snRNA) and relative to wild-type levels in 
Figure 4B.  We observed that the levels of some tRNAs dropped slightly in the trm1- strain, and 
noted that the identities of these seemed to correlate with those tRNAs known to be modified by 
Trm1p (Trm1p modified tRNAs represented by white bars, Figure 4B-D; black bars represent 
tRNAs lacking G26 or known to not be modified at G26 in S. pombe as measured by RNA-seq 
(71)). Other tRNAs, for example tRNA-PheGAA and tRNA-IleAAU, constituted a non-overlapping 
set that were more sensitive to deletion of Sla1p (compare lanes 3&4 to lanes 1&2, Fig 4A; 
summary data for sla1- strain provided in Figure 4C). Examination of the sla1-/trm1- double 
mutant strain were indicative of more substantial decreases in several tRNAs, some to the degree 
to which they became statistically significant (P<= 0.05 or 0.01), thus identifying which tRNAs 
were most dependent on Sla1p and Trm1p for their steady state abundance (Figure 4D).  
Interestingly, we observed that the fold decrease for tRNAs in the sla1-/trm1- strain correlated 
positively with the product of the fold decrease of the same tRNAs in the trm1- and sla1- single 
mutant strains (Figure 4E), suggesting that the degree of depletion of tRNAs in the sla1-/trm1- 
double mutant is indeed due to the additive effect of the two single mutations impairing a related 
process. These experiments provided us with a subset of tRNAs for further analysis whose 
abundance is most sensitive to lack of modification at G26 in the absence of Trm1p.   
 
Sla1p does not differentially engage hypomodified pre-tRNAs in vivo 
	
Our analysis of tRNA charging, tRNA-mediated suppression and tRNA abundance in our mutant 
strains identified candidate pre-tRNAs that La may preferentially engage should La display affinity 
for potentially misfolded RNA substrates. In order to sample Sla1p/pre-tRNA complexes formed 
in vivo, we integrated a C-terminal 4X protein A (PrA) tag into the S. pombe sla1 chromosomal 
locus in trm1+ and trm1- strains and confirmed its integration by sequencing and Western blot 
(Figure 5A). To confirm the activity of our endogenously tagged Sla1-PrA protein, we compared 
the ability of our Sla1-PrA strain to promote tRNA-mediated suppression relative to sla1+ and 
sla1- strains using a previously characterized, Sla1p dependent red/white assay (47) and showed 
that Sla1-PrA was active in the assay, similar to the WT sla1+ strain (Figure 5B). We pulled down 
native Sla1p-PrA ribonucleoprotein complexes using a rapid pulldown protocol optimized for 
retention of endogenous particles (120), and pre-tRNA enrichment was determined by  
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Figure 4. Variability in relative tRNA abundance in sla1-/trm1- cells. (A) Northern blot of total 
RNA extracted from indicated strains probed for various tRNAs or the U5 snRNA. (B) Relative 
abundance of G26-containing and non-G26 containing tRNAs in trm1- cells, normalized to tRNA 
levels in the wild type strain as well as the U5 snRNA as the endogenous loading control. Note 
that in S. pombe, the mature tRNA-SerCGA and tRNA-SerUGA species differ by a single nucleotide 
in the anticodon loop, and so our probe for Northern blot is expected to react with both.  White 
bars:  G26 modified tRNAs; black bars: tRNAs lacking a “G” at position 26 or lacking 
modification at G26 by Trm1p (71). Error bars: SEM. (C) Relative abundance of G26-containing 
and non-G26 containing tRNAs in sla1- cells. Significant drops in tRNA abundance relative to the 
wild-type strain are marked with * (P<= 0.05) or ** (P<=0.01). (D) Relative abundance of G26-
containing and non-G26 containing tRNAs in sla1-/trm1- cells. (E) Correlation between the 
product of the tRNA levels in the trm1- and sla1- strains versus the levels of the respective tRNAs 
in the sla1-/trm1- strain. All tRNAs are represented; some tRNAs are annotated as reference 
points. 
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quantitative real-time PCR using tRNA specific exonuclease hydrolysis probes (i.e. ‘TaqMan’) 
and mature U5 snRNA as a normalization control. To ensure we sampled nuclear pre-tRNA La 
targets and not mature tRNAs in our analyses, we took advantage of the order of tRNA processing 
in yeast. Pre-tRNAs are transcribed by RNA polymerase III, are occasionally capped (131), and 
engage La through both their terminal UUU-3’OH and other contacts to the tRNA, which affects 
the order of tRNA processing events (25).  When tRNAs are bound by La, 5’ processing precedes 
3’ trailer processing before tRNAs are exported to the cytoplasm and spliced, should they have an 
intron (122, 132), after which, under some conditions, they can re-enter the nucleus via tRNA 
import (85, 133, 134). We ensured we sampled nascent pre-tRNAs in our work by limiting our 
qPCR analysis to intron containing pre-tRNAs using intron specific forward primers   This design 
also ensured that all primers/probes would anneal downstream of G26, so that modification of this 
residue (if any) would not interfere with cDNA synthesis (see Supplementary Figure 2).   
To determine whether Sla1p might discriminate pre-tRNAs that may be misfolded as a 
result of the absence of G26 N2, N2-dimethylation, we focused on several G26 containing pre-
tRNAs that we demonstrated as having impaired charging in vivo/misfolding in vitro (pre-tRNA-
SerUGA & SerCGA; Figure 5C) or decreased steady state stability (pre-tRNA-LysCUU, LeuCAA, LeuUAG, 
LeuCAG, ArgCCG, SerGCU) (Figure 5D; mean differences in pulldowns and associated P-values 
provided in Supplementary Table 2). In order to be able to compare relative pulldown of candidate 
misfolded pre-tRNAs across the trm1+ and trm1- strains, we normalized the levels of these 
candidate G26-containing pre-tRNAs to the mean pulldown values of three pre-tRNAs whose 
folding and binding to La would not be influenced by Trm1p activity, by virtue of not possessing 
a G at position 26 (pre-tRNA-IleUAU, pre-tRNA-TyrGUA), or by virtue of being poorly modified by 
Trm1p at G26 as previously determined by RNA-Seq and Northern blot (pre-tRNA-AlaCGC; (71)). 
We found that Sla1p association with pre-tRNAs in the presence or absence of G26 modification 
did not vary significantly for any of the candidate pre-tRNAs tested, with observed fold 
enrichments in trm1- versus trm1+ strains on the order of two-fold or less, and with no differences 
in pulldown efficiency reaching statistical significance (P=0.05, Supplementary Table 2). This was 
in contrast to a highly substantial enrichment of each candidate pre-tRNA relative to a non-La 
target, the U5 snRNA, validating the effectiveness of the pulldown and quantitation (Figure 5C, 
D). Similarly, pulldown of candidate pre-tRNAs from the trm1- strain grown at 37oC versus 30oC 
also did not indicate preferential engagement of candidate pre-tRNAs at higher temperature.  In 
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Figure 5.  Association of pre-tRNAs with Sla1p-PrA +/- G26 modification in S. pombe cells.  
Endogenous Sla1p-PrA/pre-tRNA complexes from trm1- and trm1+ cells grown at 30oC versus 
37oC were immunoprecipitated and levels of candidate pre-tRNAs were quantitated by ‘TaqMan’ 
quantitative real-time PCR (qPCR).  (A) Western blot confirming the expected size and expression 
of the Sla1-PrA fusion protein relative to the parent sla1+ strain. (B) Endogenous Sla1p containing 
an integrated Protein-A tag at the C-terminus (sla1-PrA) is comparably active to wild-type Sla1p 
as determined by a tRNA mediated suppression assay using two different defective suppressor 
tRNA alleles (47).  (C) Analysis of fold pulldown levels of candidate misfolded pre-tRNAs (as 
measured by impaired charging and/or chemical probing, Figure 2) compared to an internal 
control, the geometric mean pulldown level of three pre-tRNAs not modified by Trm1p (pre-
tRNA-IleUAU, pre-tRNA-TyrGUA and pre-tRNA-AlaCGC) in the same elution samples. As a reference 
for robust pulldown of La targets versus non-targets, fold pulldown of indicated pre-tRNA in 
elution samples versus total RNA samples (wild-type strain) is provided relative to the La non-
target U5 snRNA (right hand side, histograms). (D):  same as for (C) but for candidate pre-tRNAs 
identified as having decreased accumulation in sla1-/trm1- strains (see Figure 4).   
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order to ensure that our results were not confounded by rearrangement of complexes during the 
pulldown procedure, we also repeated the analysis but in the presence of formaldehyde crosslink 
prior to harvest. These experiments were also indicative of a lack of substantial differences in 
affinity, similar to the minus crosslink cohort (on the order of 2X or less; Supplementary Table 2). 
Together, these data are consistent with a lack of discrimination of Sla1p binding to pre-tRNAs 
according to their G26 modification status in vivo. 
 
Sla1p does not differentially engage Trm1p modified pre-tRNAs in vitro 
	
To test Sla1p binding to Trm1p modified versus unmodified pre-tRNAs more directly, we tested 
Sla1p affinity for G26 modified versus unmodified pre-tRNA transcripts in vitro by 
electromobility shift assay (EMSA; Figure 6A). We performed EMSA analysis for tRNA-SerUGA, 
whose charging was defective in the sla1-/trm1- strain and whose structure was altered +/- G26 
modification in vitro, as well as two pre-tRNA sequences corresponding to tRNAs with decreased 
abundance in the sla1-/trm1- strain (tRNA-LeuUAG and tRNA-LeuCAG). For these experiments, we 
first formed complexes at the temperature which should favour misfolding (37oC) and at 100 mM 
KCl. For each of these substrates, we observed minimal (~ 2X or less) differences in affinity, 
similar to the trends we observed in vivo. Since misfolding of RNAs in vitro has been hypothesized 
to be temperature and salt dependent, we also compared complex formation between 30oC and 
37oC and between 100 mM and 300 mM KCl and still observed no modification dependent changes 
in affinity (Supplementary Figures 3-5).  Thus, our in vitro and in vivo data are consistent with 
Sla1p having similar affinity for pre-tRNAs regardless of the presence or absence of N2,N2-
modification at G26, despite our biochemical and genetic data confirming the functional overlap 
of this modification with the importance of La in promoting productive pre-tRNA processing. 
As a final proof of principle, and to compare the conservation of La binding to pre-tRNAs between 
yeast and humans, we compared the affinity of human La (hLa) for a fully modified, mature tRNA- 
PheGAA (purified from S. cerevisiae; Sigma-Aldrich) with its completely unmodified, T7 
transcribed counterpart (Figure 6B). While this mature tRNA should not normally be a substrate 
for La proteins in vivo by virtue of nuclear pre-tRNA trailer processing and 3’CCA addition, we 
reasoned that the UUU-3’OH independent La-tRNA binding mode should still be sensitive to 
tRNA modification induced structural changes should these be important for La target  
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Figure 6. Association of Sla1p and hLa with modified or unmodified pre-tRNAs in vitro.  (A):  
EMSA of Sla1p with T7 transcripts corresponding to candidate pre-tRNAs identified as having 
impaired charging/in vitro misfolding (tRNA-SerUGA) or impaired accumulation (tRNA-LeuUAG & 
tRNA-LeuCAG) in the absence (unmodified) or presence (Trm1p modified) of G26 modification.  
(B) EMSA of hLa with a T7 transcript corresponding to mature S. cerevisiae tRNA-PheGAA or its 
fully modified counterpart purified from S. cerevisiae cells.   
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discrimination. Similar to our earlier results, we observed less than a 2X difference in affinity 
between the fully modified tRNA and the corresponding S. cerevisiae tRNA-PheGAA T7 transcript, 
consistent with the specific fold imposed via tRNA modification not being an important 
determinant for La engagement, at least for the folds assumed by our tRNA substrates under the 
conditions of our analysis in vitro. 
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DISCUSSION 
	
In this work, we have attempted to shed light on how La proteins may discriminate targets on the 
basis of fold by examining pre-tRNAs, their best-characterized substrates. Proteins that enhance 
the folding of RNAs into their native conformation have been apportioned into a variety of classes 
(RNA chaperones, RNA cofactors and RNA helicases) based on their proposed mechanisms of 
action (7, 135). Unlike RNA cofactors, RNA chaperones can display activity across a variety of 
targets and do not need to remain associated with their remodeled RNA targets for these to retain 
their function. Thus, RNA chaperones are hypothesized to bind RNA relatively non-specifically 
(2, 6, 7). Some RNA chaperones have been hypothesized to have a preference for binding single 
stranded regions of RNA (12, 16, 110), and models for RNA chaperone binding have been 
proposed in which the free energy of binding to unfolded substrates varies from that for folded 
substrates (2, 6). However, it is not clear how generally these principles should be applied across 
the wide breadth of proteins with RNA chaperone activity, especially ones like La, in which a non-
specific RNA chaperone-associated RNA binding mode is juxtaposed with its sequence specific 
UUU-3’OH dependent RNA binding mode (22, 29, 48).  
La proteins engage pre-tRNAs via at least two distinguishable binding modes: the UUU-
3’OH dependent trailer binding mode associated with the La motif, and a UUU-3’OH independent 
mode associated with the canonical RNA binding surface of the RRM1 domain and with RNA 
chaperone function, with both modes contributing additively to maximize pre-tRNA binding 
affinity (22, 29, 55, 113, 136). Disordered regions C-terminal to RRM1 have also been implicated 
in RNA chaperone-like functions, and have also been proposed to contribute to La-RNA target 
affinity (48, 56, 128, 137). While the importance of the UUU-3’OH motif in La recruitment is 
well-established (136, 138), the question of whether other binding determinants influence La 
selection of targets within the UUU-3’OH containing cohort has not been tested previously. This 
issue may be of importance in light of the observation that the maturation of defective suppressor 
tRNAs benefits from additional, plasmid encoded Sla1p in sla1+ cells (43), suggesting that for at 
least some La targets, endogenous levels of La protein are limiting, and that UUU-3’OH containing 
RNAs could compete for La binding.   
Using in vivo pulldown assays of endogenous complexes as well as in vitro EMSAs, we 
have tested whether La differentially binds hypomodified pre-tRNA substrates. While it is 
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challenging to demonstrate direct evidence for misfolded conformations of precursor tRNAs in 
vivo, there are several lines of evidence consistent with a lack of modification of G26 causing 
folding defects for at least some Trm1 targets: a) we demonstrate that the synthetic lethality 
associated with the trm1-/sla1- strain is poorly rescued using mutants of La previously 
demonstrated to be defective in RNA chaperone activity but not UUU-3’OH end binding (47) ; b) 
we show that tRNA-SerUGA/CGA is charged to a lesser extent in vivo in a sla1-/trm1- strain, similar 
to other work showing impaired charging by aminoacyl-tRNA synthetases on misfolded tRNAs; 
c) we demonstrate that lack of Trm1p modification at G26 results in defective tRNA mediated 
suppression in vivo in S. pombe, for a suppressor tRNA (tRNA-SerUCA) derived from tRNA-SerUGA; 
d) we show that the anticodon stem loop hinge region of a T7 transcript of pre-tRNA-SerUGA shows 
differential reactivity to lead acetate based cleavage in the presence versus absence of Trm1p 
modification, which to our knowledge is the first experimental result supporting the importance of 
this modification on the stability of tRNA anticodon stems (75) , and e) we show that several 
tRNAs accumulate to lower steady state levels in trm1- and trm1-/sla1- strains relative to wild-
type strains.     
We did not observe substantially different binding to modified versus unmodified pre-
tRNA substrates in vitro or in vivo, suggesting that Sla1p does not differentiate a potential tRNA 
misfold associated with G26 hypomodification, despite the apparent link between Sla1p and 
Trm1p function in cellular growth. This is, to our knowledge, the first demonstrated example of 
an RNA chaperone being unable to discriminate a native from a physiologically relevant misfolded 
target.  Thus our work is reminiscent of some previously proposed models for RNA chaperones in 
which the challenges associated with discriminating native from misfolded RNA conformations 
due to the relative homogeneity of functional groups within nucleotides have been highlighted (2, 
6, 7). A significant caveat in the interpretation of our results is that we cannot account for 
differential La binding to every possible misfolded pre-tRNA conformation.  Studies on the 
absence of other tRNA modifications or tRNA anticodon stem loop mutants have also been linked 
to La function (46, 69, 116, 130), and these may present misfolded conformations that are indeed 
preferentially engaged by La. Nevertheless, for at least the misfolded RNA species used in our 
study, our data are consistent with previous work suggesting that La engages pre-tRNAs 
irrespective of their specific fold for the benefit of misfolded species and at the expense of 
processing efficiency of correctly folded pre-tRNAs (47). Consistent with this, we show that La 
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shows marginal differences in affinity between a fully modified mature tRNA substrate and its 
modification lacking, in vitro synthesized counterpart. 
In the absence of discrimination on the basis of fold, we hypothesize that the specific 
targeting of RRM1 associated La RNA chaperone activity to nascent transcripts thus relies on the 
UUU-3’OH dependent binding mode and the coupled progression of tRNA processing events.  In 
this context, the La motif (which we have previously demonstrated to lack RNA chaperone activity 
in vitro; (29)) may be viewed as an accessory domain for RNA refolding (similar to analogous 
domains in some RNA helicases), as we have hypothesized previously (29); (Figure 7). Thus, the 
time between nascent transcript binding and trailer processing provides La with a fixed window of 
opportunity to assist the pre-tRNA in reaching the native state, irrespective of whether or not the 
pre-tRNA has assumed an early misfold that necessitates La dependent rescue.  In this scheme, a 
pre-tRNA that misfolds will benefit from the window of La engagement, however, this comes at 
the cost of decreased processing efficiency for pre-tRNAs that may have assumed a native fold 
even in the absence of La binding. La RNPs contain many post-transcriptionally modified 
nucleotides found in tRNAs (118), thus one function of this window may be to provide an 
opportunity for such modifications to reinforce the native fold before La dissociates upon trailer 
(i.e. UUU-3’OH) removal (22). In this light, the engagement of La proteins to its RNA targets 
would seem more akin to the ER resident protein chaperones calnexin and calreticulin, which are 
hypothesized to recognize a specific N-linked glycosylation motif associated with an intermediate 
stage of lumenal protein maturation (reviewed in (139)), rather than the exposed hydrophobic 
regions more directly associated with misfolds that are recognized by classical protein chaperones.  
We observed that the sla1-/trm1- double mutant was synthetically lethal when grown at 
higher temperature, similar to S. cerevisiae (70). Notably, this synthetic lethality could be fully 
rescued with overexpression of S. pombe or human La but not with mutants of these previously 
demonstrated to be defective in RNA chaperone function (22, 29, 47). Previous work has 
demonstrated that La RNA chaperone activity associated with the canonical RNA binding surface 
of RRM1 can rescue defective suppressor tRNAs in a red-white assay. This work builds on this 
result, pointing specifically to the importance of La-associated RNA chaperone activity in rescuing 
viability associated with the misfolding of endogenous pre-tRNAs. We hypothesized that this 
synthetic lethality could be due to degradation of particularly sensitive pre-tRNAs, as previous 
work has demonstrated that deletion of the nuclear exosome subunit rrp6+ can rescue the  
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Figure 7. Model for La engagement of folded versus unfolded pre-tRNAs. (A) The RNA 
chaperone La preferentially engages pre-tRNAs via their UUU-3’OH containing trailers (25, 55, 
113, 136) as well as through contacts to the main body of the pre-tRNA (22, 47), but without 
discriminating folded from misfolded pre-tRNA substrates (this work). (B) During the window of 
La occupancy, misfolded pre-tRNAs acquire the native fold through post-transcriptional 
modification by Trm1 (70, 118) and/or La RNA chaperone activity (22, 26, 29, 30, 46, 47). La 
affinity for the pre-tRNA does not change as the native fold is acquired. Thus this window benefits 
the misfolded pre-tRNA but not the pre-tRNA that did not benefit from La dependent rescue. (C) 
La remains with the pre-tRNA until trailer cleavage and La dissociation (22, 25).   
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degradation and tRNA-mediated suppression associated with suppressor tRNAs that have been 
mutated such that they are predicted to misfold.  We indeed noted decreases in steady state levels 
of several tRNAs in the context of a sla1-/trm1- strain, as well as a decrease in the charging of 
tRNA-SerCGA/UGA. Instead of a rescue, we observed an exacerbated lethal phenotype when 
combining the sla1-/trm1- deletion with rrp6- deletion, as the sla1-/trm1-/rrp6- triple mutant was 
unable to grow on minimal media even at 32oC. Since the nuclear exosome is predominantly 
associated with the degradation of defective substrates, this result may be consistent with the 
synthetic lethality of the sla1-/trm1- strain being due to the persistence of a misfolded Trm1p 
substrate (or substrates) acting in a dominant negative fashion, although the specific basis for this 
phenotype is at this point still unresolved. In this sense, La and Trm1p could co-operate with the 
nuclear surveillance machinery to ensure that defective pre-tRNAs do not enter the pool of mature 
tRNAs, rather than to ensure such tRNAs are not degraded below unsustainable levels. 
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SUPPLEMENTARY DATA 
 
 
 
 
 
Figure S1. Beta-elimination measurement of tRNA charging levels for candidate tRNAs grown in 
rich media (YES). 
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Figure S2. Purification and quantitation scheme for pulldown of endogenous Sla-PrA/pre-tRNA 
complexes. Sample qPCR detection demonstrated (pre-tRNA Leu TAG); relative position of 
probes held constant for all tested pre-tRNAs. 
	
 
	
 
Supplementary Figure 2!
qPCR of query pre-tRNAs 
and U5 snRNA in total 
versus elution samples = 
pulldown efficiencies 
(Figure 5)
qPCR of candidate misfolded pre-tRNAs and control 
(G26 lacking or G26 non-modified) pre-tRNAs in elution 
samples. Abundance of candidate misfolded tRNAs 
relative to control tRNAs (geometric mean pulldown of 
three control pre-tRNAs) determined for WT or trm1- 
strains grown at 30 and 37 degrees C (Figure 5).      
Growth of Sla-PrA and trm1-/Sla-PrA strains at 30 and 37 degrees C.  !
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Supplementary Figure 2:  Purification and quantitation scheme for pulldown of endogenous 
Sla-PrA/pre-tRNA complexes.  Sample qPCR detection demonstrated (pre-tRNA Leu TAG); 
relative position of probes held constant for all tested pre-tRNAs. 
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 81 
	
 
 
Figure S3. Affinity of Sla1p for tRNA-SerUGA is not influenced by its modification by Trm1p 
irrespective of salt (A:100mM KCl vs B:300mM KCl) or temperature (incubation at 30°C vs 
37°C). 
Supplementary Figure 3
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Supplementary Figure 3:  Affinity of Sla1p for tRNA-Ser      is not influenced by its 
modification by Trm1p irrespective of salt (A: 100mM KCl vs B: 300 mM KCl) or temperature 
(incubation at 30  C vs 37   C).   
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Figure S4. Affinity of Sla1p for tRNA-LeuUAG is not influenced by its modification by Trm1p 
irrespective of salt (A:100mM KCl vs B:300mM KCl) or temperature (incubation at 30°C vs 
37°C). 
Supplementary Figure 4
A
B
Trm1 modified unmodified
Trm1 modified unmodified
30 Co
30 Co
37 Co
37 Co
[Sla1p], μM
[Sla1p], μM
Supplementary Figure 4:  Affinity of Sla1p for tRNA-Leu      is not influenced by its 
modification by Trm1p irrespective of salt (A: 100mM KCl vs B: 300 mM KCl) or temperature 
(incubation at 30  C vs 37   C).   o o
UAG
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Figure S5. Affinity of Sla1p for tRNA-LeuCAG is not influenced by its modification by Trm1p 
irrespective of salt (A:100mM KCl vs B:300mM KCl) or temperature (incubation at 30°C vs 
37°C). 
	
 
	
 
	
 
	
 
Supplementary Figure 5
A
B
Trm1 modified unmodified
Trm1 modified unmodified
30 Co
30 Co
37 Co
37 Co
Supplementary Figure 5:  Affinity of Sla1p for tRNA-Leu      is not influenced by its 
modification by Trm1p irrespective of salt (A: 100mM KCl vs B: 300 mM KCl) or temperature 
(incubati n at 30  C vs 37   C).   o o
CAG
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Table S1. Architecture of S. pombe tRNAs of interest in this study. Modification at G26 from 
Arimbasseri et al., 2015 PLoS Genetics 11, e1005671. *: a single allele of tRNA Asn GUU 
(Chromosome 2, nt 4210126) is predicted to be able to form a Type-5 misfold, albeit with a G-U 
wobble. Seq 11-13/24-26 at this locus: CGU/GCG. **: tRNA Leu UAA has an A-C mismatch in 
the anticodon stem. 
 
 
 
 
 
 
	
 
 
	
 
Supplementary Table 1
Supplementary Table 1:    Architecture of S. pombe tRNAs of interest in this study.  Modification at 
G26 from  Arimbasseri et al., 2015 PLoS Genetics  11, e1005671.  * : a single allele of 
tRNAAsnGUU (Chromosome 2, nt 4210126) is predicted to be able to form a Type-5 misfold, 
albeit with a G-U wobble.  Seq 11-13/24-26 at this locus: CGU/GCG.  **:  tRNALeuUAA has an A-
C mismatch in the anticodon stem.
G26?
G26
Modified?
C11? Seq:	 11-13/
24-26
C44? GC's	in	AC	
stem
U@38/39
Arg CCG Yes Yes Yes CCU/GCG No 2/5 C38/G39
Leu AAG Yes Yes Yes CCG/GAG No 2/5 C38/G39
Lys CUU Yes Yes Yes CUC/GCG No 2/5 A38/A39
Asn GUU Yes Yes Yes CAU/GCG* No 3/5 A38/U39
Ser AGA Yes Yes Yes CUG/GGG No 2/5 U38/U39
Thr AGU Yes Yes Yes CUC/GCG No 3/5 A38/G39
Leu CAG Yes Yes Yes CCG/GCG No 3/5 U38/G39
Leu UAA Yes Yes Yes CCG/GGG No 3/5** C38/C39
Leu CAA Yes Yes Yes CCG/GCG No 3/5 U38/U39
Arg ACG Yes Yes Yes CCC/GCG No 2/5 A38/U39
Ser CGA/UGA Yes Yes Yes CCG/GAG No 1/5 A38/U39
Lys UUU Yes Yes Yes CUC/GCG No 4/5 A38/A39
Leu UAG Yes Yes Yes CCG/GAG No 4/5 G38/U39
Ile UAU No
Ile AAU Yes Yes No UGU/AUG No 2/5 A38/G39
 Gly GCC Yes No No UUU/AUG Yes 2/5 U38/C39
Gly CCC No
Gln CUG Yes No No UGU/ACG No 2/5 U38/U39
Ser GCU Yes Yes Yes CCG/GCG No 3/5 A38/U39
Trp CCA Yes Yes Yes CUC/GUG No 2/5 A38/U39
Arg UCG Yes Yes Yes CCU/GCG No 2/5 C38/A39
Ala AGC Yes No No UGU/ACG No 3/5 U38/G39
Phe GAA Yes No No UGU/AUG No 2/5 A38/U39
Ala CGC Yes No No UUU/ACG No 1/5 U38/U39
Met CAU No
Ala UGC Yes Yes No UGC/AUG No 4/5 U38/G39
His GUG No
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Table S2. Relative pulldown efficiencies of Sla1-PrA with various pre-tRNAs 
	
	
	
 
	
 
	
 
	
	
 
Supplementary	Table	2:		Relative	pulldown	efficiencies	of	Sla1-PrA	with	various	pre-tRNAs	
Minus	Crosslink	(see	Figure	5)
pre-tRNA trm1-	30/	WT	30 P-value WT	37/	WT	30 P-value trm1-	37/WT	37 P-value trm1-	37/trm1-	30 P-value
LysCUU 0.976 0.925 0.913 0.453 0.815 0.571 0.762 0.807
LeuCAG 1.098 0.715 2.065 0.180 0.578 0.270 1.086 0.779
LeuUAG 1.191 0.581 1.914 0.535 0.493 0.076 0.792 0.273
LeuCAA 0.831 0.579 0.763 0.439 0.563 0.110 0.517 0.064
Arg	CCG 1.347 0.376 1.744 0.728 1.069 0.509 1.384 0.768
Ser	GCU 1.100 0.892 0.761 0.686 1.331 0.948 0.921 0.681
Ser	CGA 1.009 0.982 0.547 0.156 1.271 0.429 0.689 0.413
Ser	UGA 1.099 0.410 2.176 0.410 0.493 0.437 0.977 0.944
Plus	formaldehyde	crosslink:
Trial	1 Trial	2 average stdev Trial	1 Trial	2 average stdev
LysCUU 0.986 0.778 0.882 0.147 0.763 0.836 0.800 0.052
LeuCAG 0.999 0.794 0.897 0.145 0.517 0.501 0.509 0.012
LeuUAG 1.265 0.701 0.983 0.399 0.423 0.621 0.522 0.140
LeuCAA 0.752 0.602 0.677 0.106 0.646 1.436 1.041 0.559
Arg	CCG 1.716 1.513 1.614 0.144 0.852 1.242 1.047 0.275
Ser	GCU 0.650 0.851 0.751 0.142 0.450 0.749 0.600 0.211
Ser	CGA 1.904 1.667 1.785 0.168 0.514 0.854 0.684 0.241
Ser	UGA 0.637 0.686 0.662 0.035 0.457 0.661 0.559 0.144
																																				Fold	enrichment	in	Sla1p-PrA	elutions
Fold	enrichment,	tRNA	pulldown	by	Sla1p	in	trm1-	strain	versus	WT	strain	plus	crosslinking
trm1-/WT	at	37	degrees trm1-/WT	at	30	degrees
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Table S3. Probes used for Northern Blots  
 
 
 
Supplementary Table 3:  Probes used for Northern Blots
tRNA Northern	probe
Ala AGC 5’-TGG ACA AGC CAG AAC TCG AAT CTG GGA C-3’
Ala CGC 5'-GGA GAT GCC GGG AAT CGA ACC C-3'
Ala UGC 5’-TGG ACA CGC TGG GGA TTG AAC CCA GGA CGA-3’
Arg ACG 5’- CGA TCC CGC CAG GAG TCG AAC CTG GAA T-3’
Arg CCG 5’- CGG CGA GAT TTG CAC TCG CGA TC-3’
Arg UCG 5’- CAG TGT GAC AGG ACT CGA ACC TGC AG-3’
Asn GUU 5’-CGG TCA GGG AGG GAC TCG AAC CCT CGA-3’
Phe GAA 5’- TGT CAC AAA CCG GGA TCG AAC CGA TGA-3’
Gln CUG 5’- AGG TCG TAC TGG GAA TCG AAC CCA GGT-3’
Gly GCC 5’- TGC TTT GGC CGG GAA TCG AAC CCG G-3’
Gly CCC 5’- TGC ATC AGC CGG GAG TCG AAC-3’
His GUG 5’- TGC CCA CAC CAG GAA TCG AAC CTG GGT-3’
Ile AAU 5’- TGG TCA CAG CCG GGT TCG AAC CGG CGA CAT-3’
Ile UAU 5’- TGC TCC CGG CGA GGA TCG AAC TCG CGA T-3’
Leu AAG 5’-AAG CTC GTG GGT TCG AGT CCC ACC CCT TTC A-3’
Leu CAA 5’- TGA CCA GTG AGG GAT TCG AAC CCT CGC A-3’
Leu CAG 5’- CGA AGG TGG GGT TCG AAC CCA CGC-3’
Leu UAA 5’- TGC GGC CAG AGA GGT TCG AAC TCT-3’
Leu UAG 5’-ATG GGA CGG GAC TCG AAC CCG CGA G-3’
Lys CUU 5’- CTC CCA AGG CGA GAC TCG AAC TCG CAA-3’
Lys UUU 5’- CTC CCA CTG CGA GAT TCG AAC T-3’
Met CAU 5’- TTG CGC GGC CAG GTT TCG ATC CTG GGA-3’
Ser AGA 5’- GCA GGT TCA AAT CCT GCT GGT GTC G-3’
Ser CGA/UGA 5’- GTC ACC AGC AGG ATT TGA ACC TGC GCG G-3’
Ser GCU 5’- CGA CAA CGG CAG GAT TCG AAC CTG C-3’
Thr AGU 5’- TGC TCC AGC AGT GAC TCG AAC ACT G-3’
Trp CCA 5’- TGA CCC CTA AGT GAC TTG AAC ACT TGA-3’
U5 snRNA 5' GCA CAC CTT ACA AAC GGC TGT TTC TG 3'
For Beta-elimination blot to
assay tRNA charging: 
Ser CGA/UGA 5' GGG CAA AGC CCA TTA GAT 3'
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Table S4. Primers and probes used for qPCR analysis 
	
 
 
 
 
 
 
 
	
 
	
 
	
 
	
 
	
 
	
 
	
 
	
 
	
 
 
Supplementary Table 4: Primers and probes used for qPCR analysis
tRNA Forward primer Probe Reverse Primer
Ala CGC 5’-TCG CAT AGT TCG CAC CTT-3’ 5’-/56-FAM/ CGG GTT CGA/ZEN/TTC CCG GCA TCT /3IABkFQ/-3’ 5'-AAA AAT AGT TTC TAA CAT TGG-3'
Arg CCG 5’-GGA GAC TCC AGG TTC GA-3’ 5’-/56-FAM/CGA GTG CAA/ZEN/ATC TCG CCG TGG TC/3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Leu CAA 5’- AAG TAA TAC TTG GAC GAT AGT CTT G-3’ 5’-/56-FAM/AGA TGC CAG /ZEN/GGT TCG AAT CCC TCA CT/3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Leu CAG 5’-CTA GCT TCA GGT GAA AGC A-3’ 5’-/56-FAM/ TGC TAG TCT /ZEN/ACG TAT GTG GGC GTG /3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Leu UAG 5’- TGG CTT TAG GTG CGT TC-3’ 5’-/56-FAM/ TGA ATG GGA/ZEN/CGG GAC TCG AAC C/3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Leu UAA 5’- CAG ATT TAA GAG GCT TCT GC-3’ 5’-/56-FAM/ TCG AAC CTC/ZEN/TCT GGC CGC A/3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Lys CUU 5’-TCT GAC TCT TAT GAT GGT AAT CAG A-3’ 5’-/56-FAM/ CGA GTT CGA/ZEN/GTC TCG CCT TGG G /3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Ile UAU 5’-TGA TAC TCC CCT TAG GAG GTG-3’ 5’-/56-FAM/ ACG TGG AAA/ZEN/TCG CGA GTT CGA TCC T/3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Ser GCU 5’- TGC TAT TCT GTA GCC CAG C-3’ 5’-/56-FAM/CTT TGG GAG/ZEN/ CGC AGG TT GAA TCC /3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
Ser CGA 5'-GAA TTC CTA CAT TCG TGG CAT C-3' 5'- /56-FAM/CA GGT TCA A/ZEN/A TCC TGC TGG TGA CG/3IABkFQ/ -3' PerfeCta Universal PCR primer (Quanta Biosciences)
Ser UGA 5'- TAG ACT TGA ATC CTG TAT TCT AGT CA -3' Same as SerCGA PerfeCta Universal PCR primer (Quanta Biosciences)
Tyr GTA 5’- CCG GCT GTA ATT ATA AAG ATA CC-3’ 5’-/56-FAM/TTG GTC GCT/ZEN/AGT TCG ATT CTG GCT C/3IABkFQ/-3’ PerfeCta Universal PCR primer (Quanta Biosciences)
U5 snRNA 5'-TGC ACA CAC ATT TCA GCA TAA TC-3' 5'- /5HEX/AG CTA ACG T/ZEN/A TCT GTT TCT TGC CTT /3IABkFQ/ -3' 5'-ACA AAC GGC TGT TTC TGG TA-3'
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CHAPTER IV: Global protein expression regulated by 
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nuclear encoded tRNAs 
 
 
	
 
Experimental design by  
Ana Vakiloroayaei and Dr. Mark Bayfield 
 
Drafting Manuscript by  
Ana Vakiloroayaei and Dr. Mark Bayfield  
 
Conducting experiments 
 Ana Vakiloroayaei  
Dr. Joel Shore (Proteomics analysis, Figure 1A&B) 
Declan Williams (Proteomics analysis) 
 
 
 
 
 
 
 
	
 
 89 
Global protein expression regulated by Trm1p catalyzed 𝐦𝟐𝟐G26 modification 
of mitochondrial and nuclear encoded tRNAs  
 
Ana Vakiloroayaei1, Joel S. Shore1, Declan Williams2, and Mark A. Bayfield1 
 
1 Department of Biology, York University, Toronto, Ontario, Canada 
2 Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, 
Ontario, Canada  
 
 
PREFACE 
 
Post-transcriptional modification of tRNAs is associated with improvements in structural stability 
and regulation of tRNA activity in mRNA decoding. Defects in tRNA post-transcriptional 
modification have been linked to human diseases, dysregulation in the mitochondrial organelle 
and defects in synthesis and function of the OXPHOS complex. N2, N2-dimethylation of G26 by 
the methyltransferase Trm1p facilitates stabilization of tRNA hinge region at the junction of the 
D-stem and anticodon stem. S. pombe trm1- cells display reduced steady-state levels as well as 
impaired charging for specific Trm1p-cytoplasmic tRNA substrates. To assess the functional role 
of m""G26 in modulating tRNA activity, we performed stable isotope labeling with amino acids in 
cell culture (SILAC) in trm1- S. pombe cells. Our data are indicative of changes in protein 
expression levels that are linked to Trm1p abundance in both the mitochondrial and nuclear 
organelles. We have evidence of alterations in protein expression levels in trm1- cells correlated 
with the enrichment of CTA codons in the sequences of these proteins, potentially due to changes 
in the decoding activity of Trm1p-hypomodified tRNA-LeuUAG. Our data also suggests 
mitochondrial functional irregularity. S. pombe Trm1 (similar to S. cerevisiae) has two possible 
initiator AUGs (M1 and M24) separated by a mitochondrial targeting sequence. We have identified 
mitochondrial G26 containing tRNAs that are robustly modified by Trm1p and have evaluated 
their charging state. We also demonstrate that overexpression of M1 Trm1p (mitochondrial 
targeted) and not M24 Trm1p (cytoplasmic) results in growth impairment under both fermentable 
and non-fermentable carbon source. Our findings infer alterations in mitochondrial function that 
is regulated by Trm1p modification of mitochondrial targets.  
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INTRODUCTION 
	
Structural flexibility in RNA transcripts contributes to their propensity in acquiring non-native, 
dysfunctional conformations and their entrapment in thermodynamically stable aberrant folds (2, 
5, 140). Post-transcriptional modifications made to the sugar-ribose moiety of RNAs surmounts 
the tendency of nascent transcripts in forming dysfunctional conformations and commits the 
secondary and tertiary structure of RNAs to the biologically active, favored conformer (141). 
PTMs are essential in supporting structural stability and are also influential in various cellular 
processes including gene expression regulation, facilitating decoding of mRNA transcripts and 
maintaining RNA homeostasis (142).  
tRNAs are the most highly modified RNA transcripts in all organisms with on average 
more than 15% of nucleosides of yeast nuclear encoded tRNAs carrying a functional group on A, 
G, C or U (62, 114). PTMs on tRNAs have been classified into two basic groups: PTMs that are 
in close proximity or positioned in the anticodon loop that regulate gene expression by enhancing 
codon-anticodon interactions as well as maintaining a correct reading frame and PTMs on the body 
of the tRNA that facilitate the overall structural stability (63, 114). An example of the former is 
Trm9 (tRNA methyltransferase 9) which catalyzes the last step in synthesis of 5-
methylcarboxymethyl-2-thiouridine (mcm5S2U) on tRNA wobble nucleoside with the addition of 
a methyl group (143). Quantitative proteomics studies assaying changes in expression levels of 
thousands of proteins in a trm9- compared to trm9+ strain in S. cerevisiae identified a correlation 
between two Trm9 tRNA substrates (tRNA-ArgUCU and GluUUC) and the regulated translation of 
genes enriched with their corresponding codon pairs (AGA and GAA) (78). Hypomodification of 
the wobble nucleoside on tRNA-ArgUCU and tRNA-GluUUC has also been linked to translational 
stalling with ribosomal pausing in regions enriched with AGA and GAA codons (78). Wobble 
uridine modification of tRNA Arg and Glu by Trm9 has been shown to enhance the translation of 
transcripts expressing DNA damage response elements (143). These findings demonstrate a 
mechanism in which cellular protein expression levels are regulated through selective PTM of 
tRNAs (78, 144). 
The second class of PTM enzymes that decorate the tRNA body predominantly facilitate 
tRNA structural stability. An example of such is the N2, N2-dimethylation of G26 on tRNAs by 
the methyltransferase Trm1p. Studies in S. cerevisiae have alluded to a stabilized hinge region and 
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anticodon stem in the presence of m""G26 (70). Knockout of Trm1 has been associated with a 
synthetic lethal phenotype in S. cerevisiae (also conserved in S. pombe; refer to Chapter III) when 
combined with the RNA chaperone La, recapitulating the role of Trm1 in supporting tRNA 
structural stability (70). The depletion of cytoplasmic tRNAs (tRNA-ArgCCG, LeuAAG, Lys CUU etc.) 
as well as impaired tRNA charging (tRNA-SerCGA/UGA) contribute to the synthetic lethality in trm1-
/sla1- (S. pombe La; Sla1) cells (refer to Chapter III). An extension to these findings, Arimbasseri 
et al. have reported a list of 27 G26-containing S. pombe cytoplasmic tRNAs (from the total of 36) 
that are differentially modified by Trm1 (under wildtype conditions), demonstrating the tRNA 
substrate specificity of the enzyme (71). While some tRNAs are highly modified by Trm1 such as 
tRNA-ArgUCG, ArgCCG, SerUGA and SerCGA others with a G26 are poorly modified (GlyGCC, GlnUUG , 
PheGAA etc.) and are classified as non-Trm1 targets (71). Additionally, S. pombe suppressor tRNA-
SerUCA has been identified as a Trm1-specific substrate with a requirement for m""G26 for 
functionality in a tRNA mediated suppression (TMS) assay. Antisuppression of a nonsense codon 
in the ade6-704 allele has been observed in the presence of a Trm1-hypomodified suppressor 
tRNA-SerUCA (71).   
Impaired tRNA processing and defects in PTM enzymes has previously been linked to 
human diseases, particularly malfunctions of the mitochondrial organelle (145, 146). Expression 
of the mitochondrial genome (mtDNA) is facilitated through the highly-regulated communications 
between the nuclear and mitochondrial organelle. Over 100 nuclear encoded genes are expressed 
in the cytoplasm and imported to the mitochondria just to facilitate expression of mtDNA (100). 
These include ribosomal proteins, aminoacyl-tRNA synthetases and proteins involved in 
translation initiation, elongation and termination (100). The OXPHOS system is comprised of five 
multimeric complexes, in which most of the subunits of the OXPHOS complex are nuclear-
encoded and only a total of 7 subunits (in S. pombe and S. cerevisiae) are embedded in the mtDNA 
and expressed in the mitochondria (100, 145). Mitochondrial tRNAs, similar to cytosolic tRNAs 
rely on PTMs for their structural stability and functionality (101). Defects in the respiratory chain 
complex, insufficient energy production and lactic acidosis have been linked to mutations in 
TRMT5 (tRNA methyltransferase 5) and the resulting hypomodification of mt-tRNA-LeuCUN  at 
G37 (145). Additionally, decrease in mitochondrial protein translation and associated 
mitochondrial myopathy, encephalopathy and lactic acidosis have been connected to a mutated 
mt-tRNA-LeuUUR  (R being A or G) that results in hypomodification of its wobble uridine (147). 
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The list of defective tRNA processing enzymes and tRNA modifiers associated with mitochondrial 
diseases has been on a rise with other examples of impaired modifiers reported in mitochondrial-
related dysfunction including PUS1, TRMU and TRIT1 (145).  
Several recent insights have directed our attention towards identifying a novel role for 
Trm1p in global regulation of protein expression. Firstly, Trm1p modification is necessary for the 
native steady state levels of a select set of tRNAs while concomitantly supporting the wildtype 
charging state of other tRNAs (Chapter III). Secondly, tRNA-HydroSeq results indicate tRNA 
substrate specificity of Trm1p with significant variations in dimethylation efficiency detected 
depending on tRNA identity (71). Additionally, m""G26 modification efficiency by Trm1p is 
altered depending on growth conditions independent of Trm1p protein levels, indicating that the 
activity of the methyltransferase may be regulated post-translationally (71). Lastly, m""G26 is 
necessary for the functionality of S. pombe suppressor tRNA-SerUCA in TMS assay suggestive of 
Trm1p contributing to functional activity of its target tRNA substrates (71). Given the substrate 
specificity nature of Trm1, its capacity to support tRNA structural stability while maintaining 
native tRNA charging state as well as its role in stimulating suppressor tRNA-SerUCA activity in 
TMS assay, it is probable that alterations in Trm1p modification efficiency of G26 containing-
tRNAs may result in altered tRNA activity with subsequent changes in global expression patterns. 
To assess the capacity of Trm1 in fine-tuning tRNA activity upon modification, we have 
used a SILAC-based quantitative proteomics approach in trm1+ and trm1- strains of S. pombe. We 
have identified alterations in expression levels of a cohort of polypeptides that are specifically 
enriched in CTA codons, potentially associated with decrease in the decoding activity of 
hypomodified tRNA-LeuUAG as well as changes in expression levels of polypeptides linked to 
metabolic processes involved in mitochondrial function. Trm1 is a nuclear encoded tRNA modifier 
that resides both in the nuclear periphery and the mitochondrial organelle. Studies in S. cerevisiae 
have identified two isoforms of Trm1; Trm1p-I and Trm1p-II (72, 107). The expression of either 
isoform is transcriptionally regulated with two possible initiator AUGs that are connected via a 
mitochondrial targeting sequence (72, 107). Similar to S. cerevisiae, expression of S. pombe Trm1 
is predictably transcriptionally regulated with the potential for the expression of two isoforms 
depending on two initiator AUGs (M1 and M24) which are separated by a MTS. Our SILAC data 
are indicative of Trm1-mediated alterations in protein expression with significant upregulation of 
eIF3d (eukaryotic translation initiation factor 3d; Moe1 in S. pombe) reported. We have confirmed 
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robust modification of specific G26 containing mt-tRNAs by Trm1p and demonstrate that 
overexpression of Trm1p-I isoform (M1 AUG; mitochondrial) but not Trm1p-II (M24 AUG; 
nuclear) results in impaired growth on both fermentable and non-fermentable media. Our data also 
indicates that trm1- cells with and without overexpression of mitochondrial targeted Trm1 do not 
impact expression of components of the OXPHOS complex including Cox1, 2, 3 (cytochrome c 
oxidase subunits 1, 2 and 3) and Atp6, 8, 9 (ATPase subunit 6, 8, 9) as well as RpS3 (mito-
ribosomal protein of the small ribosomal subunit). Our SILAC data, the growth defective 
phenotype associated specifically with M1-Trm1p and the northern blot analyses indicate a novel 
role for Trm1p in regulating mitochondrial physiology. 
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MATERIAL AND METHODS 
 
PHA26 northern analyses 
	
S. pombe cells were cultured in EMM (Edinburgh minimal media) supplemented with 225mg/L of 
adenine, leucine, histidine and lysine, grown at 30oC to an OD600 (optical density measured at 
600nm) of ~ 0.4 - 0.6 and harvested. Total RNA was extracted from cells and northern analysis 
was performed following methods as described (22). DNA probes were made for tRNAs of interest 
by 5’end labeling of oligonucleotides using T4 polynucleotide kinase and 32P-γ-ATP. DNA probes 
used in northern analysis for detection of modification at G26 for the PHA26 (positive 
hybridization in the absence of G26 modification) assay were made complementary to the D-
stem/loop and anticodon stem. For an internal control, probes were designed to specifically 
hybridize to the TψC-loop of each tRNA. U5 snRNA was also used as a loading control. List of 
probe sequences are provided in Supplementary Table 1.  
 
Analysis of Aminoacyl-tRNA charging  
	
Cells were grown in the same manner for PHA26 northern analysis, but were harvested under 
acidic conditions with washing of the cells with 0.3M sodium acetate and 1mM EDTA at pH 5.0. 
Total RNA extraction was performed under acidic condition using Trizol reagent (Invitrogen). For 
a control sample representing migration of a deacylated sample, half of the wt + pREP4 and trm1-
(+) pREP4 total RNA was deacylated with 0.2M Tris pH 9.0 for 2 hours at 37°C, ethanol 
precipitated and stored in 10mM sodium acetate pH 5.0. For better separation of charged and 
uncharged species of tRNAs, periodate oxidation/b-elimination method was used for preparation 
of total RNA as described (119). Both the wt (+) pREP4 and trm1- (+) pREP4 deacylated total 
RNA and the untreated total RNA samples were incubated with 5mM NaIO4, 50mM NaOAc pH 
5.0, 60 min at 37°C. The periodate oxidation reaction was stopped with the addition of 50mM 
glucose and incubation at 0°C for 90 min followed by ethanol precipitation. Total RNA samples 
were resuspended in 1ml of 1M lysine pH 8.0 and incubated for 60 min at 45°C. Lastly, all samples 
were deacylated with 500μl of 0.4M Tris pH 9.0 at 37°C for 30 min and extracted with phenol 
chloroform and ethanol precipitated. Total RNA was separated on 8% polyacrylamide denaturing 
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DNA sequencing gel and the relevant region of the gel was isolated and transferred onto a 
GeneScreen Plus transfer membrane (PerkinElmer) using the iBlot Gel Transfer system 
(Invitrogen). DNA probes were prepared as stated above. Probes were made complementary to the 
TψC-loop of each tRNA. List of probe sequences are provided in Supplementary Table 1. 
 
SILAC labeling and whole cell lysate preparation 
	
S. pombe strain FY7455 (h+ leu1-32 ura4 his7 lys1) was purchased from NBRP-Yeast (National 
BioResource project). FY7455 is a lysine auxotroph used as the parent strain for generating a trm1- 
strain that is lys1- using yeast mating and tetrad dissection techniques as described (148). All 
strains used for SILAC experiments were lysine auxotrophs and grown in EMM supplemented 
with 225mg/L of adenine, leucine and histidine and 75mg/L of either normal lysine (Bioshop) or 
[13C6, 15N2] L-lysine (Cambridge Isotope Laboratories), grown at 30oC to an OD600 of ~ 0.6. To 
ensure efficient labeling of proteins with [13C6, 15N2] L-lysine, heavy labeled cells were harvested 
separately and washed with ice cold distilled water and lysed as described below. For all other test 
experiments, equal amount of heavy-labeled SILAC cells were mixed 1:1 with normal lysine 
grown cells and lysed. Cell pellets were resuspended in 100μl of lysis buffer (20mM HEPES pH 
7.6, 200mM KOAc, 1mM EDTA, 0.1mM PMSF and 1X Protease inhibitor cocktail) and 0.3g of 
acid-washed glass beads (Sigma-Aldrich) was added. Cells were homogenized using a bead beater 
for 1 minute at 4oC and subsequently centrifuged at 14,000 rpm for 10 minutes at 4oC to remove 
cell debris. The pellet was washed once more with 100μl of lysis buffer and centrifuged again at 
14,000 rpm for 10 minutes at 4oC. The lysates were pooled and centrifuged at 14,000 rpm for 30 
minutes at 4oC. Bradford assay was performed for quantification purposes and 15μg of lysate was 
isolated, lyophilized and sent for Trypsin digestion and mass spectrometric analysis (IRCM 
Proteomics Discovery Platform).  
 
Western blot analysis 
	
Lysine auxotrophic cells used for SILAC-LC-MS/MS analysis were also used for western blot 
assay. Cells were cultured in EMM supplemented with 225mg/L of adenine, leucine, histidine and 
lysine, grown at 30oC to an OD600 of ~ 0.4 - 0.6, harvested and lysed as described above. Lysates 
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were resolved on 12% SDS gel and transferred onto a nitrocellulose membrane (Life 
Technologies). The membrane was blocked for 1 hour at room temperature with TST (0.01M Tris 
pH 7.4, 0.15M NaCl, 0.075% Tween-20) containing 0.5% non-fat dry milk. This was followed by 
probing with 6xHis Monoclonal Antibody (6xHis mAb 1:10,000; Clontech) in TST + 0.5% non-
fat dry milk, for 1 hour at room temperature for detection of 6xHis tagged Trm1. Following 
washes, secondary anti-mouse IgG HRP-linked antibody (Cell Signaling) was prepared in the same 
buffer as above (1:5000) and incubated with the membrane for 1 hour at room temperature. The 
blot was washed twice for a period of 10 minutes with TST and once with TSM (0.1 M Tris pH 
9.0, 0.1M NaCl, 5mM MgCl2) for 5 minutes. The same buffers and conditions as above were used 
for subsequent probing of the blot with Moe1. The antibody was kindly shared with our lab by Dr. 
Eric Chang (Baylor College of Medicine). Moe1 primary anti-rabbit antibody was used at 
1:100,00000 dilution and detected using anti-rabbit IgG HRP-linked antibody (1:10,000; Cell 
Signaling). For loading control, anti-beta Actin antibody (Abcam) was prepared (4:10,000) in 
TBST (1X TBS +0.1% Tween-20) + 5% non-fat dry milk. All subsequent washes and preparation 
of secondary antibody, anti-mouse IgG HRP-linked antibody (1:5000) were done in TBST. 
 
In vivo labeling of mitochondrial translation products 
	
S. pombe cells were initially grown in EMM (-) ura + 2 % glucose at 30oC. The preculture was 
subsequently inoculated into fresh EMM (-) ura media containing 0.1% glucose and 2% galactose 
and grown at 30oC for ~ 6 generations to a final OD600 not exceeding 1 x 107 cells/ml. An equivalent 
of 1.5 OD (~2.5 x 107 cells) was transferred to a microtube and cells were pelleted by centrifugation 
at 12, 000g for 30s. Cell pellets were washed with 500μl of reaction buffer (40mM potassium 
phosphate pH 6, 2% galactose, 0.1% glucose) and centrifuged at 12, 000g for 30s. Pellets were 
resuspended in 500μl of reaction buffer containing 10mg/ml of cycloheximide and incubated for 
15 minutes. After incubation with cycloheximide, 5μl of [35S]-methionine was directly added to 
the cells, mixed thoroughly and incubated for 30 minutes.  The cell suspension was then pelleted 
by centrifugation at 10, 000g for 1 minute and the pellet was resuspended in 75μl of solubilization 
buffer (1.8M NaOH, 1M  b-mercaptoethanol, 0.01 phenyl-methyl sulfonyl fluoride (PMSF)) and 
mixed.  The solubilization buffer was then diluted with the addition of 500μl of H2O and all 
proteins were precipitated with the addition of 575μl of 50% TCA with incubation on ice for 5 
 97 
minutes. The precipitated proteins were spun down at 10, 000g for 5 minutes and the pellet was 
washed twice with 575μl of acetone and centrifuged as above. The precipitated proteins were 
resuspended in 25μl of gel sample buffer (2%SDS, 10% glycerol, 60mM Tris-HCl pH 6.8, 2.5% 
b-mercaptoethanol, 0.02% bromophenol blue) and separated on a 17.5% SDS gel and subsequently 
transferred to a nitrocellulose membrane (Life Technologies) using common wet Western blotting 
technique and exposed to a phosphor screen overnight. Protocol was adapted from (100) with some 
minor modifications stated above.  
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RESULTS 
 
SILAC proteomics identifies alterations in global protein expression associated with Trm1p-
tRNA methyltransferase 
	
Chemical modifications made to tRNA nucleosides are essential in regulating tRNA structure and 
function (62, 63, 114). Trm1p is a well characterized methyltransferase that selectively 
dimethylates Guanine at position 26 on many tRNAs (61, 62, 149). Dimethylation by Trm1p has 
been linked to stabilization of the hinge region at the junction of the anticodon and D-stem, 
contributing to the native steady-state abundance of specific tRNAs and their wildtype charging 
state (Chapter III) (73, 129). To date, Trm1 modification of G26 containing tRNAs has been 
studied with a direct focus on tRNA structural stability with less emphasis on the role of this 
methyltransferase in regulating tRNA activity in translation. However, recent evidence has alluded 
to m""G26 enhancing the functional activity of S. pombe suppressor tRNA-SerUCA in decoding a 
nonsense codon in the ade6-704 allele (71). Since Trm1p is a selective methyltransferase, 
modifying its preferred tRNA substrates with high efficiency and only at a single site (G26) (71), 
it is conceivable that Trm1p may be a candidate tRNA methyltransferase that specifically regulates 
tRNA activity in translation, altering protein expression levels by varying tRNA abundance, 
charging state and functionality in mRNA decoding. To characterize a potentially novel role for 
Trm1p in selective regulation of the activity of G26 containing tRNAs in protein biosynthesis, we 
have used a SILAC-based approach to assay changes in protein abundance in trm1- cells (relative 
to trm1+) in S. pombe. Alterations in protein abundance in trm1- cells is identified by comparison 
of the [13C6, 15N2] L-lysine labeled proteins (trm1-) to normal lysine containing proteins (trm1+). 
As a control and to ensure complete incorporation of heavy lysine, separate samples of the [13C6, 
15N2] L-lysine labeled proteins were assayed by LC-MS/MS indicating near complete 
incorporation of the heavy labeled lysine, validating the functionality of the assay. Our SILAC 
LC-MS/MS data has been quantified by comparison of the changes in abundance of proteins in 
the trm1- relative to trm1+ cells (abundance ratio, using two biological replicates) with an output 
of a cohort of proteins whose abundance is either upregulated or downregulated in trm1- cells 
(Supplemental Table 2). Using this cohort of proteins with variable expression levels under the  
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Figure 1. Trm1p-associated changes in global protein expression. (A) Codons of interest were 
counted in polypeptides identified from the SILAC proteomics data to determine which codons 
are more highly represented in polypeptides with varying expression in trm1- cells compared to 
trm1+ cells. Proteins generally downregulated in trm1- cells compared to trm1+ cells were more 
highly enriched in CTA codons. The reduction of protein expression as a function of CTA codon 
enrichment was determined using multiple regression. The significance of the parameter 
estimates (ie. multiple regression coefficients) was assessed using t-tests and their associated P-
values. Control codons corresponding to non-Trm1p tRNA substrates include: GGG, ATA, TAC 
(B) Linear regression for CTA codon counts in all proteins identified in the two trials of SILAC 
proteomics with LN (natural log of CTA codon count +1) codon counts on the x-axis and log2 of 
abundance ratio of trm1- to trm1+ cells on the y-axis. Some examples of proteins that were most 
downregulated and three of the most upregulated have been reported. (C) GO enrichment 
analysis of polypeptides upregulated in the trm1- cells demonstrate a link between 
overrepresentation of metabolic processes and absence of Trm1p.  
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trm1- background, we searched for enrichment of codons of interest (TCA, TCG, CTG, CTA, TTG 
and AAG), based on our previous findings of cytoplasmic tRNAs that most likely rely on Trm1p 
modification for structural stability and native charging state as well as using the list of cytoplasmic 
S. pombe tRNAs reported by Arimbasseri and colleagues as preferred Trm1p-tRNA substrates 
(Chapter III, (71)). As a control, we also searched for enrichment of codons (GGG, ATA and TAC) 
in proteins with variable expression levels in trm1- cells that correspond to tRNAs that are either 
non-Trm1p targets as reported (71) or lack G26 and cannot be modified by Trm1p (Figure 1A). 
Amongst the proteins that displayed variability in expression levels in trm1- cells and codons 
scanned in these polypeptides, we observed an overrepresentation of CTA codons supported by 
statistical significance (Figure 1A and B). This analysis has also been completed using the 
candidate and control codons and evaluating the enrichment of these codons in proteins with 
altered expression in trm1- cells, normalized to the total number of codons in the open reading 
frame (ORF) (Figure S1; CTA codon enrichment in this analysis may also be associated with 
reduced protein expression with the caveat of the P-value). As previously reported, tRNA PTMs 
enhance tRNA structural stability and influence the decoding capacity of tRNAs (62, 78). tRNA-
LeuUAG has previously been characterized as a Trm1p-tRNA target (71) and we have demonstrated 
that the absence of Trm1p modification results in the decrease in accumulation of mature tRNA-
LeuUAG levels (Chapter III). Therefore, it may be probable that hypomodified tRNA-LeuUAG is less 
efficiently capable of decoding transcripts enriched in CTA codons amounting to the alterations in 
the expression levels of CTA enriched proteins.  
 Although defects in tRNA-LeuUAG decoding activity can reason the changes observed in 
the expression of CTA enriched proteins, this alteration in protein expression detected in trm1- 
cells only accounts for ~ 5% of the variability, suggesting that other unanticipated factors may 
play a role in the observed alterations in the protein abundance. Gene Ontology (GO) enrichment 
analysis of the upregulated proteins in trm1- cells (Figure 1C) show an interesting enhancement in 
expression of proteins associated with metabolic processes particularly ones that correlate with 
mitochondrial activity (eg. carboxylic acid metabolic processes, small molecule metabolic 
processes). These findings were intriguing since Trm1p is a methyltransferase that has a dual 
targeting sequence and can potentially regulate both cellular and mitochondrial gene expression 
and physiology.   
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Expression of Moe1 altered as a function of Trm1p levels 
 
Stable isotope labeling of polypeptides in trm1- cells combined with LC-MS/MS identified  
changes in protein expression and metabolic processes that link to Trm1p abundance. In particular, 
GO analysis of these polypeptides identified a correlation between Trm1p and metabolic processes  
associated with mitochondrial physiology. Aside from the SILAC-LC-MS/MS results reported in 
Figure 1 (Supplemental Table 2), a subsequent trial showed substantial upregulation in expression 
of Moe1p (S. pombe homolog of eIF3d) in trm1- cells (Supplemental Table 3). Amidst all eIFs, 
the most complex and largest translation initiation factor is eIF3 which comprises of 11 subunits 
in S. pombe (150). eIF3 assists in the assembly of the 40S ribosome on the mRNA transcript and 
initiates the recruitment of other eIFs that facilitate translation initiation through AUG recognition 
and mRNA binding (150). Alterations in abundance of eIFs is a regulatory mechanism utilized by 
the cell to control the expression of specific mRNAs depending on cellular conditions, with 
variations in abundance of specific subunits of eIFs previously linked to human cancers (150). 
Moe1p and in its interacting partner Intp6 (eIF3e) are specifically responsible for the translation 
of mRNAs encoding components of the mitochondrial electron transport chain (ETC) (150). 
Metabolic homeostasis is under the control of eIF3 with cells deleted of Moe1 and Intp6 subject 
to respiratory defects, hypersensitivity to stress conditions and a metabolic switch to glycolysis 
with the concomitant strong reliance on glucose uptake (150). Given that our SILAC-LC-MS/MS 
data (Figure 1C) suggest a potential role for Trm1p-mediated function in mitochondrial 
physiology, with the upregulation of mitochondrial associated metabolic processes in trm1- cells 
as well as a subsequent, independent trial of SILAC-LC-MS/MS data showing significant increase 
in Moe1 levels in trm1- cells, we found interest in replicating this SILAC-LC-MS/MS data using 
an alternate method. We used western blot analysis to assess the changes in abundance of Moe1, 
conditional to the varying levels of Trm1 using the trm1+ and trm1- cells with the presence and 
absence of plasmid encoded Trm1 (pREP4 and pREP4-Trm1) (Figure 2A). While the western blot 
analysis did not clearly identify an upregulation of Moe1 in the trm1- cells relative to trm1+ cells, 
we demonstrate, that similar to the SILAC-LC-MS/MS data, a possible link between Moe1 
abundance and trm1 abundance may exist given that overexpression of Trm1 (in both trm1- and 
trm1+ cells) results in significant downregulation of Moe1 levels (Figure 2A).  To assess more 
comprehensively the connection between the abundance of Trm1 and expression of Moe1 we took  
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Figure 2. Moe1 expression regulated with Trm1 abundance. (A) Western blot analysis of lysates 
prepared from trm1+ and trm1- cells, probing for 6X-His tag for plasmid encoded Trm1, probing 
for Moe1, and b-actin as a loading control. Expression of Moe1 is variable with the abundance of 
Trm1. (B) The correlation between Moe1 expression and Trm1 abundance reconfirmed through 
partial repression of the nmt1 promoter with addition of 15μM thiamine.  
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advantage of the nmt1 promoter in pREP4 plasmid that is under the control of thiamine repressor.  
Partial repression of the nmt1 promotor in the presence of thiamine results in the decrease in 
expression levels of Trm1 and an increase in abundance of Moe1 compared to the unrepressed 
promoter and overexpression of Trm1 (Figure 2B). The SILAC-LC-MS/MS data and the western 
blot analysis, collaboratively suggest a Trm1-mediated mechanism regulating Moe1 abundance 
with potential for subsequent alterations in the translation of mRNAs that encode components of 
ETC and metabolic processes associated with mitochondrial function. 
	
Overexpression of M1-Trm1 results in growth impairment and sensitivity to non-
fermentable carbon source 
 
The in vivo SILAC-Mass spectrometric data combined with western blot analysis show an apparent 
link between Trm1 abundance and changes in metabolic processes linked to mitochondrial 
function. Intriguingly, during these experimentations we observed a growth defective phenotype 
that was detectable in both trm1+ and trm1-  cells overexpressing Trm1. Partial repression of nmt1 
promoter with addition of thiamine rescued the growth impairment (Figure 3B). Earlier studies in  
S. cerevisiae have characterized Trm1 as a PTM enzyme that shuttles between the nuclear 
periphery and the mitochondria using a N-terminal MTS (72, 107, 149). Similarly, S. pombe Trm1 
has two in-frame AUGs (M1 and M24) separated by a MTS (Figure 3A). While both isoforms of 
Trm1 have the capacity to travel to the mitochondria, M1-Trm1 is predicted to reside primarily in 
the mitochondria while M24-Trm1 is hypothesized to be much less efficiently imported into the 
mitochondria.  Given the proteomics and western blot data indicating a correlation between Trm1 
expression and alterations in metabolic processes and Moe1 levels, we anticipated that the growth 
impairment observed with overexpression of M1-Trm1 may be due to abnormalities in 
mitochondrial function. As a result, we generated a second construct of S. pombe Trm1, pREP4 
M24-Trm1 in which Trm1 in this construct is predicted to be less efficiently and minimally 
transported to the mitochondria to evaluate the role of both isoforms in this growth impairment. 
Interestingly, we noted a specific growth impairment associated with M1-Trm1 and not M24-Trm1 
in trm1-  cells, further validating the Trm1p-associated alterations in mitochondrial function 
(Figure 3C). Consistent with previous findings indicating a direct role of Moe1 in the synthesis of 
the ETC components, and the reliance of moe1- cells to glucose for growth, we next checked the  
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Figure 3. Overexpression of mitochondrial targeted Trm1 induces growth sensitivity in 
fermentable and non-fermentable media. (A) Schematic of the localization of the two isoforms of 
Trm1 (Trm1p-M1 and Trm1-M24) based on the two in-frame initiator methionine residues as well 
as the predicted site of the MTS. (B) Growth of trm1+ and trm1- cells with empty pREP4 or pREP4 
Trm1 on minimal media with and without thiamine was tested. Overexpression of Trm1p-M1 
results in growth impairment in both trm1+ and trm1- cells (left image). Partial repression of nmt1 
promoter with the addition of 15 μM thiamine rescues growth for both trm1+ and trm1-  cells with 
plasmid encoded Trm1 (right image). (C) Overexpression of Trm1p-M1 in trm1- cells impairs 
growth relative to trm1- and trm1- cells overexpressing Trm1p-M24 (left image). Partial repression 
of the pREP4 plasmid with 15 μM thiamine improves growth conditions for trm1- cells 
overexpressing Trm1p-M1 (right image). (D) Sensitivity to non-fermentable carbon source 
(glycerol) was tested for trm1+ cells with plasmid encoded Trm1p-M1 and Trm1p-M24 and empty 
plasmid as control. Cells were plated with 5-fold serial dilutions on minimal media containing 2% 
glycerol with 2% glucose or 2% glycerol with 0.5% glucose. Growth is more limiting in trm1+ 
cells with overexpression of M1-Trm1p (compared to M24-Trm1p or plasmid only) on plates 
where glycerol is the major carbon source.  
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growth sensitivity of trm1+ cells with and without overexpression of Trm1 (M1 and M24) on 
media with 2% glycerol as a non-fermentable carbon source supplemented with either 0.5% or 2% 
glucose. Growth of trm1+ cells with plasmid encoded M1-Trm1 relative to trm1+ cells with empty 
plasmid or M24-Trm1 was limiting, particularly when glycerol was the major carbon source for 
growth (Figure 3D). 
 
Trm1 catalyzes the synthesis of 𝐦𝟐𝟐G26 on nuclear and mitochondrial encoded tRNAs 
 
N2, N2-dimethylation of G26 of S. pombe cytoplasmic tRNAs has been reported through tRNA 
Hydro-Seq results (71). These findings demonstrated the tRNA-substrate specificity of Trm1p 
with certain G26-containing tRNAs more robustly modified than others. TMS assay with S. pombe 
suppressor tRNA-SerUCA demonstrated the importance of m""G26 in controlling tRNA functionality 
with antisuppression detected in trm1- cells (71). Trm1 is located in the nuclear periphery but can 
be imported into the mitochondria for G26 dimethylation of mt-tRNAs. Our SILAC data and the 
growth sensitivity of M1-Trm1 and not M24-Trm1 cells to glycerol (and in fermentable media) 
may be suggestive of alterations in mitochondrial function that is modulated through Trm1p 
modification of mt-tRNAs. To examine the modification status of G26 on mt-tRNAs, we used a 
northern blot probing method previously introduced by Arimbasseri and colleagues referred to as 
PHA26 assay (positive hybridization in the absence of G26 modification) (71). This method relies 
on the use of a probe that robustly anneals to the D-stem/loop and AC (anticodon) stem only in the 
absence of dimethylated G26. As an internal control, a probe that anneals to the TYC stem was 
used that would hybridize efficiently to the tRNA, irrespective of the modification status of G26. 
From all the S. pombe mt-tRNAs only 8 are G26-containing (ThrUGU, IleGUA, HisGUG, SerUGA, 
LeuUAG, PheGAA, TyrGUA and SerGCU) and could serve as potential tRNA substrates of Trm1p. 
Dimethylation of G26 on nuclear-encoded tRNAs by Trm1p is efficiently catalyzed in the presence 
of a consensus sequence preceding G26 in the D-stem such that G10 pairs with C25 and C11 pairs 
with G24. Additionally, the overall 3D structure of the tRNA is also an important determinant for 
Trm1p modification with tRNAs possessing 5nt in the variable loop characterized as preferred 
Trm1p-tRNA substrates (74). While these Trm1p-identity elements have been deduced for 
nuclear-encoded tRNAs, we wondered whether mitochondrial encoded G26-containing tRNAs 
possess these Trm1p-identity elements and are modified by mitochondrial targeted-Trm1p. 
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Strikingly, none of the G26-containing mt-tRNAs carry the GC rich consensus sequence in the D-
stem and in fact all of the G26-containing tRNAs carry at least one A: U base pair in the D-stem 
(Figure 4 B). Moreover, the length of the variable loop also differs amongst these tRNAs, therefore 
making it challenging in predicting which G26-containing mt-tRNAs may be targets of Trm1p 
based on the previously characterized identity rules for Trm1p modification. It is likely that mt-
tRNAs possess other identity elements for Trm1p modification that differ from those identified for 
nuclear-encoded tRNAs, possibly linked with the alternate Type 5 and Type 7 folds that they can 
take on. We have used the PHA26 assay to determine the modification status of eight G26-
containing mt-tRNAs. Our data indicates a set of mt-tRNAs that are modified by Trm1p under 
wildtype conditions and more substantially in trm1- cells with plasmid containing M1-Trm1 
(tRNA-ThrUGU, PheGAA, SerUGA and LeuUAG) and other tRNAs that are just as efficiently modified 
both under the wildtype condition as well as trm1- cells overexpressing M1-Trm1 (tRNA-HisGUG, 
IleGUA and TyrGUA) (Figure 4A). We also note that overexpression of M24-Trm1 (which can shuttle 
to mitochondria but less efficiently than M1-Trm1) does not increase G26 modification status of 
mt-tRNAs relative to wt or trm1- cells with plasmid encoded M1-Trm1, reconfirming the specific 
role of M1-Trm1 in dimethylation of G26-containing mt-tRNAs and not M24-Trm1 which is more 
prominently localized to the nucleus. As proof of the functionality of the PHA26 assay for correct 
detection of m""G26 in mt-tRNAs, we used two control nuclear-encoded tRNAs (tRNA-SerUGA N 
and PheGAA N) to examine (Figure 4A). Previous tRNA Hydro-Seq data have identified the robust 
G26 dimethylation of tRNA-SerUGA N, while tRNA-PheGAA N was reported as an unfavorable 
Trm1p-target (71). Our PHA26 assay report the same observation, validating the functionality of 
the PHA26 northern method.  
Interestingly, in our PHA26 northern assay we observed two tRNA species in trm1- cells 
as well as trm1- cells carrying plasmid encoded M24-Trm1 for tRNA-PheGAA. To ensure that the 
two species of tRNA-PheGAA detected are based on a conformational change and not associated 
with the cleavage of a portion of the tRNA in the absence of Trm1p modification, we designed 
specific probes that would anneal to the 5’ leader, 3’ CCA and acceptor, D-stem/loop region (1 to 
25) (Supplementary Figure 3) in addition to the two other probes used for the PHA26 northern blot 
assay (TYC stem and PHA26). In this manner, we confirmed that the two species of tRNA-PheGAA 
detected is likely due to the presence of two conformations of the tRNA in which one conformation  
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Figure 4. Trm1p selectively modifies G26-containing mt-tRNAs. (A)PHA26 northern blot assay 
demonstrates substrate specificity of Trm1p and m""G26 levels for eight mt-tRNAs in trm1- and 
trm1+ cells with M1-Trm1 and M24-Trm1 overexpression. Modification status of G26 also 
evaluated in trm1+ cells grown in YES supplemented with glycerol or 2% galactose and 0.1% 
glucose. Control nuclear encoded tRNAs also tested in PHA26 assay. U5snRNA was used as an 
unrelated RNA control. Modification index (Mod index) is calculated by quantitation of the 
TYC/PHA26 probe signal, normalized to trm1+ cells (wt + pREP4). Relative steady state 
abundance is calculated by normalization of the TYC probe signal for each tRNA to U5snRNA 
and wildtype tRNA abundance. (B) Identity elements for Trm1p-modification of nuclear-encoded 
tRNAs used to predict G26 modification status of mt-tRNAs tested in the PHA26 probing assay.  
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is more dominant upon Trm1p modification (Figure 4A: tRNA-PheGAA PHA26 blot lanes 1- 4, 
bottom band as modified and top band as unmodified tRNA-PheGAA). Similar observations were 
also made for other tRNAs in trm1- cells carrying plasmid encoded M24-Trm1 such as tRNA-
HisGUG, IleGUA, TyrGUA and SerGCU, again likely due to the presence of both Trm1p-hypomodified 
and m""G26 modified tRNA species that have altered mobility even in denaturing polyacrylamide 
gels due to tRNA conformational rearrangements associated with m""G26. In addition to 
identifying G26-containing mt-tRNAs that are Trm1p targets, we also noted changes in the relative 
abundance of tRNAs +/- m""G26. The relative abundance of tRNAs under trm1- cells with and 
without overexpression of M1-Trm1 or M24-Trm1 was evaluated using the TYC stem-probed 
blots, normalized to U5 snRNA and wild type tRNA abundance (Figure 4A; relative abundance). 
While some tRNAs showed decreased steady state abundance in trm1- cells relative to wild type 
conditions (tRNA-ThrUGU, IleGUA, TyrGUA, SerGCU), all tRNAs were more robustly abundant in trm1- 
cells overexpressing M1-Trm1.  
Given the growth impairment detected in trm1- and trm1+ cells with M1-Trm1 in the 
presence of glycerol, we tested for the modification status of the eight G26 containing mt-tRNAs 
under trm1+ cells in the presence of rich media (YES) supplemented with glycerol (YPG) as well 
as growth under rich media supplemented with 2% galactose and 0.1% glucose (galactose is used 
a carbon source that does not cause inhibitory effects on mitochondrial protein expression) (100). 
This assay was primarily utilized to check the modification status of G26 under a stress-related 
condition such as growth under a non-fermentable carbon source. From the mt-tRNAs assayed in 
the PHA26 northern blots, we did not observe significant alterations in m""G26  levels for trm1+ 
cells grown in YPG, or YES + galactose with the exception of tRNA-ThrUGU, LeuUAG and PheGAA  
that showed relatively higher m""G26 levels compared to trm1+ cells (wt +pREP4) (Figure 4 A; 
compare lanes 1 to 5 and 6). While we identified some alterations in m""G26 levels in cells grown 
under a non-fermentable carbon source, there are other conditions to be tested (eg. growth under 
oxidative stress) that may also cause variability in Trm1p modification efficiency.  
	
Trm1p-associated alterations in aminoacylation level of mt-tRNAs 
 
Dimethylation of G26 by Trm1p has been characterized as a crucial factor in supporting 
cytoplasmic tRNA structural stability particularly in the hinge region, the junction between the 
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Figure 5. S. pombe mt-tRNA sequence identity of the D-stem and AC stem influencing tRNA 
architecture and the m""G26 associated alterations in tRNA aminoacylation. (A) List of G26 
containing mt-tRNAs and identity elements surrounding G26 demonstrating the likelihood of these 
tRNAs conforming to the canonical Type 6 fold. (B) Periodate oxidation/b-elimination Northern 
blot analysis used to identify charging variations in G26-containing mt-tRNAs associated with 
Trm1p. 
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D-stem and anticodon stem (Chapter III) (73, 129). N2, N2-dimethylation of G26 results in non- 
Watson-Crick interactions between G26 and N44 (N = A, U or G) enforcing a six base-pair long 
anticodon stem, generating the Type 6 fold that is commonly found in cytosolic tRNAs (75). 
Conversely, mt-tRNAs have previously been characterized for their susceptibility in forming 
conformations distinct from the canonical Type 6 fold which has been associated with G26 Trm1p- 
hypomodification (75). In the absence of m""G26 and the corresponding steric hindrance 
introduced by the dimethyl groups, unmodified G26 is accessible to form Watson-Crick 
interactions with C11 in the D-stem. This results in an extended base-pairing interaction in the  
D-stem and shortening of the anticodon stem to 5 base pairs, characterized as the Type 5 fold (75). 
Alternatively, some mt-tRNAs can take on a Type 7 fold with 7 base-pair extended anticodon-
stem, given the opportunity for base-pairing interactions between N25 and N45, facilitating 
Watson-Crick pairing between an unmodified G26 and C44 (75). Since mt-tRNAs have high 
propensity in deviating from the Type 6 fold and have greater flexibility in taking on alternate 
conformations particularly in the absence of m""G26, we anticipated identifying a S. pombe G26 
containing mt-tRNA that carries the characteristic elements for taking on a Type 5 or Type 7 fold.  
Interestingly, all eight G26-containing mitochondrial encoded S. pombe tRNAs (ThrUGU, IleGUA, 
HisGUG, SerUGA, LeuUAG, PheGAA, TyrGUA and SerGCU) lack the identity elements for folding into the 
Type 5 or Type 7 associated mt-tRNA conformation (Figure 5A). Nonetheless, the PHA26 
northern blot analysis robustly illustrates the differential Trm1p affinity for G26 modification 
depending on mt-tRNA identity. We reasoned that this specificity may depict an unidentified role 
for m""G26 for those candidate tRNAs. To assess tRNA functionality, particularly tRNA activity 
in protein biosynthesis we examined the charging state of these mt-tRNAs in the presence and 
absence of M1 and M24 Trm1 under trm1+ and trm1- cells. Surprisingly, we did not observe any 
charging deficiency associated with a hypomodified G26 under the trm1-  background (except for 
tRNA-ThrUGU and tRNA-SerUGA) for any of the tRNAs, but noted an overall increase in charging 
state for tRNA-SerUGA  and SerGCU with overexpression of M1-Trm1 (Figure 5B). These results may 
be suggestive of a limiting supply of Trm1p for modification of certain G26 containing mt-tRNAs, 
with overexpression of Trm1p directing more efficient aminoacylation of specific tRNAs such as 
tRNA-SerUGA and tRNA-SerGCU. 
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Assaying changes in expression of mitochondrial encoded proteins associated with 
modification status of G26 in mt-tRNAs  
 
The semi-autonomous mitochondrial organelle, hosts the site of protein biosynthesis for several 
subunits of the OXPHOS respiratory complex (100). In addition to the nuclear encoded (> 100) 
genes that are destined to the mitochondria to facilitate mitochondrial translation, the mt-DNA 
also encodes several tRNAs and ribosomal RNA that function in mRNA decoding (100). PTM of 
mt-tRNAs has previously been demonstrated to play a crucial role in tRNA functionality with 
hypomodification resulting in mitochondrial dysfunction and respiratory defects (145). This has 
been directly demonstrated with hypomodification of mt-tRNA-LeuCUN  in cells bearing a mutated 
non-functional TRMT5 (145, 147). Hypomodification at G37 of mt-tRNA-LeuCUN has been 
associated with irregularities in mitochondrial translation corresponding to the inactive mt-tRNA-
LeuCUN  with subsequent mitochondrial related disorders (145). Since we have noted a change in 
expression of proteins related to metabolic processes linked to mitochondrial function in trm1- 
cells, a growth defective phenotype associated with M1-Trm1 and we have shown that mt-tRNAs 
are differentially modified by Trm1p, we reasoned for investigation of the role of Trm1p in 
regulating mitochondrial protein synthesis machinery. To assess mitochondrial translation 
products under trm1+ and trm1- cells with overexpression of M1-Trm1 and M24-Trm1, we have 
used an in vivo technique that incorporates [35S]-methionine into newly synthesized mitochondrial 
proteins, while inhibiting the cytoplasmic expression system by introducing cycloheximide (100). 
Using this technique, we checked the expression levels of components of the OXPHOS complex 
including Cox 1, 2, 3 and Atp 6, 8 and 9. Although, our PHA26 northern assay indicates differential 
modification efficiency of G26 containing mt-tRNAs, in combination with the growth phenotypes 
detected with overexpression of M1-Trm1 in trm1+ and trm1- cells being symptomatic of 
mitochondrial dysfunction, we did not identify any differential expression of the OXPHOS 
mitochondrial encoded subunits under the conditions tested (Figure 6). However, we did observe 
a decrease in cytoplasmic translation products ((-) cycloheximide; Figure 6 Lanes 5-8) in trm1- 
cells with plasmid encoded M1-Trm1 and M24-Trm1 suggestive of alterations in cytoplasmic 
protein biosynthesis associated with overexpression of Trm1p, in addition to the SILAC findings 
of changes in polypeptide abundance related to trm1- cells. 
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Figure 6. Examining mitochondrial translation products in S. pombe. Expression levels of newly 
synthesized mitochondrial proteins (Cox1p, Cox2p, Cox3p, Atp6, RpS3 and Atp8 and 9) under 
trm1+ and trm1- conditions overexpressing M1 and M24 Trm1 determined using 35-S methionine 
pulse-chase of mitochondrial translation products with inhibition of cytoplasmic translation with 
the addition of cycloheximide. As a control, cytoplasmic protein synthesis was also evaluated for 
the same strains with elimination of cycloheximide. 
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DISCUSSION 
	
The overabundance of chemical groups modifying tRNA nucleosides and their evolutionary 
conservation implicates PTMs with fine-tuning tRNA activity and supports the premise of these 
factors regulating protein expression (61–63, 114, 151). While modifications in the anticodon loop, 
or near this region have long been characterized as essential in the mRNA decoding capacity of 
tRNAs, PTMs on the body of tRNAs have been apportioned to supporting structural stability (61–
63). An example of the latter is Trm1p, a methyltransferase well recognized for its functionality in 
promoting native tRNA folding (70, 75, 129). N2, N2-dimethylation of G26 on cytoplasmic tRNAs 
has previously been linked to native steady state abundance of tRNAs, preservation of wildtype 
charging state (Chapter III) as well as enhancing the decoding activity of suppressor tRNA-SerUCA 
in TMS assay (71). Additionally, Trm1p contains both a nuclear and mitochondrial targeting 
sequence that allows for subcellular localization of the enzyme in both the nucleus and 
mitochondria, facilitating modification of both nuclear and mitochondrial encoded tRNAs (72, 
107, 149). This may be particularly important for mt-tRNAs as they have previously been 
characterized in forming alternate, non-canonical folds which are avoided in the presence of m""G26 (75).  
To gain greater insight into this multifaceted methyltransferase and possibly unravel novel 
roles for Trm1p-associated regulation of tRNA activity in mRNA decoding, we sought after 
potential changes in global protein expression associated with Trm1p. Stable isotope labeling of 
polypeptides in trm1- cells combined with LC-MS/MS analysis led to the identification of several 
proteins whose expression levels were altered in trm1- cells. We observed a pattern of CTA codon 
enrichment in the sequences of proteins that showed the most variation in expression levels in 
trm1- cells. While we have yet to validate the association of these data with defects in G26-
hypomodifed tRNA-LeuUAG decoding capacity, it is probable that misfolding of the anticodon 
stem, depletion of mature tRNA-LeuUAG levels or impaired tRNA aminoacylation in trm1- cells 
may play a significant role in these findings. This type of modification-based regulatory control 
on tRNA decoding activity has previously been reported for enzymes that modify the anticodon 
loop region (78), with minimal evidence of tRNA body modifiers playing a regulatory role in 
translation. This may be evidence for a novel mechanism in which Trm1p fine-tunes tRNA 
function in protein expression.  
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While downregulation of various polypeptides associated with Trm1p depletion may be 
reasoned as above, these data only account for approximately 5% of the variability detected in 
changes in protein expression. The GO analysis of the two trials of the SILAC-LC-MS/MS data 
as well an additional independent trial of SILAC-LC-MS/MS implicate a role for Trm1p in 
modulating mitochondrial function, either through an indirect mechanism by regulating Moe1 
levels which specifically translate mRNAs encoding components of the ETC chain and other 
metabolism-associated mRNAs, or through an independent unidentified mechanism. To gain 
confidence in the SILAC-LC-MS/MS data demonstrating upregulation of Moe1 in trm1- cells, we 
checked for changes in Moe1 abundance in trm1-  and trm1+ cells in the presence and absence of 
plasmid encoded Trm1 using western blot analysis (Figure 2). In line with the SILAC-proteomics 
data, we observed a correlation between Moe1 abundance and Trm1p levels, with overexpression 
of Trm1p resulting in downregulation of Moe1. The SILAC-proteomics data demonstrating 
changes in abundance of polypeptides associated with mitochondrial metabolic processes, in 
combination with western blot data suggest a Trm1p-function in alerting mitochondrial 
physiology.  
In search of a novel role for Trm1p in regulating tRNA activity, we identified an 
unexpected, reproducible, defective growth phenotype associated specifically with M1-Trm1 
overexpression in both trm1- and trm1+ cells. Repression of the nmt1 promoter of pREP4 with 
thiamine circumvented the growth impairment validating the impact of Trm1p abundance in this 
growth defect (Figure 3B and C). These findings were intriguing because Trm1p has dual catalytic 
activity. M1-Trm1 is more prominently targeted to the mitochondria compared to M24-Trm1 
(primarily found in the inner nuclear membrane). This growth impairment associated with M1-
Trm1 is suggestive of a specific Trm1p-mediated mitochondrial irregularity, possibly due to 
dysfunctions in components of ETC with the downregulation of Moe1 in the presence of 
upregulated M1-Trm1 levels.  These predictions justify further investigations.  
Since Trm1p has a dual targeting sequence and can catalyze m""G26 on both cytoplasmic 
and mt-tRNAs, and we noted a possible mitochondrial related abnormality with Trm1p levels, we 
searched for the presence of m""G26 on eight G26 containing mt-tRNAs in trm1- and trm1+ cells 
overexpressing M1-Trm1 and M24-Trm1. We identified the presence of m""G26 on several mt-
tRNAs in wildtype cells and further demonstrate that overexpression of M1-Trm1 results in 
enhancement of m""G26 modification on select mt-tRNAs (tRNA-ThrUGU, SerUGA, LeuUAG and 
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PheGAA) more than others. Given the robust detection of m""G26 for specific mt-tRNAs, we were 
interested in identifying possible changes in the aminoacylation levels of these Trm1p tRNA 
targets, should the m""G26 status of the tRNA impact the charging efficiency by tRNA aminoacyl 
synthetases. While obvious defects in charging levels were not identified for the majority of the 
G26-containing mt-tRNAs, we did note a decrease in the charging state of mt-tRNAs-ThrUGU and 
SerUGA in trm1- cells and conversely a robust increase in the charging state of mt-tRNAs-ThrUGU, 
SerUGA as well as SerGCU with overexpression of M1-Trm1. Given these differences in Trm1p 
affinity for mt-tRNA G26 modification we anticipated possible alterations in expression levels of 
mitochondrial encoded OXPHOS subunits, should m""G26 impact the decoding activity of these 
mt-tRNAs. Surprisingly, we did not find any changes in expression levels of the mitochondrial 
encoded OXPHOS subunits in trm1-  and trm1+ cells overexpressing M1-Trm1 and M24-Trm1. 
These findings are unexpected since overexpression of specifically M1-Trm1 results in a 
reproducible defective growth phenotype and we have identified specificity of M1-Trm1 for mt-
tRNA G26 modification as well as an increase in charged state of tRNA-SerUGA and tRNA-SerGCU 
under conditions where M1-Trm1 is more highly expressed. While changes in expression levels 
of the OXPHOS subunits were not observed under the condition tested, our findings suggest a 
malfunction in the mitochondria associated with elevated levels of M1-Trm1. 
In this work, we have attempted to identify a possibly novel role for the methyltransferase 
Trm1p in fine-tuning tRNA decoding activity in addition to the already well characterized role of 
this enzyme in enhancing tRNA structural stability. Unexpectedly, our data has alluded to a 
Trm1p-modulated potential alterations in mt-tRNA activity that may regulate mitochondrial 
function and fitness. This is not unprecedented, given previous reports of several human disorders 
linked to mutations in mt-tRNAs, tRNA processing enzymes and PTM enzymes. Defects in 
OXPHOS complex, inadequate energy production and lactic acidosis have been correlated with 
impaired mt-tRNA PTM enzymes (TRMT5, PUS1 and TRMU) (145–147). Although, the exact 
role of M1-Trm1 with respect to mt-tRNA functionality has not been directly elucidated here, our 
findings indicate an uncharacterized role for this methyltransferase in modulating mitochondrial 
physiology.   
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SUPPLEMNTARY DATA 
Table S1. Probes used for Northern blots 
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Table S2. List of upregulated and downregulated proteins identified in trm1- relative to trm1+ 
cells using SILAC proteomics (N=2) 
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Table S3. List of upregulated and downregulated proteins identified in trm1- relative to trm1+ 
cells using SILAC proteomics (independent trial, N=1) 
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Figure S1. Assessing alterations in protein abundance in trm1- cells associated with enrichment 
of candidate codons corresponding to Trm1p-tRNA targets. A) Multiple regression coefficients 
(parameter estimates) were used to determine whether various candidate codons can account for 
reduced protein expression. This analysis controls for ORF size by using the proportion of 
candidate codons in each ORF. While reduced protein expression can be associated with CTA 
codon enrichment (according to the parameter estimates value), these findings are not significant 
as demonstrated by the P-value. B) Abundance ratio of trm1- vs. trm1+ cells have been plotted 
against CTA codon proportions. Some examples of proteins upregulated and those 
downregulated have been reported. Control codons included in this analysis are: GGG, ATA, 
TAC which correspond to non-Trm1p tRNA substrates, as they are non-G26 containing tRNAs. 
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Figure S2. Western blot analysis used to evaluate the levels of Moe1, and endogenous Trm1. 
The abundance of Moe1 and endogenous level of Trm1 was assessed under trm1+ and trm1- 
cells with and without overexpression of M1 and M24-Trm1p. Beta-actin was used as the 
loading control.  
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Figure S3. Northern blots of mitochondrial encoded tRNA phenylalanine. In addition to the 
PHA26 and TYC probe used in Figure 4 to assess G26 modification status of the tRNA by 
Trm1p, other probes annealing to additional sites on the tRNA such as the 5’ leader, 1 to 25 
(anneals to the acceptor stem and D-stem loop) and 3’ CCA were used to investigate the two 
tRNA-PheGAA species detected under trm1- and trm1- (+) pREP4 M24 Trm1 cells.  
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CHAPTER V: Summary and Future Directions 
 
SUMMARY OF DISSERTATION 
	
RNA molecules are virtually essential in all cellular processes and their functionality is tightly 
regulated by their complex three-dimensional conformation (2, 3). All RNA species have 
significant propensity in developing alternate non-functional conformations. This structural 
promiscuity stems from the lack of chemical complexity in the building blocks of RNA giving rise 
to a multitude of stable non-native RNA conformations from a single primary sequence (2, 4). 
Interactions with RNA binding proteins and PTM of RNA nucleosides directs RNA molecules 
towards the formation of the native, biologically active conformation (2, 4, 7, 63). Proteins with 
RNA chaperone activity are predicted to resolve misfolded RNA conformations and promote an 
accelerated escape from kinetic folding traps through transient and weak electrostatic interactions 
(1-7). The mechanistic insights of RNA chaperone activity and target discrimination has remained 
largely ambiguous because of the overlapping function and the non-specific nature of RNA 
chaperones and challenges in identifying a physiologically relevant RNA target that an RNA 
chaperone of interest assays in vivo.  
La proteins are RNA chaperones that associate with coding and noncoding RNAs with pre-
tRNAs being their best characterized substrates (20). In this work, we have attempted to compare 
the affinity of the RNA chaperone La in targeting a misfolded pre-tRNA relative to its folded 
counterpart. N2, N2-dimethylation of G26 containing tRNAs by the methyltransferase Trm1p has 
been predicted to function redundantly with La in tRNA structural stability in S. cerevisiae (70). 
As in S. cerevisiae, we have demonstrated that the deletion of S. pombe La in combination with 
Trm1p results in synthetic lethality at elevated temperatures.  The lethality can be rescued with 
overexpression of full-length La but not hLa or Sla1 mutants defective in RNA chaperone activity, 
recapitulating the notion that Trm1p and La redundantly stabilize pre-tRNA structure. Using lead 
acetate chemical probing and Northern blot analyses we identified tRNA-SerUGA as a candidate 
tRNA that undergoes structural changes in the absence of Trm1p modification and has a reduced 
charged state in sla1-/trm1- cells. In addition to tRNA-SerUGA, we have identified a set of G26 
containing tRNAs that have reduced steady-state abundance in trm1-, sla1- and sla1-/trm1- cells. 
Using this cohort of structurally vulnerable G26 containing pre-tRNAs, we have assessed the target 
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discrimination capacity of La as an RNA chaperone in differentiating between a misfolded Trm1p-
hypomodified pre-tRNA from its Trm1p-modified, folded state. Our in vivo and in vitro data 
indicate an indiscriminate binding affinity of La for both native and G26 hypomodified misfolded 
pre-tRNAs. These findings are consistent with previous data demonstrating that the primary 
binding determinant of La proteins is the UUU-3’OH trailer sequence found at the ends of all 
nascent polymerase III transcripts (20, 29, 47) . La binding defective and non-defective pre-tRNAs 
occurs indiscriminately as La engages both species initially via the UUU-3’OH trailer sequence, 
with the RNA chaperone activity function of La concurrently resolving misfolded structures. 
While other RNA chaperones (StpA and hnRNP A1) have previously shown preference towards 
single stranded regions of RNA that are predicted to be more prevalent in misfolded conformations 
(7), La proteins are targeted to their RNA substrates by identifying features on their targets that 
validates them as processing intermediates rather than discriminating based on their folded state. 
Although La target discrimination deviates from other RNA chaperones, La proteins function 
comparably to protein molecular chaperones calnexin and calreticulin (139). RNA chaperones are 
a heterogeneous class of RNA binding proteins with no similarity identified in fold, sequence or 
structure amongst this class of proteins with the single commonality that they resolve misfolded 
RNA structures (7). Consistent with this, it is challenging to generalize a universal mechanism in 
which all RNA chaperones utilize to target misfolded RNA substrates. In this work, we have 
demonstrated that the RNA chaperone La specifically targets pre-mature poly (U) containing RNA 
substrates and subsequently utilizes this window of opportunity to enforce correct RNA folding 
using its non-specific RNA chaperone activity function. In this time frame, RNA molecules 
concurrently acquire PTMs on their nucleosides further supporting their native structural 
conformation. Our data has shed some clarity to the previously predicted mechanism of target 
discrimination by RNA chaperones. 
Post-transcriptional modification of tRNAs is universal, signifying their essential role in 
tRNA functionality. Modifications on the body of tRNAs has been associated with structural 
stability, while modifications made to the anticodon loop regulate translation fidelity and rate (62, 
63, 114). Trm1p modification of G26-containing tRNAs supports native tRNA folding and a 
normal charged state (Chapter III). Additionally m""G26  regulates suppressor tRNA-SerUCA 
activity in decoding a nonsense codon in the ade6-704 allele (71). To assess the capacity of a PTM 
enzyme distant from the anticodon loop in regulating tRNA decoding activity, we used a SILAC-
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based quantitative proteomics approach to investigate changes in protein abundance in trm1- cells 
relative to trm1+ cells in S. pombe. Our data suggests possible changes in tRNA-LeuUAG decoding 
activity, likely associated with Trm1p-hypomodification of the tRNA in trm1- cells that results in 
alterations in expression levels of a set of polypeptides whose sequences are enriched with CTA 
codons. We have also noted alterations in abundance of metabolic processes, associated with 
mitochondrial physiology in trm1- cells suggestive of a Trm1p-mediated mitochondrial functional 
regulation. Consistent with this, we have observed a specific growth defective phenotype 
associated with overexpression of mitochondrial targeted Trm1p in both trm1- and trm1+ cells. 
Additionally, we have identified the G26 modification status of eight G26 containing mt-tRNAs 
and demonstrate the substrate specificity of Trm1p towards these tRNAs given the variability 
detected in the m""G26 levels based on tRNA identity. While we did not observe defects in 
charging state of G26-containing mt-tRNAs, we did note that Trm1p levels under trm1+ 
conditions may be limiting for certain tRNAs (tRNA-SerUGA and tRNA-SerGCU) and overexpression 
of M1-Trm1p may enhance the charging state of these mt-tRNAs. Since defects in PTM of mt-
tRNAs has previously been linked to mitochondrial dysfunction (145, 147), we examined the 
expression levels of mitochondrial translation products, particularly the mitochondrial encoded 
OXPHOS subunits under trm1- and trm1+ cells (with and without M1 and M24-Trm1 
overexpression) and report no clear changes in the expression levels of these subunits. Although, 
the exact role of Trm1p modulating mitochondrial fitness has not been directly revealed, we have 
reason to be believe that there exists an unidentified mechanism in which Trm1p alters mt-tRNA 
activity, regulating mitochondrial physiology. 
 
	
FUTURE DIRECTIONS AND CONCLUSIONS 
	
Cellular survival and gene expression is vigorously controlled at various stages, with the universal 
nucleoside modification of tRNAs playing a crucial role in this process. It is consensually agreed 
upon that PTM of tRNA nucleosides in the anticodon loop regulate protein biosynthesis by 
stabilizing codon-anticodon interactions, minimizing frame-shift mutations, increasing codon-bias 
or alternatively weakening the codon-anticodon interaction to allow near-cognate codon decoding 
(61–63, 151). In addition to the anticodon nucleoside modifications that regulate gene expression 
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directly, PTMs made to the tRNA body enhance structural stability and regulate tRNA 
functionality. In this work, we have demonstrated that N2, N2-dimethylation of G26 supports the 
structural stability and the native charged state of a subset of cytoplasmic tRNAs. Although distant 
from the anticodon loop, m""G26  has also been linked to regulating decoding activity of suppressor 
tRNA-SerUCA (71). We have attempted to examine the role of m""G26 in tRNA functionality in 
protein biosynthesis more globally by assessing alterations in protein abundance that are related to 
Trm1p levels using SILAC-LC-MS/MS analysis.  Our preliminary data indicate a correlation 
between the alteration in expression levels of a subset of polypeptides in trm1- cells and the 
enrichment of CTA codons in these transcripts. This is likely a reflection of the inefficient 
translation of these codons by the G26 hypomodified tRNA-LeuUAG. This pattern of variation in 
protein expression levels associated with tRNA hypomodification has previously been reported 
with Trm9 in which transcripts enriched with AGA and GAA codons were downregulated as a 
result of Trm9-hypomodified tRNA-ArgUCU and GluUUC (78).  Our data, consistent with previous 
work with other tRNA PTM enzymes demonstrates the role of tRNA PTMs in regulating protein 
biosynthesis. While tRNA-LeuUAG has previously been identified as a Trm1p target (71), and there 
is evidence of this tRNA showing reduced steady-state abundance in trm1- cells (Chapter III), there 
is still significant gaps in knowledge for the reasoning behind the necessity of m""G26 in the 
efficient decoding capacity of tRNA-LeuUAG. In addition to depletion of mature tRNA-LeuUAG 
levels in trm1- cells (possibly due to misfolding and subsequent degradation) it is probable that 
any alterations in tRNA-LeuUAG structural conformation due to the absence of m""G26 in trm1-  
cells may also impact the charging state of this tRNA, resulting in variable expression levels of 
proteins enriched with CTA codons. Moreover, examining the charging state of tRNA-LeuUAG, as 
well as using chemical probing assays to evaluate the structural conformation of this tRNA +/- m""G26 may give reasoning for the changes in expression levels of CTA enriched proteins in trm1- 
cells.  
tRNA processing enzymes and chemical modification of tRNA nucleosides has not only 
been implicated as crucial regulatory factors in nuclear gene expression but has also been 
associated with maintenance of mitochondrial biology (146). Mitochondrial tRNA mutations, 
tRNA-hypomodification and alterations in tRNA folding and abundance have all been linked to 
two well-recognized mitochondrial-associated diseases; mitochondrial encephalomyopathy, lactic 
acidosis, and stroke-like episodes (MELAS) and myoclonic epilepsy with ragged red fibers 
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(MERRF) (146). Alterations in mt-tRNA functionality results in malfunctions in the mitochondria, 
largely due to a general decrease in mitochondrial protein synthesis of the OXPHOS complex 
(145–147). S. pombe Trm1 (similar to S. cerevisiae Trm1) is predictably, transcriptionally 
regulated with two in-frame AUG codons, resulting in the formation of two isoforms of Trm1p; a 
mitochondrial and a nuclear localized enzyme. While presumably both isoforms are present under 
normal conditions, there is little known regarding the abundance and the catalytic activity of each 
isoform. In this work, we have observed a growth defective phenotype that is specifically 
associated with the overexpression of mitochondrial-targeted Trm1 (M1-Trm1, not M24-Trm1) 
suggestive of a specific, unidentified role for this methyltransferase in modulating mitochondrial 
fitness. Although, our current findings lack clarity in the exact functionality of this 
methyltransferase in mitochondrial physiology, experimentation in identifying cellular stress cues 
that regulate transcriptional start site of Trm1p will be informative. Additionally, SILAC-LC-
MS/MS analysis of trm1- cells overexpressing M1-Trm1 and M24-Trm1 may give more 
comprehensive insights into the proteins that are upregulated or downregulated uniquely in trm1- 
cells overexpressing M1-Trm1 that may be causing the growth impairment.  
Since mt-tRNA modification and folding status has previously been linked to 
mitochondrial related disorders due to downregulation or defects in the OXPHOS complex (145–
147), we reasoned that the growth impairment detected with overexpression of M1-Trm1 may be 
due to alterations in expression levels of the OXPHOS complex. Our in vivo labeling of 
mitochondrial translation products demonstrated a lack of variation in the abundance of the 
mitochondrial-encoded OXPHOS subunits +/- M1-Trm1. Although, we have shown minimal 
alterations in the abundance of these proteins under the strains tested, we are unaware of their 
functional, enzymatic activity in the growth defective, plasmid encoded M1-Trm1 strain. PTM of 
tRNAs is used as a regulatory mechanism by the cell to control tRNA activity in protein translation, 
with hypomodification potentially decreasing tRNA activity, and modification or 
hypermodification, upregulating the activity of tRNAs in protein translation. It may be probable 
that the overexpression of M1-Trm1 results in m""G26 modification of a mt-tRNA that is 
considered a non-Trm1p target under wildtype conditions. This unusual modification status on the 
tRNA with overexpression of M1-Trm1 may result in misrecognition of the tRNA by a non-
cognate tRNA aminoacyl synthetase. Error in tRNA aminoacylation has previously been linked to 
decrease in translation fidelity and synthesis of mutant proteins (152). While we did not observe 
 129 
alterations in the abundance of mitochondrial-encoded OXPHOS subunits, it is plausible that cells 
overexpressing M1-Trm1 possess tRNAs that are misacylated, or functionally more active 
compared to wildtype conditions, causing their misuse in mitochondrial translation, producing 
mutant, inactive OXPHOS subunits. It would be informative to check the correct aminoacylation 
of mt-tRNAs under trm1- and trm1+ cells with plasmid encoded M1-Trm1 compared to trm1+ 
cells. Additionally, assessing mitochondrial fitness by evaluating oxygen consumption, ATP levels 
and activity of the OXPHOS enzymes (153) in trm1- and trm1+ cells with plasmid encoded M1-
Trm1 may give insight into the growth defective phenotype observed with these cells.   
 Our work has alluded to a novel role for Trm1p modification of both cytoplasmic and 
mitochondrial encoded tRNAs. While it was previously assumed that modifications made to the 
tRNA body play an ancillary role in tRNA functionality, our data demonstrates an unexpected role 
of m""G26, distant from the anticodon loop in modulating nuclear and mitochondrial-encoded 
tRNA activity in translation, as well as potentially serving as a communicator link between the 
nuclear and mitochondrial genome. 
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